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Aims:   
Binge eating disorders have a substantial impact on the lives of those affected, both 
psychologically and physically.  The trend towards using a transdiagnostic model to 
understand binge eating disorders highlights the importance of understanding specific 
characteristics associated with binge eating rather than relying on diagnostic groupings to 
inform treatment.  The aims of the current study were to examine neuropsychological 
functioning and ghrelin secretion patterns in women with binge eating to contribute to 
understanding factors that may be involved in the development and maintenance of binge 
eating.   
Method:   
Participants were 112 women with transdiagnostic binge eating using DSM-IV- criteria, 
who were recruited for the Binge Eating Psychotherapy Study (BEP), and 50 healthy 
control women.  All participants completed the CANTABeclipse neuropsychological 
battery, the National Adult Reading Test-Revised and the Trail Making Test.  A biological 
assessment of the neurohormone ghrelin, (total ghrelin and C-ghrelin), insulin and glucose 
after an overnight fast and then following an oral glucose challenge test was completed on 
51 of the women with binge eating disorders and 46 of the heathy control women.   
Results:  
Key findings were: 
 No significant impairments were found in neuropsychological functioning in the 




memory, and set-shifting in women with binge eating compared with women who 
do not binge eat. 
 Women with binge eating disorder performed more poorly on a test of verbal recall 
compared to women with bulimia nervosa and women who do not binge eat. 
 Neuropsychological functioning was not associated with higher rates of eating 
disorder severity, depression, anxiety or impulsivity in women with binge eating. 
 Total ghrelin secretion is blunted in women with binge eating compared with 
women who do not binge eat. 
 Some aspects of eating disorder pathology including frequency of binges, 
frequency of vomiting, extent of exercise, perfectionism and drive for thinness 
were associated with total ghrelin levels.  
 Ghrelin levels were not associated with neuropsychological functioning in women 
with binge eating. 
Conclusion:   
Results of the current study suggest that neuropsychological functioning is not 
significantly impaired in women with binge eating, and if relative impairments are present 
they are unlikely to have a major impact on overall functioning.  However, it is possible 
that the specific neuropsychological tests used may have been of insufficient difficulty to 
demonstrate differences in this population.   
Significant differences in ghrelin secretion were found in women with binge eating 
suggesting that this may be a useful area to study further in order to understand binge 
eating.  Further research in this area is warranted, with a particular focus on exploring 
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1.1 Thesis Structure 
This thesis is in four parts.  Part A describes the role of the author in the current study, 
describes the characteristics of binge eating and ghrelin secretion in order to present the 
rationale for the study and state the research questions to be addressed in this thesis. Part B 
reviews existing research on neuropsychological functioning in binge eating, describes the 
methodology used to investigate this and reports the results from neuropsychological 
testing in the current study.  Part C reviews existing research on ghrelin, describes the 
methodology and reports the results regarding ghrelin from the current study.  Part D 
brings these two topics together and explores the relationship between neuropsychological 
function and ghrelin in women with binge eating. 
1.2 Role of the author 
My role as the author of this thesis and as a therapist in the Binge Eating Psychotherapy 
Study is described below.  As a treating clinician on the research trial, I was involved of all 
aspects of delivering the three protocol therapies under investigation, as well as conducting 
research diagnostic and neuropsychological assessments.) 
As one of four therapists working on this study I carried out initial clinical interviews with 
potential participants to establish eligibility for the study.  Once eligibility was established 
I was involved in the consenting process, and administered the formal assessments 




neuropsychological assessments. As a team member, I was involved in consensus 
discussions on diagnostic issues and global assessment of functioning ratings.  
I devised the research questions investigated in this thesis, carried out the literature 
reviews, selected the variables to be used to examine these questions, and was responsible 
for data cleaning and all statistical analysis and interpretation.   
1.3 Overview of Binge Eating 
A binge is widely considered to be the ingestion of a large amount of food over a discrete 
time period with an accompanying sense of loss of control over the eating (Wolfe et al., 
2009). Bingeing tends to be preceded by negative emotion and is often followed by a sense 
of shame and guilt.  Regular bingeing is the primary symptom of bulimia nervosa and 
binge eating disorder (American Psychiatric Association, 2013).  
Bingeing was recorded in early writings about female saints in the 14th to 18th centuries 
(Russell, 1997a) in the context of food restriction followed by over eating.  Diagnostic 
criteria for Bulimia nervosa were not published until 1979 (Russell, 1979b), although there 
were descriptions of patients being admitted to hospital in the 1930’s with over-eating, 
vomiting and weight concerns whom today would likely be diagnosed with bulimia 
nervosa.  Binge Eating Disorder was not formally recognised as a separate disorder until 
DSM-5 (see section 1.4 for further discussion of diagnostic issues). 
The leading theoretical model of binge eating is the Cognitive Behavioural Theory as 
described in Fairburn, Cooper & Shafran, (2003).  This model proposes that eating 
disorders are both developed and maintained by a dysfunctional belief system which is 
biased towards negative evaluation of the self with respect to eating habits, weight and 




behaviours.  Risk factors for developing bulimia include genetic factors and early 
developmental experiences with ongoing research into the interactions between genes and  
environmental factors (see Striegel-Moore, 2007 for a discussion on the research regarding 
risk factors in eating disorders). 
The lifetime prevalence of bingeing disorders in the general population has been estimated 
as being between two and three percent (van Hoeken, Seidell, & Hoek, 2003).  The World 
Health Organisation Mental Health survey of 24 000 people across 14 upper to high 
income countries, including New Zealand, found a lifetime prevalence of 1.0% for bulimia 
nervosa and 1.9% binge eating disorder (Kessler et al., 2013) with the rates for New 
Zealand alone  as 1.3% for bulimia nervosa and 1.9% for binge eating disorder.   Women 
were 3.6 times more likely to have a bingeing disorder than men.  The median age of onset 
for bingeing disorders was found to be late teens to early 20s (Kessler et al., 2013). 
The impact of a bingeing disorder on an individual can be significant across psychological 
and physical domains.  Bingeing disorders have a high rate of psychiatric comorbidities 
compared to the general population.  Rates of lifetime prevalence of over 70% for any 
Axis-I disorder have been reported for both bulimia nervosa  (O'Brien & Vincent, 2003) 
and binge eating disorder (Grilo, White, & Masheb, 2009; Kessler et al., 2013).  In a 
review of comorbidities in eating disorders, Pearlstein, (2002) reported depression rates in 
bulimia nervosa were two to three times that in the general population. Other frequently 
occurring comorbidities in bingeing disorders include anxiety and substance use disorders 
(Kessler et al., 2013; Grilo et al., 2009).    
Significant health problems in individuals with regular binge eating include 
musculoskeletal problems, chronic pain, diabetes and hypertension (Mitchell, Specker, & 




particularly diabetes and musculoskeletal problems are likely to be related to, or 
exacerbated by high body weight.   In bulimia nervosa there may be additional physical 
complications related to regular purging including gastrointestinal complications, 
degradation of dental enamel, gum disease, enlarged salivary glands, and damage to the 
oesophagus (Mehler, 2011). 
Mortality rates have been reported as nearly twice that of non-eating disordered individuals 
(Crow et al., 2009).   In one of the largest studies to date,  Crow et al., (2009) found that 
mortality from all causes was very similar between bulimia nervosa (3.9%)  and “other 
eating disorders” (5.2%) which is a catch-all category and includes binge eating disorder.   
These rates were very similar to that in anorexia nervosa (4%) which is usually considered 
to have higher mortality rates compared with the general population and other psychiatric 
populations (Sullivan, 1995) .  Standardised mortality rates due to suicide were 6.5 times 
greater in bulimia nervosa and 3.9 times greater in “other eating disorders” than the 
general population and comparable to that found in anorexia nervosa (Crow et al., 2009).   
Although the lifetime prevalence of bingeing disorders in the general population is fairly 
low, the impact on the lives of those affected, both psychologically and physically is 
significant and therefore this is an important area for further research. 
1.4 The Issue of Diagnostic Classification and a Transdiagnostic 
Approach 
Binge eating disorders are most frequently diagnosed using criteria defined in various 
editions of the Diagnostic and Statistical Manual of Psychiatric Disorders (DSM), although  
ICD codes are also sometimes used (World Health Organisation, 1992).  All editions of the 




nervosa; however, the frequency and duration of bingeing has varied among editions.  
Despite these variations, there seems to have been little change in prevalence of bulimia 
nervosa across various DSM editions (van Hoeken et al., 2003), although a recent study 
using criteria from the latest edition, DSM-5, suggests that prevalence rates may be higher 
using this edition, due to the reduction in required frequency of bingeing from twice 
weekly to weekly in bulimia nervosa (Stice, Marti, & Rohde, 2013).  Up until DSM-5, 
binge eating disorder was not recognised as a separate disorder and instead was captured 
under the catch-all category of Eating Disorder Not Otherwise Specified (EDNOS); 
however, DSM-IV contained diagnostic criteria for binge eating disorder under a category 
for further research. In DSM-5, binge eating disorder has become a separate disorder, with 
the required duration of bingeing has reducing from six to three months.   
Regardless of which criteria are used for diagnostic purposes there appears to be 
movement of individuals between different eating disorder categories over time. There is 
significant diagnostic cross over between bulimia nervosa and binge eating disorder (Stice 
et al., 2013) and it is not uncommon for individuals with anorexia nervosa to move to 
bulimia nervosa or EDNOS (Agras et al., 2000; Sullivan et al., 1998).  This apparent 
fluidity of movement between diagnostic criteria has led to the development of a 
transdiagnostic approach to eating disorders.  Fairburn, Cooper & Shafran (2003) suggest 
that eating disorders including anorexia, bulimia nervosa and those previously captured 
under EDNOS (including binge eating disorder) share distinct clinical features that are 
maintained by the common underlying psychopathological processes regardless of 
diagnostic label, and that these features are distinct from other psychiatric diagnoses.  This 
has led to the development of a transdiagnostic treatment approach where treatment is 




present rather than which DSM diagnostic category the individual is placed in by 
diagnostic criteria (Fairburn et al., 2015).   
Following on from this approach, the greater understanding of the factors that influence the 
development and/or maintenance of eating disorders the greater the opportunity to tailor 
treatment to suit individuals with bingeing disorders.  Neuropsychological functioning and 
neuroendocrine factors including the hormone ghrelin are two areas of research which are 
contributing to understanding bingeing disorders and could potentially inform treatment 
approaches.  
1.5 Neuropsychological Function in Binge Eating 
Neuropsychological impairments in eating disorders were first reported over 40 years ago 
but it was not until the 1980s that research studies looking into this area began to be 
published.  Since then there have been a small, yet steady number of publications 
investigating the neuropsychological aspects of eating disorders.   Initially the focus of this 
research was on anorexia nervosa and the impact of starvation on neuropsychological 
function, following on from the findings from the Minnesota Starvation Study (Keys et al.,  
1950). Over time there has been an increasing focus on neuropsychological function in 
bulimia nervosa and more recently binge eating disorder.   
Changes in neuropsychological function in bulimia nervosa have been reported in some 
studies but not others; however, methodological issues and small sample sizes have 
compromised some studies ( Lena, Fiocco, & Leyenaar, 2004; Tchanturia et al., 2005).   
Problems with set-shifting and central coherence have been the most commonly reported 
areas of impairment in bulimia nervosa (Alvarez-Moya et al., 2009; Degortes et al., 2015; 




functioning in binge eating disorder.  Those studies that found differences have reported 
changes mainly in decision-making ability and inhibitory control (Aloi,et al., 2015; Danner 
et al., 2012; Kelly et al., 2013).  At present it remains unclear as to whether specific 
neuropsychological changes are characteristic of binge eating and whether there are 
differences between bulimia nervosa and binge eating disorder. 
There are many factors known to impact on neuropsychological functioning including 
depression and anxiety, both of which are common in patients with binge eating (O'Brien 
& Vincent, 2003).  Although there have been a number of studies reporting levels of 
depression in binge eating, few have directly investigated the association between 
depression and neuropsychological functioning.   The effect of anxiety on 
neuropsychological functioning in binge eating is also unclear as even fewer studies have 
investigated this relationship.  More research is needed to understand the impact of 
depression and anxiety on neuropsychological functioning in binge eating. 
1.6 Ghrelin in Binge Eating 
Recently there has been interest in the neuroendocrine influences on eating 
psychopathology (Gottero et al., 2004).  Ghrelin, a neuropeptide discovered in 1999, has 
been of particular interest to eating disorder researchers because of the role of ghrelin in 
appetite and energy balance.   Ghrelin levels are increased by fasting and energy restriction 
and are decreased by food ingestion and over-eating.  This pattern has been found in 
individuals with eating disorders and obesity.  Studies have consistently found elevated 
ghrelin levels in individuals with anorexia nervosa (Monteleone et al., 2005; Soriano-
Guillen et al.,  2004;  Tanaka et al., 2003; Otto et al., 2004); however, the pattern of 




been expressed in the potential manipulation of ghrelin levels to treat individuals with 
eating disorders.   
Ghrelin is involved with multiple systems in the body including cardiovascular and 
reproductive, and could potentially play a role in neuropsychological function as there are 
ghrelin receptors in many areas of the brain including the hippocampus (Müller et al., 
2015).  The first study to explore the association between ghrelin and neuropsychological 
function was published by Diano et al. (2006).  Levels of circulating ghrelin were 
manipulated in rats and mice.  Animals with increased ghrelin levels performed better on 
tests of learning and memory performance, whereas, animals without ghrelin receptors 
performed poorly on these tests.  The authors proposed that ghrelin acted on areas of the 
brain, including the hypothalamus, by increasing synapse density resulting in improved 
function despite being in a starved state.  It was suggested that increased ghrelin levels 
may be an evolutionary advantage in times of food shortages.  The effect of ghrelin on 
cognitive functioning in humans has not been extensively studied to date.  Results of such 
studies may have implications for the use of ghrelin in future treatment of not just eating 
disorders but also obesity and dementia (Dickson et al., 2011).  However, questions remain 
about the impact of ghrelin levels on neuropsychological functioning. If cognitive function 
is negatively affected by low ghrelin levels, as in experimental conditions in rodents, this 
has implications for the treatments that may attempt to reduce circulating ghrelin levels to 
treat problems such as binge eating or obesity in humans.   
1.7 Current Treatment for Binge Eating 
Cognitive Behavioural Therapy (CBT) is the treatment of choice for bulimia nervosa and 
binge eating disorder (Hay et al., 2014; National Institute for Health and Clinical 




developed for use across the eating disorders and found to be effective in treating binge 
eating (Fairburn et al., 2015).  CBT-E incorporates the core foci and techniques used in 
standard CBT but emphasises an individualised formulation looking at associated 
difficulties seen in those with eating disorders.  It incorporates optional modules 
addressing more concerns including clinical perfectionism, low self-esteem and 
interpersonal relationship difficulties.  Other adaptations of CBT for binge eating which 
have included either a schema focus or appetite focus have also been found to be effective 
(McIntosh et al., 2016). Other therapies, including Interpersonal Therapy and 
psychodynamic therapies, have been investigated but a meta-analysis found them not to be 
different from CBT (Spielmans et al., 2013).   
Therapies incorporating cognitive rehabilitation have been developed to help those with 
eating disorders improve cognitive flexibility have also been explored as a treatment to 
help improve emotion regulation and social function in anorexia (Tchanturia et al., 2015), 
and bingeing disorders (Fagundo et al., 2013; Roberts, Tchanturia, & Treasure, 2013).   
The use of medication to treat binge eating has been an area of investigation over the past 
30 years (for a review see McElroy et al., 2012).  Studies investigating antidepressant 
medication in bulimia nervosa have demonstrated a decrease in the frequency of binge 
eating and purging in bulimia nervosa  (Bacaltchuk & Hay, 2003; Goldstein et al., 1999;   
Guerdjikova et al., 2012); however, few participants experienced remission and there is a 
high rate of relapse (Agras, 1997).  There is some evidence that a combination of 
medication and psychotherapy (CBT) could be beneficial for some (Agras, 1997).  Other 
areas of interest for potential development in medication include those designed to affect 




In summary, two to three percent of the population is likely to have a bingeing disorder at 
some point during their lifetime. The burden of a bingeing disorder can have a significant 
negative impact on psychological and physical health which is reflected in mortality rates 
similar to that of anorexia nervosa.  A transdiagnostic approach to understanding and 
treating bingeing disorders has been proposed.  A better understanding of 
neuropsychological function and neurohormone systems involved in appetite and energy 
regulation such as ghrelin, could make contributions to better understanding binge eating. 
1.8 Study Rationale 
The broad aim of the current study is to contribute to the existing understanding of the 
neuropsychological functioning and ghrelin secretion in women with binge eating and 
investigate the relationship between neuropsychological function and ghrelin secretion in 
this population. 
The data on neuropsychological functioning and ghrelin secretion in women with binge 
eating presented in the current study has been gathered as part of a large randomised 
controlled clinical trial, the Binge Eating Psychotherapy Study (McIntosh et al., 2016).  
The Binge Eating Psychotherapy Study was carried out in the Clinical Research Unit, 
Department of Psychological Medicine, University of Otago, Christchurch, in 
collaboration with the Canterbury District Health Board.  This randomised controlled 
clinical trial compared three cognitive-based therapies for treating women with 
transdiagnostic binge eating and examined a broad selection of factors which could inform 




1.9 Research Questions  
The specific aims are: 
1. To describe the pattern of neuropsychological function in women with bulimia 
nervosa and binge eating disorder and compare with those of women without binge 
eating. 
2. To investigate the effects of depression and anxiety on neuropsychological 
performance in women with binge eating.   
3. To describe patterns of ghrelin secretion and associated biological factors (insulin 
and glucose) in women with binge eating and compare with women who do not 
binge eat. 
4. To investigate the relationship between neuropsychological function and ghrelin 
secretion in women with binge eating. 
 
Hypotheses: 
1. Women with binge eating will have poorer neuropsychological performance 
compared to women who do not binge. 
2. Depression and anxiety will be associated with poorer neuropsychological 
performance in women with binge eating.  
3. The severity of eating disorder symptoms will be associated with poorer 




4. Ghrelin levels will be altered in women with binge eating compared to women who 
do not binge. 
5. Higher ghrelin levels will have a positive association on some aspects of 
neuropsychological functioning, particularly an improvement in memory, whereas 
lower ghrelin levels will be negatively associated with neuropsychological 





2. LITERATURE REVIEW: NEUROPSYCHOLOGICAL 
FUNCTIONING IN WOMEN WITH BINGEING 
DISORDERS 
2.1 Why Examine Neuropsychological Functioning? 
Neuropsychological testing is used as a tool to explore brain functioning in a non-direct 
way.  It relies on behavioural expression to inform understanding of internal brain 
processes (Lezak et al., 2012).  Lezak et al., (2012) describe the development of the field 
of neuropsychology from an interest by early philosophers, physicians and scientists in the 
connections between bodies and how they behaved in certain situations, through to the 
development of specialised neuropsychological tests to understand the effects of brain 
damage caused during world war two and the need to develop rehabilitation programmes 
for surviving soldiers.   
Neuropsychological functioning can be divided into several broad areas of functioning; 
receptive functions (how well the person perceives information), memory (how perceived 
information is retained), expressive functions (how can the person express a response to 
the information perceived), thinking (manipulating the information perceived), and 
executive functions (combining a number of neuropsychological functions to perform a 
complex task).  Neuropsychological tests have been developed to measure these domains; 
however, the tests generally require more than one domain to complete tasks making it 
difficult to design “pure tests”.   Neuropsychological testing involves examining these 




neuropsychological deficits correspond to specific areas of brain damage.  More recently, 
the development of imaging techniques, particularly functional imaging, may supersede 
neuropsychological testing but at present imaging remains expensive and is not widely 
used in people with eating disorders other than for research.   
Neuropsychological testing has traditionally been a deficit model, that is, results are 
compared to normative results from non-brain-injured people to look for deficits.  
Although initially the focus of neuropsychology was in understanding both normal 
functioning and how this is affected after brain injury, in recent times this has been taken 
further again and focus has been on using neuropsychology to better understand the impact 
of mental illnesses on neuropsychological functioning.  Keefe, (1995) describes 
neuropsychological testing in psychiatric populations as being a method of gathering 
information about an individual that can help inform prediction of the course of illness 
(i.e., poor performance implies impaired functioning which is associated with poorer 
prognosis), can be used as a tool for improving diagnostic classification, and may be 
helpful in treatment planning.  These factors have been part of the rationale behind the 
exploration of cognitive functioning and the development of cognitive remediation (Davies 
& Tchanturia, 2005; Tchanturia, Lounes, & Holttum, 2014) in anorexia nervosa and other 
eating disorders such as bulimia nervosa (Fagundo et al., 2013; Roberts, et al., 2013a). 
Lena et al. (2004) discuss a potential role of cognitive impairments in the development of 
eating disorders and propose several mechanisms by which neuropsychological factors 
may influence the development and maintenance of eating disorders including impairments 
in set-shifting, decision-making and inhibitory control.  Many women report the onset of 




neuropsychological impairments in adolescents with eating disorders (Lock et al., 2011), 
whereas other studies have not (Darcy et al., 2012; Lang et al., 2014).  
There is some evidence that specific neuropsychological traits which may increase 
vulnerability to the development of an eating disorder are heritable.  For example, a British 
epidemiological study (Kothari et al., 2013) compared the neuropsychological profile of 
children at age 8 years born to mothers with eating disorders with that of children born to 
mothers with no life-time history of eating disorders.  They found the children of women 
with bulimia nervosa, a high risk group for developing later eating disorders, showed 
poorer performance in tests of visuo-spatial functioning and a trend towards decreased 
behavioural inhibition.   
Alternatively, impairment in neuropsychological functioning may be as a result of the 
eating disorder, rather than a pre-existing condition.  If this is the case, neuropsychological 
function could be expected to improve after treatment of the eating disorder.  For example, 
Lauer et al. (1999) assessed 12 individuals with anorexia nervosa and 14 with bulimia 
nervosa who were undergoing standard treatment at an eating disorders clinic.  They found 
cognitive impairments were present in 11 of the individuals and these impairments 
improved after treatment. 
 Association between Brain Structure and Neuropsychological 
Functioning in Binge Eating 
There is some evidence to suggest brain structure is different in individuals with bingeing 
disorders that may impact on neuropsychological function.  Woolley et al. (2007) used 
MRI to examine the brains of individuals with neurodegenerative disease who exhibited 




orbitofrontal cortex than the left side.  They concluded that “ damage to a right orbito-
frontal-insular-striatal circuit is associated with overeating behaviour in humans and 
supports the hypothesis that these regions integrate internal satiety signals with 
environmental food cues to produce adaptive eating behaviour” (p1429).  However, not all 
studies report changes in brain structure in individuals with binge eating.  Joos et al. (2010) 
found no differences in grey matter volumes using MRI in 17 women with bulimia nervosa 
compared to healthy controls.  
Patterns in brain activity may also be affected, for example, differences in activity in the 
fronto-striatal learning system area of the brain using fMRI have been found between 
individuals with sub-clinical bulimia nervosa and matched controls (Celone et al., 2011).  
Changes in brain activity have been linked to specific areas of functioning that are 
implicated in bulimia nervosa. Lock et al. (2011) used fMRI to investigate brains of 
adolescents with binge/purge behaviours and found increased activation in the right 
dorsolateral prefrontal cortex which they interpreted as an indicator of inefficient or 
compensatory activation in this region which is involved in executive control.   
2.1 Neuropsychological Functioning in Women with Binge Eating 
Researchers investigating neuropsychological functioning in people with bulimia nervosa 
and binge eating disorder have covered a broad range of neuropsychological domains.  In 
the following review, results from these studies have been organised to broadly reflect the 
neuropsychological domain assumed to being tested.  Areas discussed are premorbid 
functioning, motor function, attention, inhibition, learning and memory and executive 












































































































































































Bulimia nervosa                
Alvarez-Moya et al. (2009)   O            
Batty et al. (1990)   O            
Boeka & Lokken (2006)               
Brand et al. (2007) O  O    O  O  O  O  
Bosanac et al. (2007)       O   O     
Brogan et al., 2010)               
Chan et al. (2014)               
Darcy et al. (2015)               
Darcy et al. (2012)  O O        O  O  
Degortes et al. (2015)    O O O  O       
Galimberti et al. (2012)        O   O    
Harrison et al. (2011)               
Kim at al. (2011) O    O          
Laessle et al. (1990)        O       
Liao et al. (2009)               
Lopez et al. (2009)               
McKay et al. (1986) O              
Murphy et al. (2004)   O  O O       O  
Pendleton Jones et al. (1991) O   O  O         
Roberts et al. (2010)                
Roberts et al. (2013b)               
Tchanturia et al. (2012)               
Tchanturia et al. (2004) O              
Van den Eynde et al. (2012)        O  O     
Weider et al. (2014) O  O            
Weider et al. (2015)   O            
Weider et al. (2016)               
Wu et al. (2013)          O     
Binge eating disorder               
Aloi et al. 2015)            O   
Danner et al. (2012)               
Davis et al. (2010)               
Kelly et al. (2013)   O        O    
Manasse et al. (2015)   O            
Mole et al. (2015)        O       
Svaldi et al. (2010)               
Wu et al. (2013)        O  O     




A summary of studies and the specific aspects of neurocognitive functioning investigated 
is reported in Table 2.1.  A fuller description of these studies is given in  Table 2.3.  Note 
that some tests have been used to investigate more than one domain. 
 
2.1.1 Intellectual functioning  
It is important to consider intellectual functioning (IQ) when comparing other 
neuropsychological domains among different groups in order to rule out the possibility that 
any differences in functioning found are due to differences in IQ rather than the 
neuropsychological domain itself that is being tested.   Ideally a full IQ assessment battery 
would be carried out but in the interest of time many studies have used shortened forms or 
reading tests to approximate pre-morbid IQ levels (see summary presented in Table 2.2).  
Intellectual functioning has been measured in two ways by studies reporting 
neuropsychological functioning in binge eating.  Some studies have used a measure of pre-
morbid IQ such as the Nation Adult Reading test (NART) or the Wechsler Test of Adult 
Reading (WTAR).  Others have used tests of current intellectual function such as the 
Wechsler Adult Intelligence Scales (WAIS).  Each of these approaches has limitations 
with reading tests such as the NART being only an estimation of pre-morbid IQ which 
relies on verbal functioning remaining intact, whereas current IQ assessments cannot 
account for changes in IQ functioning due to the effects of the psychological disorder and 





Table 2.2 Summary of existing studies reporting measures of premorbid intellectual 
functioning in women with bingeing disorders 
Study Diagnosis Mean IQ Psychometric Test 
Premorbid IQ    































Current IQ    




WAIS (4 subtests) 














WAIS-III (General Ability 
Index) 
*BN < HC, p<0.01, all other comparisons are not significant  
AN = anorexia nervosa; BN = bulimia nervosa; BED = binge eating disorder; BEDO = binge eating 
disorder with obesity; HC = healthy controls; HCO = healthy controls with obesity; NART = National 
Adult Reading Test; WAIS = Wechsler Adult Intelligence Scale; WTAR = Wechsler Test of Adult 
Reading. 
 
The average IQ score of individuals with bulimia nervosa or binge eating disorder, both 
premorbid estimate and current score, is generally around the top of the average range.  No 
significant difference in IQ scores between individuals with binge eating and those without 
binge eating were reported by all studies, apart for one study (Van den Eynde et al., 2012) 
which reported a slightly lower IQ in women with bulimia nervosa compared to healthy 
controls. There is no obvious reason for this finding as the sample they recruited does not 
seem to differ in from those in other studies with respect of age, BMI or illness severity.  




nervosa and binge eating disorder there does not appear to be any major differences when 
comparing results between studies. 
2.1.2 Motor functioning 
Motor functioning must be considered where tests involve the need to move or manipulate 
objects to complete the task and in particular where tests are timed.  Impairments in motor 
function can therefore mask ability in other areas of neuropsychological function. Slowing  
in motor functioning occurs due to ageing, physical problems or can also be caused by 
higher order processing problems (Lezak et al., 2012).  Although there is evidence of 
motor slowing in anorexia nervosa which is likely to be related to the effects of starvation 
(Green et al., 1996), few studies have reported motor function in bulimia nervosa or binge 
eating disorder.  One study of women with bulimia nervosa found motor processing was 
slower in bulimia nervosa on an assessment of motor function using a drawing task 
(McKay et al., 1986).  A recent study of women with bulimia nervosa found evidence of 
impairment in motor function (fine motor skills and strength of pencil grip) compared with 
healthy controls but not to the same degree as that found in women with anorexia nervosa 
(Weider et al., 2015).  There have been no studies reporting on motor function in binge 
eating disorder (see Table 2.1) 
Although there may not be strong evidence of impairments in motor function in women 
with binge eating, it is important to include in test batteries that include other tasks that 
require motor function to complete in order to exclude this as a confounding variable.  
Haptic perception is a distinct concept from motor function although motor function is 
required to manipulate physical objects.  Haptic perception is an area of neuropsychological 




characteristics of objects (Southgate, Tchanturia, & Treasure, 2005). More recently haptic 
tasks, such as the Haptic Illusion Task, have been used to investigate the ability to 
integrate sensorimotor information in people with eating disorders.  There is some 
evidence of impairment on haptic tasks in bulimia nervosa (Roberts et al., 2010; 
Tchanturia et al., 2004).  To date this research group have been the only ones to investigate 
this area. 
2.1.3 Attention  
Attention can be divided into different categories with sustained attention and divided 
attention being the two most common aspects examined in neuropsychological testing 
(Lezak et al., 2012).  Sustained attention or vigilance is the ability to remain focused on a 
task without being distracted.  Tasks measuring sustained attention typically ask the 
participant to respond when they perceive a target stimulus and can vary from simple (one 
target stimulus) to more complex in which the participant must respond only under certain 
conditions, for example only when the target item is preceded by a specified item.  Tests of 
sustained attention are typically forms of a continuous performance test paradigm.  
Divided attention involves completing tasks with more than one focus of attention and 
often uses different modalities such as visual and auditory concordantly.  Lezak et al., 
(2012) notes that performance of these attention tasks are relatively unaffected by age and 
are usually easily completed by people with intact attention and as such, even a small 
number of errors may indicate a impairment in attention.  Commonly used tests of divided 
attention in eating disorders research include Letter Cancellation Tasks and the Symbol-
Digits Modalities Test. 
Sustained attention in bulimia nervosa has been assessed as unimpaired in most studies 




of 38 women with bulimia nervosa of normal weight was no different to 39 healthy 
controls (Pendleton Jones et al., 1991).  Attention has been found to be unaffected even 
when impairments have been found in other areas of neuropsychological functioning.  For 
example, Weider et al. (2015) used Connor’s Continuous Performance Task and found no 
impairment in sustained attention in a group of 38 women and two men with bulimia 
nervosa compared with matched healthy controls, while finding neuropsychological 
impairments in other domains of functioning in the bulimia nervosa group. 
However, sustained attention may be reduced in individuals with bulimia nervosa if they 
have poor nutritional status.  A degraded-stimulus continuous performance test was used to 
compare sustained attention in a group of 30 women with bulimia nervosa (DSM-III-R) 
with 23 healthy controls (Laessle et al., 1990).  Those women with bulimia nervosa had a 
lower hit rate and reduced sensitivity to the target stimuli.  They were also slower to 
respond to the target which the authors interpreted as participants taking a more cautious 
approach.  Half of the bulimia nervosa group had a history of anorexia nervosa.  Signs of 
starvation were measured by levels of betahydroxybutyric acid (BHBA) in the women with 
bulimia nervosa.  Those with signs of starvation were found to have poorer performance 
on this task than those without such signs of starvation. 
Overall results from studies using continuous performance tests as a measure of attention 
lend more support to sustained attention being unaffected, at least in women who binge eat 
but are not underweight or exhibiting signs of starvation. 
Divided attention can assessed using the d2-Letter Cancelation Task (d2-LCT) which is 
also a measure of processing speed.  Participants are required to cross out a target character 
(the letter d with two dashes either above and/or below) and not mark distractor targets 




The d2-LCT was also used in a study involving 40 women with bulimia nervosa, 30 
women diagnosed with Eating Disorder Not Otherwise Specified-Bulimia Nervosa Type 
(EDNOS-BN), and 65 healthy controls (Van den Eynde et al., 2012).  The EDNOS-BN 
group performed less well than the bulimia nervosa group, and both eating disorder groups 
had lower attention than the healthy control group.  However, once baseline group 
differences were accounted for (age, NART scores, depression) only the EDNOS-BN 
group remained significantly poorer in performance than the bulimia nervosa and healthy 
control groups.  The authors noted that the EDNOS group would have met criteria for 
bulimia nervosa in DSM-5 due to changes in binge frequency and that EDNOS-BN group 
did not include women with binge eating disorder as they were specifically excluded from 
the study in order to reduce heterogeneity of the EDNOS-BN group.  It is unclear why the 
EDNOS-BN group had more neuropsychological impairment than the BN group as their 
ED symptoms (at least in terms of binge frequency) was by definition less severe than full 
diagnosis cases.   
In contrast, Brand et al. (2007) compared 14 women with bulimia nervosa to 14 matched 
healthy controls using the d2-LCT and found no difference in performance.  
Comprehensive matching to control for demographics and levels of psychopathology was 
evident; however, the study was underpowered and would have been unable to identify a 
difference of moderate effect size.   
Lauer et al. (1999) used the d2-LCT along with a different divided attention task using 
both visual and auditory stimuli in 14 women with bulimia nervosa and 12 women with 
anorexia nervosa.  An overall score of attention/vigilance was calculated (but not described 
in the paper) using outcomes from these two measures which indicated mild to moderate 




Lauer et al.’s study did not include a control group or describe how the norms were used to 
define a normal response were obtained.  The bulimia nervosa group in were on average 
99.6% ideal body weight which suggests that a reasonable proportion of the sample may 
have lower body weight than that found in the current study. 
The Symbol-Digits Modalities Test (SDMT; Lezak et al., 2012) measures visual attention 
and tracking ability.  Geometric designs are presented to the participant who uses a key to 
substitute a number for each design.  The test is scored by the number of correct 
substitutions made in a 90 second period.  Murphy et al. (2004) compared 16 women with 
bulimia nervosa and 16 healthy controls using the SDMT and found no difference in visual 
attention between the groups. Another study compared 23 participants with bulimia 
nervosa with 28 healthy controls using the SDMT (Ferraro, Wonderlich, & Jocic, 1997). 
They found that the bulimia nervosa group completed the task faster but made more errors, 
and had greater variability in responses than the healthy control group. 
Overall the results from studies investigating divided attention in bulimia nervosa are 
mixed.  Many have methodological issues (including small sample size, lack of detail 
regarding diagnostic classification and lack of a control group), which makes comparison 
difficult.  In studies that have controlled for confounding factors it appears that if 
deficiencies in divided attention are present they are likely to be small. 
In the only study of attention in women with binge eating disorder to date, Kelly et al. 
(2013) compared 50 women with regular binge eating but no compensatory behaviours 
with 66 healthy control women using the Connor’s Continuous Performance Task.  They 
found no difference in attention between the two groups.  Women in this study were 




of 24.5. This sample may not reflect the majority of women in the general population with 
binge eating disorder. 
In summary, nine studies have reported on attention/vigilance in women with binge eating.  
All studies investigated bulimia nervosa, while the remaining study investigated binge 
eating disorder.  Some studies had small sample sizes and were unlikely to have enough 
statistical power to detect a moderate effect size.  No consistent approach to measuring 
attention has been taken with at least three different tasks employed.  On balance it seems 
that both sustained and divided attention remains reasonably unaffected in women with 
binge eating but there is a suggestion that divided attention may be impaired if women are 
in a state of physical starvation and/or low body weight. 
2.1.4 Memory and learning 
Memory is the ability to hold information, verbal or visual, over time and use it for some 
purpose.  Word lists such as the Rey Auditory-Verbal Learning Test and the California 
Verbal Learning Test are commonly used to assess memory and learning verbal 
information.  The Rey Osterrieth Complex Figure Test is a test of recall of visual 
information and also investigates strategies used by participants to carry out this task.  
Memory can be tested immediately after presentation of the information (immediate 
recall), or after a time delay (delayed recall) or can be measured using a recognition 
condition where participants identify whether or not the information has previously been 
presented to them. 
Research on learning and memory with individuals with bulimia nervosa is mixed, with 
some studies showing impairment in verbal memory in bulimia nervosa and others 




recall condition in women with bulimia nervosa compared with healthy controls and Brand 
et al. (2007) reported poorer auditory learning in bulimia nervosa.  In contrast, two further 
studies found no impairment in verbal recall memory, both short and long term delay 
(Murphy et al., 2004;  Pendleton Jones et al., 1991).  A more recent study reported lower 
verbal and visual learning and memory in individuals with bulimia nervosa compared with 
healthy controls but did not report results of individual tests (Weider et al., 2015). 
Visuospatial memory has been found to be no different in women with bulimia nervosa 
compared with matched controls using the Rey-Osterrieth Complex Figure Test (Degortes 
et al., 2015; Murphy et al., 2004).  However, a large study of 42 adolescents with bulimia 
nervosa did find some impairment in delayed recall in the Rey-Osterrieth Complex Figure 
Test compared with healthy controls (Darcy et al., 2012).  The bulimia nervosa group also 
showed impairment in the copy condition suggesting that their ability to process spatial 
information was not as high as their non-eating disordered peers. Reduced delayed recall 
scores and impairment in the copy condition have also been reported in adults with bulimia 
nervosa (Brand et al., 2007; Weider et al., 2016).  
Surprisingly, a literature search did not reveal any publications reporting verbal learning 
and memory in individuals with binge eating disorder.  There is some evidence for reduced 
visuospatial memory in binge eating disorder compared to healthy controls both in the 
ability to accurately copy the figure but also in recalling information (Aloi et al., 2015). 
In summary, although there is some evidence for impairment in verbal and spatial 
memory, there is not a consistent pattern of learning and memory impairment reported in 
individuals with binge eating.  The limited number of studies investigating each aspect of 
memory (e.g. verbal or visual, immediate or delayed, recall or recognition) makes it 




eat.  Methodological issues including small sample sizes, the range of different tests used, 
and problems with diagnostic categories in many of these studies is also problematic. 
2.1.5 Inhibitory control  
The ability to inhibit responses is known as inhibitory control and can be demonstrated in 
different modalities such as inhibition of motor or verbal responses (Evenden, 1999).  
Inhibitory control is necessary to avoid making impulsive decisions and has some overlap 
with tests of decision making such as the delayed discounting task (see the next section: 
executive functions).  Tests which are commonly used to measure response inhibition 
include various forms of the Stroop Test; however, this is not considered a pure test of 
inhibition as it also incorporates cognitive interference and attentional bias (Wu et al., 
2013).  Go/No-go tasks and Stop Signal tasks are more reliable measures of motor 
inhibition. 
There is little evidence of inhibitory control problems in bulimia nervosa.  The Stroop task 
has not found differences between individuals with bulimia nervosa and healthy controls 
when using neutral stimuli (Alvarez-Moya et al., 2009; Van den Eynde et al., 2012).  No 
difference in inhibitory control was found using a Go/No-go task in one study (Van den 
Eynde et al., 2012); however women with bulimia nervosa were found to make more errors 
of commission (respond in the absence of target stimuli) on a Go/No-go task than healthy 
controls suggesting that those with bulimia nervosa had an increased tendency to respond 
in an impulsive manner (Rosval et al., 2006).  Studies using the Stop Signal Task have 
consistently shown no difference in motor inhibition between bulimia nervosa and healthy 




In contrast with the results from individuals with bulimia nervosa, there appears to be 
some evidence of inhibitory control impairment in individuals with binge eating disorder.   
Verbal inhibitory control was measured in women with binge eating disorder using 
Hayling’s Sentence Completion Task (Aloi et al., 2015).  Women with binge eating 
disorder were faster to respond but showed reduced inhibitory control by demonstrating 
less flexibility in their answers.  Another study found reduced motor inhibition in binge 
eating disorder using the stop signal tasks (Mole et al., 2015).  However, two further 
studies have shown no differences in inhibitory control in individuals with binge eating 
disorder using the Stroop Test (Manasse et al., 2015) and the Stop Signal Test (Wu et al., 
2013). 
In summary, inhibitory control in women with bulimia nervosa appears to be intact; 
however, there is a mixed pattern of results for women with binge eating disorder. The 
small sample sizes in some studies, the use of different tasks measuring inhibitory control, 
and the lack of replication by other researchers make it difficult to be confident that there 
are differences in inhibitory control in women who have binge eating disorder. 
2.1.6 Executive Function 
Executive function is the term given to a higher level of neuropsychological functioning 
which requires the combination of more than one basic neuropsychological domain in 
order to successfully complete a task.  Examples of executive function include set-shifting, 
planning, decision-making and central coherence.  These executive functions have been 





2.1.7 Set-shifting  
Set-shifting describes an individual’s ability to shift attention back and forth between 
multiple tasks (Miyake et al., 2010).  Tests that measure set-shifting include the Trail 
Making Test Part B, the Wisconsin Card Sorting Test, the Brixton Test and the Cat Bat 
Task.  These tests require the participant to switch between different stimuli and show 
flexibility in thinking to avoid perseverative errors.   
Roberts et al. (2007) in their systematic review of set-shifting in eating disorders note that 
set-shifting problems are often observed as either cognitive inflexibility where problem-
solving approaches become concrete and rigid, or response inflexibility where behaviours 
are perseverative or stereotyped.  Set-shifting has perhaps shown the most promise in 
identifying an eating disorder endophyte (Holliday et al., 2005).  Roberts et al. (2010) 
reported that poor set shifting was associated with eating disorders and that this 
characteristic was maintained after recovery from the eating disorder and was also detected 
in patients’ sisters with no eating disorder.  They found poor set-shifting was associated 
with longer duration of illness, and severity of eating disorder rituals but was not 
associated with BMI.  Roberts et al. (2010) concluded that set-shifting is a diagnostic 
feature of eating disorders, including bulimia nervosa, is not related to nutritional status, 
and is likely to be a familial trait that is involved with the maintenance of eating disorders.   
The Wisconsin Card Sorting Test is often used as a measure of set-shifting.  An 
amalgamation of participants from previously published studies from one research group 
was reported in Tchanturia et al. (2012) to produce an analysis of 82 participants with 
bulimia nervosa and 199 healthy controls on this task.  Results from this large data set 




In contrast, Galimberti et al. (2012), using the Intra-Extra Dimensional Set-shift Test from 
the CANTABeclipse battery, found no evidence of set-shifting impairments in 16 women 
with bulimia nervosa compared with 40 healthy controls.  The authors speculate that the 
Intra-Extra Dimensional Set-shift Test does not measure the same set-shifting component 
as other studies that report impairments in set-shifting.  Of note, this study did not find 
evidence of set-shifting impairment in women with anorexia nervosa in contrast to other 
literature.  Again this suggests that the Intra-Extra Dimensional Set-shift Test may not be 
as sensitive to impairment in set-shifting compared with some other measures such as the 
Wisconsin Card Sorting Test. 
Alvarez-Moya et al. (2009) suggest that bulimia nervosa is a disorder of impulse control 
and therefore should show similar neurocognitive impairment as individuals with 
pathological gambling. They compared executive functioning in 15 women with bulimia 
nervosa with 15 women with pathological gambling and 15 healthy controls using the 
Wisconsin Card Sorting Test.  Despite their study being small and underpowered, they 
found that both groups showed impairment in set-shifting compared with controls, and the 
bulimia nervosa group exhibited greater distractibility by making more random errors.   
Few studies have reported set-shifting in binge eating.  Kelly et al. (2013) compared 
executive functioning in 50 women with objective binge eating episodes and/or subjective 
binge eating at least weekly over the past month and 66 women with no history of binge 
eating.  After controlling for depression, anxiety, BMI and psychotropic medication they 
found no difference in cognitive impulsivity or rigidity, or in set-shifting, and overall both 
groups fell in the normal range.  The authors noted that their sample was relatively young 
(mean age 19 years) compared with many other studies investigating set-shifting in 




consequently may be early in the development of the disorder.  Average BMI was just 
within the normal range and likely to be lower than other studies including the current 
study.  The authors also speculate that impairment in executive function may be evident 
only when these functions are taxed, such as when experiencing negative affect or being 
confronted with food or body related stimuli. 
Svaldi et al. (2010) used the Trail Making Test to investigate set-shifting using the 
proportional score (B-A/A) and found lower scores in a group of binge eating disorder 
compared with a similar weight control group, with both groups in the normal range for 
weight. 
In summary, the findings from several well controlled studies support an impairment in 
set-shifting in individuals with bulimia nervosa compared with individuals without binge 
eating.  Difficulties in set-shifting may be, at least be in part, due to an impulsive response 
style resulting in increased errors compared to controls.  However, some studies have not 
found impairments in set-shifting, possibly due to the choice of test used to explore set-
shifting. In binge eating disorder the picture is less clear as there are fewer studies 
reporting on set-shifting. Those studies that have report either no impairment or small 
impairment in set-shifting; however there are methodological problems with sample 
characteristics which may not reflect the age and BMI of many individuals with binge 
eating. 
2.1.8 Planning  
Planning tasks examine the ability to identify and organise the steps needed to reach a 
specific goal.   This ability requires a combination of sustained attention, impulse control, 




2012).  Commonly used tests of planning ability include tower tasks such as the Tower of 
London, Tower of Hanoi and Stockings of Cambridge.  Tower tasks are thought to be good 
measures of planning and strategy, and are able to present problems of increasing levels of 
complexity to challenge high functioning participants.   
Planning ability rarely been investigated in individuals with bulimia nervosa and binge 
eating disorder.  One small, underpowered  study of 14 women with bulimia nervosa and 
14 healthy controls found no difference in planning ability using the Tower of Hanoi 
(Brand et al., 2007).  In another study, a group of 31 high weight women with binge eating 
disorder were found to be no different in performance on tower tasks than a group of 43 
high weight healthy controls (Manasse et al., 2015).   
With so few studies available to review, no conclusion can be drawn regarding planning 
ability in individuals with binge eating at present.  As planning ability brings together a 
number of neuropsychological tasks this would seem to be a useful area for further 
research of neuropsychological functioning binge eating. 
2.1.9 Decision-making  
Decision making is the ability to weigh up multiple choices and to be able to evaluate 
which is the best course of action under given circumstances.  The most commonly used 
decision-making tasks include the Iowa Gambling Task, the Delayed Discounting Task 
and the Game of Dice.   
Decision-making may be impaired in bulimia nervosa.  A number of studies have reported 
on decision-making using the Iowa Gambling Task.  Brogan et al. (2010) found 
impairments in decision-making in 17 women with bulimia nervosa compared with 20 




estimates which could impact on decision-making ability, were not reported. Boeka & 
Lokken, (2006) compared 20 women with bulimia nervosa and 20 healthy controls using 
the Iowa Gambling Task to measure decision-making and also found poorer performance 
by the group with bulimia nervosa.  Performance on this task was negatively correlated 
with bulimic symptomatology. Liao et al. (2009)  also used the Iowa Gambling Task and 
reported poorer performance by a group of 26 women with bulimia nervosa compared with 
a group of 51 healthy controls. Brand et al. (2007) investigated decision-making in 15 
women with bulimia nervosa compared to matched controls.  They also found poorer 
decision-making in the bulimia nervosa group. 
In binge eating disorder there is evidence of some impairment in decision-making.  Danner 
et al. (2012) found impaired decision-making on the Iowa Gambling Task in 20 women 
with binge eating disorder, and 21 obese women without binge eating disorder compared 
with 34 healthy controls of normal weight.   
Davis et al. (2010) conducted an interesting study comparing women with binge eating 
disorder with high weight women without binge eating disorder and healthy weight 
controls.  Decision making was impaired in both the binge eating disorder and high weight 
groups.  Furthermore an association was found between poor decision-making and 
difficulty in delaying gratification measured on the Delay Discounting Task, which is 
based on the premise that those that are more impulsive prefer more immediate rewards 
despite the value of the immediate reward being reduced.  The binge eating disorder and 
obese groups had significantly lower level of education and the authors speculated that this 
may not be an artefact of recruitment but could reflect the impact of obesity (possibly with 




achievement.  Further evidence of impulsivity in decision making has been reported in 
high weight women with binge eating disorder (Manasse et al., 2015; Mole et al., 2015). 
However, another study which has also considered the association between decision-
making and high weight suggests that impairments in decision-making in binge eating are 
independent of high weight (Svaldi et al., 2010).  Decision-making was measured using the 
Game of Dice Task in 17 women with binge eating disorder and 18 high weight controls 
without binge eating.  No difference was found in BMI between the two groups.  The 
binge eating disorder group made more risky decisions and did not utilise feedback as 
effectively as the overweight controls, suggesting that may not be due to the effects of high 
weight.   
In summary there appears to be some evidence of impairment in decision-making in 
individuals with bulimia nervosa and binge eating disorder.  Women who binge eat may 
make decisions based on immediacy of reward and are more impulsive in their decision-
making than women who do not binge eat. Some studies suggest that high weight may be 
associated with poor decision-making, although other studies do not support this.  Again 
small samples sizes mean that many of these studies are underpowered.  Unlike some of 
the other neuropsychological domains there is a consistency in tests chosen to measure 
decision-making which more easily allows comparison among studies.  Decision-making 
was not directly assessed in the present study. 
2.1.10 Central coherence  
Weak central coherence is described as a cognitive bias towards processing local detail at 
the expense of more global information processing (Happé & Booth, 2008). Lopez et al. 




concluded that such research is at an early stage and neither supports nor refutes this 
hypothesis.  Weak central coherence may be a trait, rather than a state and may be involved 
in the development of eating disorder cognitive traits such as fear of mistakes, 
perfectionism and fear of change (Lopez et al., 2009).  The majority of research has 
investigated central coherence in anorexia nervosa.  For a systematic review of central 
coherence across the eating disorder spectrum see Lang et al., (2014).  
Harrison et al. (2011) used the Rey Osterrieth Complex Figure Test and the Group 
Embedded Figures Task to examine central coherence in 48 women with bulimia nervosa, 
50 women with anorexia nervosa and 89 women with no eating disorder.  They found that 
although women with bulimia nervosa displayed superior detailed processing compared to 
healthy controls and performed at a similar level to those with anorexia nervosa, the 
bulimia nervosa group did not exhibit the global processing deficit found in the anorexia 
group.  In contrast, Roberts et al. (2013) examined central coherence in individuals with 
bulimia nervosa and did not find superior attention to detail in bulimia nervosa and 
concluded that poor global integration was more likely to be problematic. 
Aloi et al. (2015) compared 45 women with binge eating disorder, 45 women with 
anorexia nervosa and 45 healthy controls, using the Rey Osterrieth Complex Figure Test.  
Women with binge eating disorder did not have a pattern of weak central coherence found 
in individuals with anorexia nervosa, rather they showed a pattern of disorganisation and 
lack of attention to detail.  
In summary weak central coherence appears to be a trait mainly associated with anorexia 
nervosa; however, some aspects of it including a superiority in processing detailed 
information was found in one study on women with BN.  Another study suggests no 




study of binge eating has investigated central coherence and findings suggest a lack of 
attention to detail in binge eating.  More research is needed in this area before conclusions 
can be drawn about central coherence in women with binge eating.  Central coherence was 
not directly assessed as part of the current study, but appears to be an important area to 






Table 2.3 Summary of studies reporting on neuropsychological function in women with bingeing disorders 
Study Diagnostic 
Groups 
Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 
Bulimia nervosa        
Alvarez-Moya 













Trials to first category 
Trials administered 











No impairments detected 
other than non-perseverative 
errors suggesting greater 
distractibility in BN. 
Beatty et al. 
(1990) 




























Verbal fluency, Memory,  
Impairment in recall of 
verbal material, increased 












Iowa Gambling Task 
Verbal intelligence 





Low BMI, young age 














Game of Dice Task 
Colour Word Interference 
Test 
Trail Making Test 
 
Nelson’s Modified Card 
Sorting Test 



















Problem solving, Working 
memory, Visuospatial, 
Intelligence 
Overall performance no 
different to HC and within 






Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 











d2 Selective Attention Test 
ROCFT 
 


























exceptions of verbal and 
visuospatial memory and 
set-shifting.  Decision-
making showed poorer 
decision-making and 
impaired learning in BN 
group. 


















Planning.  Poorer 
performance by BN but not 
all variables reported. Not 
well controlled for 
confounding variables  
















Attention, Verbal memory 
and Motor function 
imparted in BN.  Small 
sample size.  Composite 
scores only reported. 











Iowa Gambling Task Overall net score 
Blocks 1 & 2 net scores  





group older, no comparison 






Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 








Iowa Gambling Task Total score BN<HC* Decision-making 
BN more sensitive to gains 
than losses – reward 
sensitivity 






















WAIS (4 subtests) 
Accuracy delay 
Accuracy copy 







Adolescents. BMI not 
reported – used % median 
body weight.  












Memory with interference 










control. High proportion 
with previous AN – 
associated with poorer 

















Detection errors on “go” 
Mean correct reaction 
time 
SSRT ## 
Errors block 6  







Set-shifting, motor control  
No difference in in BN 
compared to HC.  









Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 








Group Embedded Figures 











Central coherence: No 
global details problem but 
suggests more attention on 
detail rather than global in 
BN. Included AN 
participants.  Age reported 
for ED overall and not for 
BN 


















on copy, no memory 
impairment in BN 
Laessle et al. 
(1990) 
30 BN$$ 




























Letter Cancellation Task 
 
Trail Making Test 
Free Paragraph Recall Test 
 
CVLT 






Items long term 












Memory.   No difference 
between AN and BN. 
Compared to norms some 
impaired performance in 
attention tasks but not in 
other domains. Small 
sample, no HC, Norms used 
were not defined. 









Iowa Gambling Task 
Premorbid IQ 











Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 






















Sentence Completion Task 
 
Homograph Reading Task 
Premorbid IQ 
Total time taken 






























AN/BN performed better on 
tasks requiring detail 
focussed processing but 
performed more poorly on 
tasks requiring global 
integration compared to HC 
 
 


















Motor function impaired in 
BN.  Pathognonomic 
indicates possible right 
hemisphere dysfunction. 
DSM-III inpatients 


















































Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 
























NR Neuropsychological battery 
reported in domains rather 














Concluded any differences 
in function were “subtle”. 
% ideal weight reported 






























BN poorer set-shifting 
overall than HC. 
Some evidence for 
impairment set-shifting in 
unaffected sisters. 






















Van den Eynde 




























WCST Number of trials 
Total correct 







BN performed slightly 



















Failure to maintain set 



















Trail Making Test 
 
Brixton Test 
Picture Set Test 
Verbal Fluency Task 
Cat Bat Task 
 



























Trail Making Task B-A BN>HC** Set-shifting 
Van den Eynde 












Stroop Word/Colour Test 
Go/No-Go Task 
Game of Dice Task 
Number items processed  


















ANCOVA for differences in 
age, NART and depression. 







Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 















BN lower in verbal but not 
performance IQ 










Verbal learning & 
memory 
Visual learning & 
memory 
Visuospatial ability,  
Working memory,  











Working memory, Motor 
function 
BN lower performance on 
all measures than HC. 
No data reported for 
individual tests 















When controlling for 
depression differences were 
no longer significant 











Stop Signal Task 









BIS – no significance 
ED psychopathology no 
different 
Binge Eating Disorder        












Iowa Gambling Task 
ROCFT 
 






















Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 





Part B (flexibility) BED<HC** 











Iowa Gambling Task Overall net score 




BN, OB NS 
Decision-making 
impairments in BN and OB 
both in overall score & 
learning. 











Iowa Gambling Task 
Delay Discounting Task 





HC group sig higher 
education. 





















NS after controlling for 
depression, anxiety, BMI, 
IQ and medication use.  








Delayed Discounting Task  
Tower Task  
Stroop, colour/word 
Penn Conditional Exclusion  
Penn Letter N-back Task  
Balloon Analogue Risk 
Task  












control, Problem solving, 
Working Memory, 
Intelligence. BED group 
includes subthreshold 
Controlled for age and IQ 











Delayed Discounting Task 
Stop Signal Task 






Svaldi et al. 
(2010) 
17 BED 






















Age BMI Neuropsychological Test Outcome variable Results# Domain tested/Comments 
Game of Dice Task Net score BED<HCO* 









Stop Signal Task 









* p<0.05, ** p<0.01, ***p<0.001, NS = not significant 
# The group in bold had the superior performance 
## SSRT is the mean time in ms to suppress motor response 
$ Obese sample recruited from an obesity management clinic.  No definition of obesity reported. 
$$ DSM-III-R diagnostic criteria used 
AN = anorexia nervosa  
AN/BN =  mixed group of anorexia and bulimia nervosa  
BED = binge eating disorder  
BEDO = obese binge eating disorder 
BN = bulimia nervosa 
EDNOS = eating disorder not otherwise specified 
HC = healthy controls 
HCO = obese healthy controls 
IBW = ideal body weight 
NR = Not reported 
CVLT = California Verbal Learning Test  
DSM-III-R = Diagnostic and Statistical Manual, 3rd edition, revised 
IED = Intra Dimensional/Extra Dimensional Shift Task 
IGT = Iowa Gambling Task  
NART = National Adult Reading Test, NS = no significant difference 
ROCFT = Rey Osterrieth Complex Figure Test  
SSRI = selective serotonin reuptake inhibitor  






2.2 Neuropsychological Functioning in Obesity 
Obesity is defined as the excess of body fat (adipose tissue) and is increasing in prevalence 
worldwide (World Health Organization, 2000) and in New Zealand (Ministry of Health, 
2015b).  Body Mass Index (BMI) is commonly used as a way of measuring levels of obesity.  
A BMI of less than 20 is considered to be underweight, 20-25 is considered to be a normal, 
healthy weight, whereas a BMI of between 25 and 30 is considered overweight and BMI 
over 30 is classified as obese (World Health Organization, 2000).  
 There are significant health risks associated with obesity including diabetes, hypertension, 
other cardiovascular problems, cancer, sleep apnoea and depression (Dixon, 2010; Mokdad 
et al., 2003).  There is also some evidence of reduced neuropsychological functioning in 
obese individuals. As a proportion of women who binge eat have BMIs in the overweight 
(BMI between 25 and 29) and obese (BMI 30 and above) ranges, it is important to 
consider the potential contribution of obesity itself as a factor when examining 
neuropsychological functioning in this group.  Possible mechanisms include genetically 
influenced factors, the impact of known medical consequences such as hypertension and 
insulin resistance, and direct effects of obesity through mechanisms such as inflammation. 
Recent studies indicate that obesity and neuropsychological functioning could be 
genetically linked.  Specific single nucleotide polymorphisms (SNPs) found in higher 
levels with increasing obesity have been associated with cognitive decline in adults 
(Whitmer et al., 2005).  Further to this finding, Bressler et al. (2013) found that a specific 
SNP called FTO, is more prevalent in obese individuals, and has negative effect on 




The effect of obesity related illnesses such as cardiovascular disease and diabetes on 
neuropsychological function has also been examined.  It has been suggested that lower 
neuropsychological function in obese individuals has been linked to the impact of these 
illnesses rather than the effect of obesity.  Yesavage et al. (2014) explored these 
associations among obesity, hypertension, diabetes and sleep breathing disturbance and 
performance on tests of executive function and auditory verbal memory in four different 
community samples of men and women aged over 50 (mean ages 61 to 69, total sample 
n=369) .  They found in this older population that poor executive function and auditory 
verbal memory were more likely to be due to insulin resistance and “metabolic syndrome”.  
The authors note that this could have implications for individuals with binge eating as they 
are more likely to have insulin resistance. 
Fitzpatrick, Gilbert, & Serpell, (2013) in their systematic review of obesity and 
neuropsychological functioning note that none of the studies they identified could be used 
to examine the direction of any association between obesity and neuropsychological 
functioning.  Theories have been postulated for both directions.  Boeka & Lokken, (2006) 
suggest that the tendency for some individuals who have had weight loss surgery and have 
difficulty maintaining the weight loss and adjusting to changes following surgery indicates 
a pre-existing weakness in executive functioning.  Others have theorised that obesity 
causes changes in physiology that are detrimental to neuropsychological functioning as 
already described (Yesavage et al., 2014). 
There have been two comprehensive reviews of obesity and neuropsychological function 
(Prickett, Brennan, & Stolwyk, 2015;  Smith et al., 2011).  Few studies have been 
published in this area but there is some evidence for reduced functioning in tests of 




making.  There was no strong evidence of impairments in memory, divided attention or 
verbal fluency.  The majority of studies did not account for potential confounding variables 
such as depression and other comorbidities. 
A few studies have looked at the association between obesity, binge eating and 
neuropsychological functioning.  Inhibitory control was explored using a go/no-go task 
using food related stimuli in one condition and body related stimuli in the other (Mobbs et 
al., 2011). Obese participants were no different from healthy weight controls in 
performance on this task; however, obese participants who also met criteria for binge 
eating disorder made significantly more errors than the other two groups.  This suggests 
that differences may be due to the presence of binge eating rather than obesity. 
Decision-making in obese women was compared with that in women with binge eating 
disorder and healthy controls using the Iowa Gambling Task (Davis et al., 2010).  Both the 
obese and binge eating disorder groups had poorer performance than the healthy controls 
but were not different from each other; however when levels of education were controlled 
no significant difference was found.  The same study investigated delayed gratification 
using the Delayed Discounting Task which assumes that more impulsive participants 
would select more immediate rewards even when the size of the reward is smaller than if 
they had waited.  Again the authors found that the obese and binge eating disorder groups 
were more impulsive than the healthy control group but again this after controlling for 
level of education no significant differences were found. Another study also using the Iowa 
Gambling Task found that obese women with binge eating disorder had similar 
impairments in decision-making to obese women without binge eating (Danner et al., 




Manasse et al. (2015) found that obese women with binge eating disorder performed less 
well on tasks of decision-making and risk taking than obese women without binge eating.  
However, there was no difference between groups on tasks of problem solving (Tower 
Task) or working memory (Penn Letter N-back Task, Penn Conditional Exclusion Task) or 
sustained attention (Stroop Test). 
Mole et al. (2015) also found no difference in decision-making between obese women with 
and without binge eating disorder, yet both groups scored more poorly than non-obese 
healthy controls.  The obese binge eating group had better inhibition control than the obese 
non-bingeing group.  Svaldi et al. (2010) found no difference between the obese binge 
eating group and the obese control group on motor inhibition control on the Stop Signal 
Task and decision-making on the Game of Dice Task. 
A small study (Roberts et al., 2007) investigating set-shifting and central coherence in 
obese participants compared with healthy weight controls found evidence of weak central 
coherence exhibited by a disorganised response style in the obese group but did not find 
any differences in set-shifting ability.  This study was limited by the small sample size (10 
in the over-weight group) so was underpowered. 
In summary findings on the impact on obesity in binge eating on neuropsychological 
function are inconsistent.  Some studies show impairment, particularly in decision-making, 
are greater in obese binge eating groups than in obesity without binge eating.  Other 
studies suggest decision-making in obese groups with binge eating is no different from 
obese controls.  Other neuropsychological domains including motor inhibition are also 
inconsistent with one study showing enhanced performance in obese binge eating group 
compared with obese controls. The use of different neuropsychological tests to measure 




and may contribute to different findings being reported by different research groups. As 
with research into binge eating reported in the preceding section, many studies have not 
taken potential confounders into account and some suffer from being statistically 
underpowered. 
2.3 Comorbidities: Depression and Anxiety  
2.3.1 Depression 
Depression is the most common comorbid psychiatric disorder in bulimia nervosa (O'Brien 
& Vincent, 2003) and is associated with severity of bulimic symptoms (Spindler & Milos, 
2007).  The life time prevalence of any mood disorder has been reported at 59% in bulimia 
nervosa and 46% in binge eating disorder in a World Health Organisation survey of over 
24 000 individuals across 14 countries including New Zealand (Kessler et al., 2013).  
Depression is known to have a negative impact on neuropsychological functioning.  Meta-
analyses have found evidence for a negative association between level of depression and 
processing speed, episodic memory, working memory, inhibitory control, problem solving 
and planning  (Marazziti et al., 2010; McDermott & Ebmeier, 2009), with semantic 
memory and visuospatial memory being unaffected.   
As depression is common in women with binge eating and is known to negatively affect 
neuropsychological functioning, it is important to investigate this further.  A number of 
studies of neuropsychological functioning in women with binge eating have reported the 
rate of comorbid depression or have measured the severity of depression using a 
psychometric tool such as the Beck Depression Index (BDI).  Some studies have used 
depression measures as co-variates in their analyses; however, few have directly 




individuals with binge eating.  A summary of studies that have examined this association is 
presented in Table 2.4    
Table 2.4 Summary of studies reporting on impact of depression on neuropsychological 
function in women with binge eating 
Study Groups Depression 
measures  
Relationship with neuropsychological tests 







Verbal memory: negative association with 
BMI 
Verbal fluency: negative association with 
BMI 






Decision-making (IGT):  no association 
with BDI-II 




Decision-making (IGT):  no association 
with BDI-II 




Decision-making (IGT):  no association 
with BDI-II 




HADS D Set-shifting composite variable small 
association with HADS D 




HADS D Weak central coherence: positive 
association with HADS D  






Visual memory (ROCFT): negative 
association with BDI-II 




Cognitive flexibility (HSCT): negative 
association with BDI 
IGT, ROCFT, WCST, TMT: no association 
with BDI  
Svaldi et al. 
(2010) 
17 BED 
18 HC  
BDI-II 
BN>HC*** 
Decision-making (GDT): no association 
with BDI-II 
* p<0.05, ** p<0.01, ***p<0.001 
BED = binge eating disorder; BN = bulimia nervosa; HC = healthy controls; BDI = Beck Depression 
Inventory; GDT = Game of Dice Task; HADS D = Hospital Anxiety and Depression Scale Depression; 
HSCT = Hayling Sentence Completion Task;  IGT = Iowa Gambling Task; ROCFT = Rey Osterrieth 
Complex Figure Test; TMT = Trail Making Task; WCST = Wisconsin Card Sorting Test 
 
Levels of depression were found to be slightly higher in women with bulimia nervosa who 
showed greater set-shifting difficulties than those with lower levels of set-shifting 
difficulties (Roberts et al., 2010), although effect sizes were small.  A similar pattern of 




central coherence than those with better performance in this area (Roberts et al., 2013).  In 
these studies severity of eating disorder symptoms was more strongly related to 
neuropsychological difficulties than depression.   
Only one study has reported impairment in verbal memory and verbal fluency in 17 
individuals with bulimia nervosa and severe depression compared with 15 individuals with 
bulimia nervosa who had less severe levels of  depression  (Beatty et al., 1990).  No 
difference between the groups was reported for verbal fluency; however, verbal recall was 
found to be lower in the severely depressed group. 
No association between severity of depression and decision-making ability measured by 
the Iowa Gambling Task has been found in individuals with bulimia nervosa or binge 
eating disorder (Boeka & Lokken, 2006; Chan et al., 2014; Liao et al., 2009). This 
suggests that if impairments in decision-making are present in women with binge eating is 
not likely to be due to the influence of depression. 
In binge eating disorder, (Aloi et al., 2015), found reduced cognitive flexibility to be 
correlated with depression; however no correlations were found for test of decision-
making, visuospatial ability or set-shifting. 
Reduced ability to manage negative mood states in individuals with binge eating have been 
associated with impairments in set-shifting using an experimental paradigm (Dingemans et 
al., 2015).  Women with binge eating disorder (DSM-5 criteria) completed the Trail 
Making Test (TMT) after to exposure to either a sad film clip (n=36) or a neutral clip of a 
weather report (n=39).  The participants randomised to the negative film clip reported 
lower mood states on a visual analogue scale and recorded lower ratio scores on the TMT 




relatively impaired when individuals are in a negative mood state compared with a positive 
mood state.  This is interesting as it suggests that affective state at the time of testing may 
influence set-shifting ability in a very immediate way that may not be captured in 
traditional measures of mood such as diagnostic criteria or psychometric measures of 
depression.  
In summary, few studies have directly investigated the association between depression and 
neuropsychological functioning in individuals with binge eating and to date there is not 
sufficient evidence as to whether depression impacts on neuropsychological performance 
in this group.  However, some interesting findings regarding mood states and set-shifting 
suggest further exploration of this is warranted.  
2.3.2 Anxiety 
Anxiety is a highly prevalent comorbidity in binge eating.  Lifetime prevalence of any 
anxiety disorder has been reported as high as 65% in bulimia nervosa (Kessler et al., 2013) 
and 56% in binge eating disorder (Hudson et al., 2007).  The prevalence of anxiety 
disorders in individuals with binge eating is much higher than in general population and 
can precede development of an eating disorder (Kaye et al., 2004).  Attentional Control 
Theory (Eysenck et al., 2007) suggests that anxiety has a negative impact on goal directed 
attention resulting in problems with shifting attention and inhibitory control but conversely 
anxiety may improve function in conditions where compensatory strategies such as 
enhanced effort are used.  Therefore the effect of anxiety could be detrimental in some 
areas of neuropsychological function but may enhance others.  As might be expected, the 
pattern of neuropsychological impairments have been reported to differ depending on the 




A number of studies investigating neuropsychological function in women with binge 
eating have reported the prevalence of comorbid anxiety disorders using diagnostic criteria 
or have measured anxiety with psychometric measures to describe their sample’s 
characteristics.  However, very few have directly investigated this relationship in bulimia 
nervosa and none in binge eating disorder (see Table 2.5).   
Consistent with Attentional Control Theory (Eysenck et al., 2007), Roberts et al. (2010) 
found a small association between anxiety during the past week and poorer performance 
on set-shifting tasks in women with bulimia nervosa.  There was also found to be a small 
association with anxiety and weak central coherence (Roberts et al., 2013).  However, 
Pendleton Jones et al. (1991) found no significant correlations between anxiety and any of 
the neuropsychological domains tested as part of a large neuropsychological battery.  
Specific statistics were not reported in this study, making it difficult to interpret the results. 
 
Table 2.5 Summary of studies reporting on impact of anxiety on neuropsychological 
function in women with binge eating. 
Study Groups Anxiety 
measures  
Relationship with neuropsychological tests 
Pendleton Jones 




TSCT  Comprehensive test battery: relationship 
between deceased performance and anxiety. 
Specific statistics not reported.  AN and BN 
were not differentiated in results. 




HADS A Set-shifting: small negative association with 
HADS A 




HADS A Weak central coherence: positive 
association with HADS A 
NS= no significant difference;  * p<0.05, ** p<0.01, ***p<0.001 
AN = anorexia nervosa;  BED = binge eating disorder; BN = bulimia nervosa; HC = healthy controls; 
MDE = major depressive episode;  BDI = Beck Depression Inventory; GDT = Game of Dice Task; 
HADS A = Hospital Anxiety and Depression Scale Anxiety; HADS D = Hospital Anxiety and 
Depression Scale Depression; HSCT = Hayling Sentence Completion Task;  IGT = Iowa Gambling 
Task; ROCFT = Rey Osterrieth Complex Figure Test; TMT = Trail Making Task; TSCT = Tryon Stein 





In summary the prevalence of comorbid anxiety disorders is very high in individuals with 
binge eating.  Potentially anxiety could reduce or enhance performance on 
neuropsychological tests depending on the domain being measured. There is some 
evidence for anxiety to be associated with attention and set-shifting, and possibly central 
coherence in women with bulimia nervosa; however, there have been no studies reporting 
on this association in binge eating disorder.  More research is needed in this area. 
2.4 Impulsivity in Neuropsychological Functioning  
A number of studies reviewed in previous sections of this chapter have noted the tendency 
for individuals to respond impulsively on some neuropsychological tests, particularly on 
decision-making tasks. An impulsive response on a test does not necessarily indicate a 
more general impulsive personality but is useful to investigate this characteristic in more 
detail in individuals with binge eating as a potential mechanism to understand 
neuropsychological function in this group. 
Impulsivity can be defined as “a predisposition toward rapid, unplanned reactions to 
internal or external stimuli without regard to the negative consequences of these reactions 
to the impulsive individual or to others” (Moeller et al., 2001, p 1784) and has found to be 
present in a range of psychiatric disorders including eating disorders.  Impulsivity has been 
found to be able to differentiate those with binge eating from those without binge eating 
(Waxman, 2009) and may even play a role in the development of binge eating (Dawe & 
Loxton, 2004).  Impulsivity in binge eating may also extend to increased comorbidity of 
other impulsive behaviours such as alcohol and substance use in this population (Bulik et 




Impulsivity has generally been measured using self-report questionnaires, with the 
Eysenck Impulsiveness Scale and the Barratt Impulsiveness Scale the most commonly 
used (Waxman, 2009).   The BIS-11 is comprised of three subscales; Non-planning which 
measures lack of future orientation, Motor which is a measure of impulsive actions, and 
Cognitive which measures impulsive thinking and lack of patience (Barratt, 1994).   
In neuropsychological testing, impulsivity has been examined in two main domains; motor 
impulsivity and cognitive impulsivity and can further be broken down into the failure to 
stop a response (inhibitory control) or responding prematurely in anticipation of the target 
stimuli (Mole et al., 2015).   
Studies directly investigating impulsivity in individuals with binge eating have examined 
tests of set-shifting, impulsivity control, and decision-making and are summarised in Table 
2.6.  Claes et al., (2006) compared 63 women with bulimia nervosa to 67 healthy controls 
and reported no association between impulsivity and set-shifting.   At present there are 
insufficient studies to be able to state whether impulsivity in binge eating has an impact on 
set-shifting ability.   
Kemps & Wilsdon, (2010) investigated the role of impulsivity in neuropsychological 
function in 13 women with bulimia nervosa and 13 healthy control women.  They found 
impairment on tasks of verbal inhibitory control (Stroop Test and Excluded Letter 
Frequency Test) in the bulimia nervosa group which correlated with scores on the Barratt 
Impulsivity Scale.  The authors concluded that “poor inhibitory control in bulimia nervosa 
is at least partially attributable to an impulsive disposition” (Kemps & Wilsdon, 2010, 
p515).  Impulsivity in bulimia nervosa has also been associated with increased errors on 
tests of motor inhibitory control on the Stop Signal Task (Galimberti et al., 2012) and 





Table 2.6  Summary of papers reporting on impulsivity and neuropsychological function in 
women with binge eating 
Study Groups Impulsivity measures Relationship with 
neuropsychological tests 










Inhibitory control: stop 
signal task no association with 
BIS subscales 






BN>HC*** No association between 
impulsivity and 
neuropsychology measures 




BIS total NS Set-shifting: TMT, Stroop no 
association with BIS 






BED>HC IGT No association with BIS  










Inhibitory control:  Stop 
signal errors associated with 









Inhibitory control: Stroop 
Task, HSCT, Excluded Letter 
Frequency, Matching Familiar 
Figures. Controlling for 
impulsivity removed 
significance for Stroop and 
Excluded Letter Fluency 
differences.  Concluded that 
impulsivity contributes at least 
in part to poor inhibitory 
control. 






IGT: no association with BIS.   




BIS BN>HC* Go/No-go:  BN more 
commission errors but 
omission errors no different 
Svaldi et al. 
(2010) 
17 BED 









GDT: No association with BIS 
Negative correlation between 
BAS fun seeking and GDT net 
score i.e. more fun seeking, 
more riskier decisions. 
NS=no significant difference; * p<0.05, ** p<0.01, ***p<0.00; # sample made up of 12BN and 9 EDNOS; 
BED=binge eating disorder; BEDO = binge eating disorder with obesity; BN=bulimia nervosa; HC=health 
controls. BAS = Behaviour Approach Scale; BIS= Barratt Impulsiveness Scale-11; ID/ED = Intra 




Despite the small number of studies, there seems to be some evidence of impulsivity 
personality traits to be associated with increased errors in task of inhibitory control in 
women with bulimia nervosa.  In binge eating there is a paucity of studies investigating 
this area.  Svaldi et al. (2010) did not find an association between impulsivity and decision-
making in 17 women with binge eating disorder compared to 18 healthy control women; however, 
this study was underpowered.  
It has been suggested that individuals with binge eating may perform poorly on decision-
making tasks due to a tendency to choose immediate rewards despite long-term 
consequences which may be related to “impulsive personality traits” (Danner et al., 2012, 
p60).  However, several studies have not found an association between impulsivity using 
the Barratt Impulsivity Scale and decision-making using the Iowa Gambling Task. (Danner 
et al., 2012; Liao et al., 2009; Svaldi et al., 2010).  As with set-shifting and inhibitory 
control, there have not been enough studies directly investigating the links between 
impulsivity and neuropsychological performance to be able to conclude whether there is an 
association between these factors in women who binge eat. 
2.5 Potential Confounding Factors on Neuropsychological 
Functioning 
A number of factors can affect performance on neuropsychological tests.  Some of these 
factors are fixed and long term influences such as history of head injury or handedness 
whereas others are not fixed and have a proximal influence, such as recent consumption of 
psychoactive substances.  This section discusses the relevance of factors that could 




Handedness is genetically determined and can influence relative strength and weaknesses 
in neuropsychological testing (Lezak et al., 2012).  There is evidence that right-handers 
tend to score more highly on tests requiring visuospatial ability whereas left-handers may 
have an advantage in artistic and mathematical tasks (Lezak et al., 2012).   Handedness has 
not been investigated in people with binge eating but a study by Tenconi et al., (2010) 
found that handedness did not alter neuropsychological functioning in a group of  153 
people with anorexia nervosa. 
Head injury through accident or illness may impact neuropsychological abilities depending 
on the area and extent of damage.  A few studies of anorexia have reported rates of 
potential brain injury which were no different from the healthy control groups (Southgate 
et al., 2006).  Most studies of bulimia nervosa and binge eating disorder have not reported 
histories of brain injury. 
As noted earlier, psychiatric co-morbidities, particularly depression and anxiety, are 
common in bulimia nervosa and binge eating disorder (Pearlstein, 2002) and  may impact 
on neuropsychological function.  Physical health may also impact on neuropsychological 
function.  Health conditions may affect auditory and visual perception, influence physical 
ability to carry out the tasks required, or increase levels of fatigue. 
Severity of illness in eating disorders could potentially influence test performance and can 
be measured a number of different ways.  The most common measure of severity in 
anorexia is BMI; however in the binge eating population the utility of this as a proxy for 
illness severity is questionable as it may or may not reflect the extent of disordered 
cognitions and behaviors (such as bingeing and purging frequency).  Other common 
measures of eating disorder illness severity include the duration of illness, a past history of 




Disorder Inventory (EDI).  Measures of overall global functioning are less commonly 
reported. 
Medication status of participants is sometimes not reported despite medication commonly 
being prescribed to treat individuals with eating disorders.   Southgate et al. (2005) noted 
in their review of neuropsychological function in eating disorders that this was a weakness 
in the literature in this area.  The lack of reporting in this area makes it more difficult to 
directly compare results of studies. 
In New Zealand alcohol use is common in the general population (Ministry of Health, 
2015a).  The effect of alcohol consumption on neuropsychological functioning is 
contentious.  There is some evidence that moderate levels of consumption are not 
detrimental to neuropsychological performance and long term may even confer a small 
positive effect on neuropsychological function in adults. (Britton et al., 2004).  Immediate 
effects of alcohol intoxication include mental and psychomotor slowing and are likely to 
negatively affect performance on neurological tests particularly verbal working memory  
(Sullivan et al., 2000), inhibition control (Ray & Bates, 2007) and depth perception 
(Wegner & Fahle, 1999).  Chronic alcohol abuse can lead to Wernicke–Korsakoff 
syndrome which is characterised by significant decline in cognitive function (Sechi & 
Serra, 2007).   
Caffeine is known to improve psychological function if consumed immediately before 
testing.  Improvements in sustained attention and psychomotor speed, verbal working 
memory, sustained attention, spatial memory, and reduced mental fatigue have been 




Cannabis is the most commonly used recreational drug after alcohol in New Zealand 
(Ministry of Health, 2015c).  Cannabis use has found to be higher in the bulimia binge-
purge subtype compared to bulimia nervosa non-purging and binge eating disorder in this 
sample (Jordan et al., 2014). Cannabis intoxication has been associated with impairments 
in recall, decision-making, inhibitory control and reaction times (Gonzalez, 2007). 
Studies investigating neuropsychological functioning in binge eating vary widely in the 
extent to which they have reported and controlled for potentially confounding factors.  A 
summary of confounding factors reported by various studies is shown in Table 2.7. Almost 
all studies have reported age and BMI; however many have not reported other significant 
confounders such as substance use, medication use and premorbid IQ estimates. 
In summary, it is important to account for a range of factors that could potentially 
influence neuropsychological test performance.  Many studies have not reported these 





Table 2.7  Reporting of confounding factors in previous studies investigating 
neuropsychological functioning in bulimia nervosa and binge eating disorder.  X signifies 


















































































































Bulimia nervosa                 
Alvarez-Moya et al. 
(2009) 
X  X       X     X 
Beatty et al. (1990) X X X     X X X      
Boeka & Lokken, (2006) X X X      X  X X   X 
Brand et al. (2007) X X X     X X    X   
Bosanac et al. (2007) X X      X X X   X  X 
Brogan et al. (2010) X X X             
Ruiz et al. (2008) X  X             
Chan et al. (2014) X X       X       
Claes et al. (2006) X X              
Darcy et al. (2015) X X       X X  X X  X 
Darcy et al. (2012) X X       X X X X X  X 
Degortes et al. (2015) X X X X      X      
Galimberti et al. (2012) X X X       X   X   
Harrison et al. (2011) X X X     X X X  X X  X 
Kim et al. (2011) X X X     X X X  X X  X 
Laessle et al. (1990) X X        X  X X   
Lauer et al. (1999) X X X      X   X X   
Liao et al. (2009) X X X      X  X  X X X 
(Lopez et al. (2009) X X X     X X  X    X 
McKay et al. (1986) X  X       X      
Murphy et al. (2004) X X       X X X X   X 
Pendleton Jones et al. 
(1991) 
X X X X    X X X      
Roberts et al. (2010) X X X     X X  X X X   
Roberts et al. (2013) X X X   X  X X   X X   
Rozenstein et al. (2011) X X X      X   X    
Tchanturia et al. (2012) X X           X   
Tchanturia et al. (2004) X X              
Van den Eynde et al. 
(2012) 
X X      X X X  X X  X 
Weider et al. (2014) X X X      X X X  X   





















































































































Weider et al. (2016) X X X      X X X X X  X 
Wu et al. (2013) X X X             
Binge eating disorder                
Aloi et al. (2015) X X X      X  X X    
Danner et al. (2012) X X              
Davis et al. (2010) X X X      X       
Kelly et al. (2013) X X X     X X X X X   X 
Manasse et al. (2015) X X       X X X X   X 
Mole et al. (2015) X X X   X X  X  X X X  X 
Svaldi et al. (2010) X X X      X   X    
Wu et al. (2013) X X         X X    
 
2.6 Summary 
Neuropsychological testing is a non-invasive way to explore brain function.  The 
information gathered from such testing can help inform understanding of the processes 
involved in the development, maintenance factors and treatments for individuals with 
binge eating.  To date there have been a number of studies investigating the 
neuropsychological functioning in individuals with binge eating. Overall studies often 
report contradictory findings and methodological issues make direct comparisons difficult.  
For example, studies use different tests to measure the same neuropsychological concepts, 
and even when the same test are used, often different variables have been reported. This 
results in little replication of studies which is important to establish that a finding is able to 
be replicated by other research groups.  Where variables have been calculated there is often 
no explanation of how they have been calculated.  Many studies are underpowered and 




diagnostic categories also differs with some studies using a standard clinical interview with 
others using the more robust method of a structured clinical interview such as the SCID-I.   
Changes in DSM classifications over time also has implications when comparing studies as 
although changes are not usually large they do affect who is eligible for studies.  The use 
of EDNOS is also problematic as each study has defined their own criteria.  Despite these 
problems with methodology there have been a few larger and well controlled studies, 
mainly investigating bulimia nervosa with a growing number investigating binge eating 
disorder. 
A review of the literature suggests possible impairment across a range of domains 
including attention, memory and inhibitory control, and executive function.  However, 
where impairments have been found they tend to be relatively small.  On balance, 
neuropsychological functioning in binge eating is likely to be relatively intact, with some 






3. METHODS  
3.1 Main Study Design 
Data reported in this thesis were obtained as part of the Binge Eating Psychotherapy Study 
(McIntosh et al., 2016) which was carried out in the Clinical Research Unit, Department of 
Psychological Medicine, University of Otago, Christchurch, and the Canterbury District 
Health Board.  The Binge Eating Psychotherapy Study was a randomised controlled 
clinical trial comparing three cognitive-based therapies for treating women with 
transdiagnostic binge eating. Inclusion criteria were: 
 Women aged 16 years or older 
 Regular binge-eating (at least twice weekly for three months if compensatory 
behaviours are present: at least two days weekly for six months if no compensatory 
behaviours) 
 Body mass index (BMI) >17.5 
Exclusion criteria were: 
 Current severe major depression 
 Current severe psychoactive substance dependence 
 Current or past history of bipolar I disorder or schizophrenia  
 Developmental learning disorder or cognitive impairment 
 Major medical or neurological illness that could interfere with assessment or 
treatment 
 Treatment (psychotherapy and/or medication) for binge eating or other eating 
disorder in the previous 12 months. 




Data was also collected from a recruited control group of women who had no eating 
disorder (healthy control group).  The control group were recruited through community 
advertisements placed on notice boards in supermarkets, gyms, universities, buses and 
other public spaces around Christchurch.  Inclusion and exclusion criteria were the same as 
for the treatment group as described above, other than regular binge eating being an 
exclusion criterion rather than an inclusion one.  Absence of eating disorders symptoms in 
the control participants was determined using the Eating Disorders Examination (EDE), a 
structured clinical interview.  
Ethical approval was granted by the Upper South A Regional Ethics Committee for the 
initial BEP study and for the subsequent control group extensions (Ethics reference 
number: CTB/04/08/139).   
3.2 Participants 
Participants were recruited by referrals from General Practitioners, The Eating Awareness 
Team (EAT), The South Island Eating Disorders Service, as well as by self-referral 
through advertising.  Advertising posters were placed at tertiary institutions, on public 
buses, at supermarkets and gymnasiums in Christchurch.  Awareness of the study was also 
raised by newspaper articles.  Participation was voluntary and written informed consent 
was obtained.  One hundred and twelve women consented to participate in the 
psychotherapy study.  Figure 3.1  shows the number of women screened, eligible and 
completing neuropsychological and biological assessments is shown.  Fifty women were 

























Figure 3.1  Flow chart showing number of participants screened, eligible, and completing 
neuropsychological and neuroendocrine assessment    




11 Did not attend 
45 not BN/BED 
69 Psychotropic medications 
19 Other exclusion criteria 
43 Declined 
Attended clinical assessment: 
161 49 Excluded: 
13 Not BN/BED 
 5 Psychotropic medications 
 4 Other exclusion criteria 







Progressed to baseline 
assessments: 
112 
34 Did not complete 
neuroendocrine assessment: 
  8 Declined 
16 Poor veins 
10 Samples lost due to 
earthquakes and resulting loss of 




The comprehensive baseline assessment of eating disorder psychopathology, 
neuropsychological functioning and biological measures completed before the initiation of 
treatment of current binge eating symptoms is reported below. 
3.3 Procedure 
Potential participants were screened over the telephone by the study coordinator.  Those 
meeting entry criteria were then allocated to a study therapist who contacted the participant 
to organise the initial assessment (clinical interview to confirm diagnosis and confirm 
inclusion and exclusion criteria were met).  Informed written consent was gained at this 
point. Patient Information Sheets and Consent Form are reproduced Appendices A and B 
respectively. Participants were then scheduled for subsequent assessments.  
Neuroendocrine assessment was conducted in the morning and neuropsychological 
assessment in the afternoon.  Between these assessments participants were given lunch and 
had an hour of free time. Most participants completed both assessments on the same day 
but 25% of participants were unable to commit to this and their neuroendocrine and 
neuropsychological assessments were conducted on different days. All self-report 
questionnaires were completed on the day of the neuroendocrine assessment. 
3.4 Screening Instruments and Clinical Rating Scales 
Structured Clinical Interview I  for DSM-IV – Patient Version (SCID-IP, Spitzer, 
Williams, & Gibbon, 1987) is a clinician rated interview that assesses the presence of 
current and past Axis I major psychiatric disorders including eating disorders.  The SCID 
is made up of various modules that can be put together for a comprehensive assessment of 
mental health diagnoses.  In the current study the modules selected were:  Modules A and 




disorders. There has been a wide range of reliability scores reported for this measure.  
Factors affecting reliability include staff training, subject population and base rates.  
Zanarini et al., (2000) reported Kappa values for inter-rater reliability of 0.77 (good) and 
test re-test in 7 days of 0.64 (fair).  All staff were fully trained in administrating this 
measure.  Reliability data was not available for the SCID-I measures used in the current 
study, however, these most of the raters used in this study have conducted inter-rater 
reliability checks for Axis I in an anorexia treatment study and a depression study. The 
overall kappa for these range from 0.78 to 0.85 which suggests good concordance for these 
raters (Carter et al., 1999; Jordan et al., 2008).  Although the validity of categorical 
diagnostic systems has been widely debated the SCID-I has been described as the “gold 
standard” in determining diagnostic accuracy and has been found to be more accurate than 
standard clinical interviews (Basco et al., 2000; Fennig et al., 1994). 
The Global Assessment of Functioning (GAF), Axis V of Diagnostic and Statistical Manual  
4th Edition (DSM-IV, American Psychiatric Association, 1994) is a measure of current 
psychological, social and occupational functioning over the previous week.  Scores range 
from 0 to 100 and are grouped in bands describing levels of functioning.  For the current 
study the clinical aspects of eating disorder symptomatology were specifically considered 
along with other factors such as levels of anxiety and depression, and social and occupational 
functioning.  Guidelines for rating the GAF, developed for the current study are reported in 
Appendix C.   
The GAF has been criticised for problems with reliability and validity partly due to the 
minimal guidelines for administrators (Aas, 2011).  Despite these difficulties good inter-
rater reliability has been reported where administrators have been trained in using this 




(good).” In the current study those administrating the GAF discussed each GAF rating as a 
group to overcome some of this difficulty. 
The Eating Disorder Examination  (EDE), is a semi-structured interview designed to 
assess eating disorder psychopathology over the previous 28 days (Cooper, Cooper, & 
Fairburn, 1989).  It comprises of four subscales; Restraint, Eating Concern, Shape Concern 
and Weight Concern.  Items are scored on a scale from 0 to 6 depending on the prevalence 
of the behaviour.  It is extensively used for diagnosing eating disorders in research settings 
(Guest, 2000) and is seen as the ‘gold standard’. It has good validity and reliability (for a 
systematic review see Berg et al., 2012). 
The Eating Disorders Inventory-2  (EDI-2) is a 91 item self-report questionnaire 
measuring behaviours and other psychological constructs related to eating disorders 
(Garner, 1991).  Items are rated on a 7 point scale from 6 (never) to 1 (always).  Eight 
subscales are calculated; Drive for Thinness, Bulimia, Body Dissatisfaction, 
Ineffectiveness, Perfectionism, Interpersonal Distrust, Interoceptive Awareness, and 
Maturity Fears.  The first three subscales assess eating disorder specific attitudes and 
behaviours, whereas the following five subscales investigate more general psychological 
constructs.  The EDI has good reliability, particularly in adult clinical samples (Gleaves et 
al., 2014).  This test was administered in pen and paper form as part of a larger booklet of 
self-report questionnaires.  Note that since the initiation of this study the EDI-3 was 
released in 2004.  This updated measure has six composite scores which cannot be directly 
compared with the EDI-2. 
The Barratt Impulsiveness Scale -11 (BIS-11) is a 30 item self-report measure of 
impulsivity (Barratt, 1994).  It is comprised of three subscales; Non-planning which 




Cognitive which measures impulsive thinking and lack of patience.  The Barratt 
Impulsiveness Scale -11  has good test-retest reliability and convergent validity (Stanford 
et al., 2009).  This test was administered in pen and paper form as part of a larger booklet 
of self-report questionnaires. 
The Edinburgh Handedness Inventory assesses hand dominance using 10 items including 
preferred hand for writing, drawing and throwing (Oldfield, 1971).  Handedness has been 
found to influence some aspects of cognitive functioning (Lezak et al., 2012).  The 
Edinburgh Handedness Inventory has good test-re-test reliability (McMeekan & 
Lishmman, 1975; Ransil & Schachter, 1994) and internal consistency (Dragovic, 2004).  
This test was administered in pen and paper form as part of a larger booklet of self-report 
questionnaires.   
The Neuropsychology Demographic Questionnaire was designed specifically for the 
current study to obtain information factors that could influence neuropsychological test 
performance.  It includes items on the need for hearing or visual aids, and alcohol, 
cannabis, caffeine and nicotine use in the 24 hours preceding the assessment. The 
questionnaire is reproduced in Appendix D. This test was administered in pen and paper 
form at the beginning of the neuropsychological assessment. 
 
3.5 Demographic Factors  
Information was collected on age, ethnicity, marital status and years of education. 
3.6 Physical Measurements 
Physical measurements were collected as part of the baseline biological assessment carried 




body fat were measured using the Tanita Body Composition Analyzer Electronic Scale 
(Model TBF-300).  Body Mass Index (BMI), was calculated by the following equation:  BMI 
= weight (kilograms) divided by height squared (metres squared).  A BMI of less than 20 is 
considered to be underweight, 20-25 is considered to be a normal, healthy weight, whereas 
a BMI of between 25 and 30 is considered overweight and BMI over 30 is classified as obese 
(World Health Organization, 2000).  
3.7 Neuropsychological Assessment 
A battery of neuropsychological tests was selected to cover a broad range of 
neuropsychological functions and each test is described more fully in the following 
section. Tests included were based on previous research on neuropsychological function in 
women available at the time of initiation of this project. 
Premorbid intellectual functioning was assessed as this is a potential confounding factor in 
neuropsychological functioning.  Motor functioning was important to include as motor 
skills are required to successfully carry out some of the subsequent tests that were 
administered.  A range of basic neuropsychological skills were tested including attention, 
verbal and visuo-spatial memory and learning, and inhibitory control.  These skills are not 
only informative in their own right but impairment on these tasks may have implications 
for interpreting performance on tasks of executive function which require some ability in 
lower order neuropsychological skills (Lezak et al., 20012).  Executive functions examined 
in the current study were set-shifting and planning.  Unfortunately at the time the current 
study was being developed, neuropsychological domains such as central coherence and 




3.7.1 National Adult Reading Test  
The National Adult Reading Tests is a list of 50 phonetically irregular words developed by 
Nelson & O'Connell, (1978).  It is assumed that correct pronunciation infers familiarity 
with the word and hence higher intellectual ability.  NART scores are correlated with IQ 
scores in the region of 0.72, and as word pronunciation is somewhat resistant to cognitive 
decline, NART scores are used as a measure of pre-morbid intellectual ability.  Individuals 
for whom English is not their first language have been shown to be disadvantaged in this 
test even if they are fluent English speakers (Struben & Tredoux, 1989), reported in (Lezak 
et al., 2012).  NART scores are correlated with education (r = 0.51), social class (r = 0.36) 
and age (r = -0.18) (Crawford, Moore, & Cameron, 1992). 
3.7.2 CANTABeclipse Neuropsychological battery 
The majority of tests administered were part of the CANTABeclipse computerised 
neuropsychological battery developed by Cambridge Cognition Limited (2004) to 
differentiate between those with and without dementia (Robbins et al., 1994).  This 
comprehensive battery has been widely used both in the general population and with 
samples of those with mental health diagnoses including schizophrenia (Bartok et al., 
2005), mood disorders (Matthews et al., 2008) and anorexia nervosa (Fowler et al., 2006).  
CANTABeclipse had not been used in an eating disorder population at the time of the 
current study development.  Tests included in this battery were assumed to test the same 
domains as their non-computerised versions although more recent investigation suggests 
that this may not always be the case (Lenehan et al., 2016).  Despite over 1300 published 
articles using CANTAB test batteries there is a surprising lack of independent reliability 
and validity information available (Lenehan et al. 2016).  The suitability of this test battery 




Individual tests selected from the CANTABeclipse battery used in the current study are 
described below. 
3.7.3 Motor Screening  
The purpose of this test is twofold; first to train the participant to use the computer and 
touch screen, and second to screen for difficulties with vision, movement and 
comprehension that may affect subsequent tests.  The participant is asked to touch a series 
of crosses that appear in different locations across the screen.  Latency to respond (ms) and 
accuracy are recorded.  
3.7.4 Affective Go/No-go  
Affective Go/No-go is a test of processing bias for positive and negative stimuli and as a 
measure of the ability to inhibit erroneous responses.  In this test, participants are presented 
with a series of words which are briefly displayed (300ms) in the centre of the screen.  The 
words are each one of three valences: 
 Positive (e.g. joyful, warmth, courage) 
 Neutral (e.g. item, pause, element) 
 Negative (e.g. mistake, hopeless, burden) 
Participants are given a target valence and are required to press the response pad when 
they see a word matching the target valence.  They are instructed to respond as fast as they 
can whilst trying not to make mistakes.   Words are presented at intervals of 900ms in 
blocks of 18.  Within blocks only two valences are presented – positive and negative, 
positive and neutral, or neutral and negative.  A total of 20 blocks of words are presented 




and participant are aware of the target valence and distractor valence for each block 
presented as this is displayed on the screen between blocks.  
The main outcome variables fall into three categories: mean correct responses, total 
commissions (response in absence of target stimuli) and total omissions (absence of 
response in the presence of target stimuli).  These variables are differentiated depending on 
the valence of the target word and whether there is a shift in valence from the previous 
condition; shift to a negative valence (SN), shift to a positive valence (SP) or shift to a 
neutral valence (SO).  An Emotional Bias Index  (EBI) defined as  [latency to shift 
negative targets] – [latency shift to positive targets] was also calculated (Maalouf et al., 
2012).   
3.7.5 Big/Little Circle  
Big/Little Circle is a training test for the Intra-Extra Dimensional Set Shifting test in which 
participants are required to follow a simple rule and then reverse the rule.  Participants are 
presented with a pair of circles, one big and one small.  They are required to touch the 
small circle for the first 20 trials and then switch to the big circle for the subsequent 20 
trials.  The variables reported are % correct response and latency of correct responses (ms). 
3.7.6 Intra-Extra Dimensional Set Shift  
The Intra-Extra Dimensional Set Shifting test was developed from the Wisconsin Card 
Sorting Test and is reported to be sensitive to cognitive changes associated with the fronto-
striatal areas of the brain (Cambridge Cognition, 2004).  It is designed to measure 
attentional flexibility by requiring the participant to reverse a previously correct rule (intra-
dimension) and then to shift attention from a previously correct dimension to a previously 




response by choosing between two block colour shapes and they later learn to shift 
attention to white line shapes (see Figure 3.2).   
After six correct responses the rules are changed and the next stage is reached. There are 
nine stages which progress in demand from shape discrimination (two pink shapes), 
compound discrimination (two pink shapes and two white line shapes), intra-dimensional 
shifts (maintaining responses to the pink shapes) and extra-dimensional shifts (switching 
from pink shapes to white lines). If six consecutive correct answers are not made the trial 
terminates after 50 incorrect responses.  Performance is assessed by the number of errors, 
number of trials, and number of stages reached.  
 
Figure 3.2 An example of an Intra-Extra Dimensional Set Shift screenshot showing pink 
shapes and white lines 
 
3.7.7 Delayed Matching to Sample  
Delayed Matching to Sample is a test of visual memory.  Participants are shown a complex 
figure, made up of four different elements which vary in pattern and colour (Figure 3.3).  
After a brief delay, participants are required to select the matching figure from a selection 
of four options.  All four options have one quadrant in common with the target figure to 




presented followed by 20 counterbalanced test trials.  Delays vary from simultaneous 
presentation to zero, four or twelve second delays.   
Variables reported for DMS are the percent correct over all delays, mean latency (the mean 
delay to respond correctly over all delays measured in milliseconds) and two further 
variables, DMS A and DMS B, which involve analysis of the style of responding.  DMS A 
is a measure of the probability that the participant will make an error following an error.  
The score ranges between 0 and 1 with high scores indicating a higher likelihood of an 
error following a previous error, i.e. a measure of an individual’s sensitivity to making an 
error independently of how many errors they make.  DMS B measures the strength of the 
effect of making an error.  Scores range from -1 to +1.  A negative score indicates many 
errors regardless, whereas a high positive score indicates the participant is likely to make 
errors only if they have just made an error in the previous response.  DMS B is thought to 
give an indication of the emotional response to an error (Cambridge Cognition, 2004).  
 
 
Figure 3.3 Delayed Matching to Sample screenshot showing a simultaneous presentation 





3.7.8 Rapid Visual Information Processing  
Rapid Visual Information Processing is a test of sustained visual attention, which is 
thought to be sensitive to the parietal and frontal lobes (Cambridge Cognition, 2004).  
Digits appear in a white box in the centre of the screen in a pseudo-random order (see 
Figure 3.4).  Participants are required to respond using a press pad when they detect the 
target sequence of 3 numbers (e.g. 2-4-6, 3-5-7, or 4-6-8).  Digits are presented at a rate of 
100 per minute and target sequences occur at the rate of 16 every two minutes.  Initially 
participants complete a practice phase of two minutes duration followed by a test phase of 
three minutes duration. The rate of correct identification, false responses (incorrect 
identification of a target sequence) and misses are reported.  
 
 
Figure 3.4  Rapid Visual Information Processing screenshot showing number in the centre 





3.7.9 Stockings of Cambridge  
Stockings of Cambridge is a measure of spatial planning and is based on the Tower of 
London Task (Shallice, 1982).  Participants are presented with images of two series of 
hanging stockings with coloured balls (see Figure 3.6).  Participants are asked to move the 
coloured balls in the lower display so they match the pattern in the upper display.  If there 
is a target ball beneath another ball, the top ball must be moved first. The position of 
individual balls can be changed by touching the ball to be moved and then touching the 
position where it is to be moved to.  As the test progresses, the number of moves needed to 
match the upper pattern increases, hence increasing the demand on the participant.  If a 
participant fails to solve the problem in less than double the minimum number of moves 
then the next problem is presented.  Failure on three problems in a row will terminate the 
test. Performance is measured by the number of problems solved using the minimum 
number of moves, the mean number of moves for each level of problem (2, 3, 4, and 5 
moves), initial thinking time (time taken before the first move is made) and subsequent 






Figure 3.5 Stocking of Cambridge screenshot showing hanging stocking with coloured 
balls.   
 
3.7.10 Spatial Recognition Memory  
Spatial Recognition Memory assesses the ability to recall spatial information.  Participants 
are presented with a white square which appears in five different locations on the screen in 
sequence.  The participants are then given a forced-choice in which they are asked to 
choose which one of two white squares presented is in a position that they have seen 
before.  Results are reported as the number correct, percent correct, and mean correct 
latency (ms).  
3.7.11 Spatial Working Memory  
Spatial Working Memory measures the ability to retain spatial information and to 
manipulate this information in working memory.  Participants must find blue “tokens” 





Figure 3.6  Spatial Working Memory Screenshot showing examples of coloured boxes 
(light blue) under which a token may be hidden.  An uncovered token (dark blue) is shown 
in the opened box at the top of the screen.  
 
As the test progresses the number of boxes increases, thereby increasing the load on 
working memory.  Results are reported as Between Errors (the number of times a 
participant revisits a box in which a token has previously been found), Within Errors (the 
number of times a box is revisited during a search that was already found to be empty 
during the same search), Total Errors (combined Between and Within Errors) and Strategy 
(how efficient the search strategy was, with a high score representing poor use of strategy 
and a low score representing effective use of the strategy). 
3.7.12 Verbal Recognition Memory  
Verbal Recognition Memory tests recall and recognition of verbal information using both 
immediate and delayed conditions.   Participants are shown a list of 12 words, one at a 
time, on the computer screen.  The participants are asked to state as many words from this 
list as they can recall (immediate recall condition).  The test administrator then reads out a 
list of 24 words, 12 of which were words presented on the screen along with an additional 
12 distractor words. The participant is asked to respond whether each word was on the 




are asked to recognise the original words from a list of 24 words containing the 12 original 
words and 12 new distractor words (delayed recognition condition).  This test does not 
include a learning component as some other verbal recall tests such as the Rey Auditory-
Verbal Learning Test and California Verbal Learning Test.  
Outcome variables for this test are the number of words recalled in the immediate 
condition, the number of words recognised in the immediate condition and the number of 
words recalled in the delayed condition. 
3.7.13 Trail Making Test  
This pen and paper test was developed as part of the Army Individual Test Battery in 1944 
and has been widely used since this time (Bowie & Harvey, 2006).  It is a measure of 
visual attention and tracking ability. There are two parts; A and B.  In the A condition the 
participant must draw lines to connect consecutively numbered circles.  Condition B is 
more complex as it requires participants to alternate between circles with numbers and 
circles with letters.  Instructions are given to connect the circles as quickly as possible 
without making errors. Each form is scored for the time taken to complete and the number 
of errors.  The time to complete each stage is recorded.  In the current study a proportional 
score was calculated using the equation (B-A)/A which is thought to compensate in part 
for the effect of basic motor skills and is therefore more sensitive to prefrontal cortex 
functioning (Stuss et al., 2001) and has been used as a measure of set-shifting.  
3.7.14 Order of administration 
Tests were administered in the same order to all participants. The order of tests was 
consistent with requirements for some tests to include delayed testing after specific time 




1. Demographic questionnaire 
2. Motor screening (CANTAB) 
3. Rapid visual information processing (CANTAB) 
4. Verbal recall and recognition memory – immediate (CANTAB) 
5. Verbal recognition memory – delayed (CANTAB) 
6. Trail making test 
7. Affective go/no-go (CANTAB) 
8. Big circle/little circle (CANTAB) 
9. I/ED set shift (CANTAB) 
10. Stockings of Cambridge (CANTAB) 
11. Spatial recognition memory (CANTAB) 
12. Delayed matching to sample (CANTAB) 
13. Spatial working memory (CANTAB) 
14. Nation Adult Reading Test 
Duration of the neuropsychological test battery was approximately 110 minutes. 
3.8 Data Management 
Data were entered into the study database.  All paper copies of self-report questionnaires, 
clinical interviews and physical measurements/blood results were stored in a locked filing 
cabinet in the Department of Psychological Medicine, University of Otago, Christchurch, 
and were available for data checking. 
3.9 Statistical Analysis 
Results were analysed using IBM SPSS Version 22.  Variables were checked for missing 




a high number of zero responses e.g. vomiting frequency or the number of errors made on 
some tests) these variables were converted to categorical variables.  Where some variables 
were approaching normality it was decided that the sample size allowed analysis of these 
variables using parametric techniques.  The validity of this was tested by re-analysing 
variables with non-parametric techniques.  For variables that could not be transformed to a 
normal or near normal distribution non-parametric statistics were used.  Descriptive 
statistics were used to describe the sample characteristics. 
Comparisons of neuropsychological performance among the three diagnostic groups 
(bulimia nervosa, binge eating disorder, and healthy controls) were made using Analysis of 
Variance (ANOVA) for continuous variables and Chi-square analysis for categorical 
variables.  Results are reported as means and standard errors for continuous variables and 
number and percentage for categorical variables. Post hoc analysis was carried out using 
Least Significant Difference (LSD) analysis.   
 Analysis of neuropsychological performance was repeated using an Analysis of Co-
variance (ANCOVA) to control for differences among the three groups with respect to age.   
Z score analysis was used to determine whether the current sample differed from published 
norms.  Correlational analysis was used to investigate associations between 
neuropsychological performance and variables from the Barratt Impulsivity Scale.   
Although there were a large number of analyses carried out it was decided after 
consideration not to apply a Bonferroni correction for the following reasons: 
 The analyses are seen as largely exploratory as there are few studies to date that 




populations. The analyses are intended to generate hypotheses which would need 
further research. 
 Within the groups of variables the analyses are testing a range of correlated 
outcomes which would mean an application of a Bonferroni correction would be 
excessively conservative. 
 Using a LSD analysis approach provides some adjustment for comparison amongst 
the different groups (that is comparisons between two groups is only done where a 
significant difference among all the groups was found).  Overall a cautious 
approach has been used when interpreting significant differences among the groups 
and use of a Bonferroni correction is unlikely to alter the conclusions of this 
research. 
3.10 Power Calculation 
For clinical significance in neuropsychology research a medium effect size is considered 
necessary  and a power of 0.8 is recommended (Bezeau & Graves, 2001).  A sample size 
of  at least 135 allows detection of a medium effect size at a level of significance of p < 0.5 
with statistical power of  at least 0.8 (Cohen, 1992).   A sample size of 25 would be able to 
detect a large effect size at a level of power about 0.8 or less depending on the type of 
analysis. These sample sizes were exceeded in the neuropsychological section of the 





4. RESULTS: NEUROPSYCHOLOGICAL FUNCTIONING 
4.1 Demographic Characteristics by Diagnostic Group 
Demographic characteristics among the three groups (BN, BED and HC) were compared 
using ANOVA for continuous variables and Chi-square for categorical variables.  Results 
are reported in Table 4.1. Women in the BED group were significantly older and had 
higher BMIs than those in either the BN or HC groups.  There were no differences among 
the groups for years of education or pre-morbid intelligence (NART scores).  There were 
no differences among the groups for ethnicity.  The majority of the sample (85.6%) were 
New Zealand European/Other Caucasian, with 8.8% Maori, and 5.6% Asian.   
Table 4.1  Comparison of demographic characteristics by diagnostic group. 
 BN  
n =58 
mean (sd)  
or n (%) 
BED 
n =54 
mean (sd)  
or n (%) 
HC 
n=48 
mean (sd)  




p d Post Hoc  
(LSD) 










15.2 (2.3) 15.5 (3.4) 15.7 (2.9) 0.46 a 0.46   
NART 104.0 (7.4) 105.9 (7.8) 104.8 (8.3) 0.75 a 0.48   
Ethnicity: 















7.89 b 0.10   
a = ANOVA df = (2,156); b = Chi square (χ2); d = Cohen’s d;  BN = bulimia nervosa; BED = binge eating 





4.2 Potential Confounding Factors on Neuropsychological 
Performance 
Factors which could potentially impact on neuropsychological functioning were compared 
among diagnostic groups.  Results of ANOVA for continuous variables and Chi-square for 
categorical variables are reported in Table 4.2.   
Usual daily caffeine intake did not differ among the groups but there was a trend towards 
higher caffeine consumption in the binge eating groups.  Overall participants reported 
reduced consumption of drinks containing caffeine on the day of testing compared with 
their usual pattern. As 75% of participants were fasting for a biological assessment in the 
morning, before neuropsychological testing in the afternoon this is not unexpected.  The 
remaining 25% of the sample completed the two assessments on different days and so were 
able to have their usual caffeine intake on the day of neuropsychological testing.  There 
was a difference among the groups for caffeine intake on the day of testing with both binge 
eating groups having higher consumption than the control group.  To check whether 
caffeine ingestion may have contributed to neuropsychological performance the total 
sample was divided into those that had consumed a caffeine drink before testing and those 
that had not.  A 2-tailed t test found no significant differences between the two groups on 
any of the neuropsychological test variables.  This suggests that caffeine did not have a 
significant impact on neuropsychological functioning. 
No differences were found among the three groups for recent consumption of alcohol or 
medications within the previous 24 hours.   The medications reported by participants were 
paracetamol, ibuprofen, salbutamol (Ventolin) and aspirin and were unlikely to impact on 




with three participants having used cannabis within 24 hours of testing.  One participant 
had used cannabis with 12 hours of testing (2.5 hours before).  This participant’s results 
were retained in the analyses as they were found not to be different from the bulimia 
nervosa group results. 
Table 4.2  The prevalence of potential confounding variables on neuropsychological 
performance by diagnostic group 
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2.02 a 0.12   






1.59 b 0.45   






5.33 b 0.07   








7.17 b 0.03   






4.18 b 0.38   






6.91 b 0.03   






1.06 b 0.59   








2.03 b 0.36 
 
  






8.32 b 0.02   
a = ANOVA, df = (2,156); b = Chi square (χ2);  d = Cohen’s d; 
BN = bulimia nervosa; BED = binge eating disorder; HC = healthy controls; 
*2 BED participants reported being ambidextrous  
**glasses or contact lenses 
# Hearing impairments were only slight impairment, or only in one ear (self-reported).  One 
participant wore hearing aids.  
## History of brain injury/neurological problems was from self-report. Problems reported 
included loss of consciousness, previous bicycle accident or car accident.  Some participants 
reported seizures but all were of mild seriousness and were not recent events. Neurological 
illnesses were reported by two participants, one having a history of migraines and the other a 





No differences were found among the groups for handedness, hearing impairment or 
history of brain injury or neurological condition.  Significantly more of the BED group 
required glasses or contact lenses compared with the other two groups.  All participants 
requiring visual aids used them during neuropsychological testing. The BED group 
reported significantly higher levels of current medical illness (see Table 4.3 for a list 
illnesses reported).  Differences in the need for visual aids and increased rate of illness is 
likely to be due to the higher average age of the BED group. 
Table 4.3 Current medical illnesses reported by all participants on the day of 
neuropsychological testing 
Illness reported Number of participants 
Arthritis 1 
Asthma 4 
Broken arm (non-dominant) 1 
Chronic fatigue syndrome 1 
Coeliac 1 








Irritable bowel 2 
Kidney reflux 1 
Leukaemia in remission 2 
Osteoarthritis 2 
Polycystic ovary syndrome 7 
Skin cancer 1 





4.3 Neuropsychological Test Performance by Diagnostic Group  
The results comparing neuropsychological functioning among BN, BED and HC groups 
are presented below.  As there were significant differences among the groups for both age 
and BMI, these variables were used as co-variates in subsequent analyses.  ANCOVA was 
used for continuous variables and Chi-square analysis was used for categorical variables.  
All results are reported as mean and standard error for continuous variables and number 
and percentage for categorical variables.  Effect sizes have been calculated for ANOVA 
and ANCOVA analyses using Cohen’s d (d = Mean1-Mean2 / pooled standard deviation).   
4.3.1 Motor function  
Comparison of motor function among the groups is presented in Table 4.4.  No differences 
were found among the three groups for accuracy of motor response measured by the mean 
number of errors.  However, the BED group had a significantly lower mean latency than 
the BN and HC groups, indicating that overall the BED group responded more quickly to 
the presented stimuli.  
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#  = ANCOVA (F), df = (2,156), age and BMI as covariate;  d =  Cohen’s d 






Attention was measured by the Rapid Visual Processing Test and results from this test are 
reported in Table 4.5.  No differences were found among the three groups for measures of 
accuracy, and latency to respond.  














RVP total hits 18.60 (0.69) 17.35 (0.60) 18.56 (0.59) 0.42 0.66 
RVP total misses 8.38 (0.69) 9.65 (0.60) 8.42 (0.58) 0.44 0.65 
RVP mean latency (ms) 408 (12) 428 (11) 423 (10) 0.61 0.51 
# ANCOVA, df = (2,156), age and BMI as covariates;  BN = bulimia nervosa; BED = binge eating disorder; 
HC = healthy controls;  RVP = Rapid Visual Information Processing.  
 
4.3.3 Memory and learning 
Comparisons of performance on verbal and visuospatial memory and learning among the 
groups are presented in Table 4.6.  On a test of verbal memory (Verbal Recognition 
Memory) the BED group recalled fewer words in the Free Recall condition compared with 
the BN and HC groups.  The BED group gave more false positive responses in the delayed 
recognition condition compared with the HC group (χ2  = 9.65, df=1,  p=0.002).  No other 
significant differences were found among the groups on tests of verbal memory.    
No significant differences were found among the three groups for accuracy or speed on the 
Spatial Recognition Memory Task.  No significant differences were found among the three 
groups for accuracy or speed of response on the learning task Delayed Matching to Sample 
test. No significant differences were found among the groups on the learning strategy 




accuracy or speed on the Spatial Working Memory test.  No significant differences were 
fund on the Spatial Working Memory strategy measure. 
Table 4.6 Comparison of verbal and visual memory and learning by diagnostic group 
 BN 
n=58 









p d Post Hoc 
(LSD) 
VRM free recall  8.48   
(0.22) 
7. 65   
(0.24) 












0.40 0.67   






1.30 0.28   






1.88 0.16   








0.44 0.64   






0.46 0.63   








0.06 0.94   






0.17 0.85   






2.35 0.10   








0.34 0.72   








0.83 0.44   






0.36 0.70   






0.53 0.59   
#  ANCOVA, df = (2,156), age and BMI as covariates;  d =  Cohen’s d; BN = bulimia nervosa; BED = binge 
eating disorder; HC = healthy controls; DMS = Delayed Matching to Sample;  SRM = Spatial Recognition 
memory;  SWM = Spatial Working Memory;  VRM = Verbal Recognition Memory 
 
4.3.4 Executive function 
Set shifting was assessed using the Big Circle/ Little Circle test, the Intra-Extra Dimensional 
Set-Shift test, and the Trail Making Test.  The Big Circle/Little Circle Test (BCLC) is a 




comprehension, learning and reversal skills which are required before the IED is 
administered.  There were no significant differences in accuracy or latency to respond 
among the groups on BCLC.  All groups scored highly on this test which suggests skill 
level was at the required level to continue to the IED test.  There were no significant 
differences among the three groups for the number of errors on the IED.  However, on 
average, the BN group completed more stages than the healthy control group. A greater 
proportion of the BN (82.8%) and BED (77.8%) groups completed all nine stages 
compared to of the healthy control group (60.4%).  There were no significant differences 
among the groups in the proportion of participants that made at least one error on Part B, 
the time to complete Part B or the Trail Making Test proportional score. 
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0.61   








2.42   
(2,158) 











0.02 0.50 BN>HC 








7.37 b 0.03   
TMT B time (s) 57.5 
(2.7) 






0.67   



















0.19   
# ANCOVA, df = (2,156), age and BMI as covariates; b = Chi square (χ2);   d = Cohen’s d; BN = 
bulimia nervosa; BED = binge eating disorder; HC = healthy controls;  BCLC = Big Circle/Little Circle; 






Inhibitory control and attentional bias to emotional targets was tested in the Affective 
Go/no-go (AGN) test and results are reported in Table 4.8.  No significant differences were 
found in latency of a correct response among the groups.  There were no statistical 
differences in the number of commission errors or omission errors among the groups. 














AGN SO mean correct latency (ms) 587 (11) 605 (11) 590 (12) 0.46 0.64 
AGN SP mean correct latency (ms) 526 (9) 539 (9) 524 (10) 0.24 0.79 
AGN SN mean correct latency (ms) 518 (9) 530 (8) 528 (10) 0.44 0.65 
AGN SO commissions 4.2 (0.4) 4.6 (0.4) 3.9 (0.4) 1.13 0.34 
AGN SP commissions  2.9 (0.4) 4.1 (0.4) 3.2 (0.5) 2.17 0.12 
AGN SN commissions  1.9 (0.3) 2.3 (0.3) 2.3 (0.4) 0.67 0.51 
AGN SO omissions 4.3 (0.5) 4.1 (0.5) 4.7 (0.6) 0.25 0.78 
AGN SP omissions  2.3 (0.3) 2.8 (0.4) 3.1 (0.4) 1.19 0.31 
AGN SN omissions  1.5 (0.2) 1.7 (0.3) 1.7 (0.3) 0.19 0.83 
# ANCOVA, df = (2,156), age and BMI as covariates; BN = bulimia nervosa; BED = binge eating 
disorder; HC = healthy controls; AGN SN = Affective Go/No-go Shift Negative; AGN SO = Affective 
Go/No-go Shift Neutral; AGN SP = Affective Go/No-go Shift Positive.   
 
An Emotional Bias Index  (EBI) defined as  [latency to shift negative targets] – [latency 
shift to positive targets] was calculated (Maalouf et al., 2012).  There was no statistical 
difference among the three groups (F(2,156) =1.29, p=0.28) despite the mean Emotional 
Bias Index  being positive for the HC group but negative for both the BN and BED groups 





Figure 4.1 Emotional Bias Index by diagnostic group. 
Mean and standard error shown.  A negative score indicates a bias for negative stimuli 
whereas a positive score indicates a bias for positive stimuli. 
Problem solving was assessed with the Stockings of Cambridge Test (SOC) and results of 
a comparison among the groups are presented in Table 4.9. No significant differences were 
found among the groups for the number of problems solved in minimum moves.  On 5- 
move problems there was no significant difference among the groups for the mean number 
of moves taken to solve the problem. No significant differences were found among the 

















































0.61  0.55 








0.30  0.74 
SOC mean initial  thinking time  







2.10  0.13 
SOC mean subsequent thinking time 







0.53  0.59 
# ANCOVA, df = (2,156), age and BMI as covariates; BN = bulimia nervosa; BED = binge eating 
disorder; HC = healthy controls; SOC = Stockings of Cambridge. 
 
4.3.5 Comparison with CANTAB test norms 
Very few significant differences were found between the binge eating groups and the 
healthy control group.  Results were combined and compared to Cambridge CANTAB test 
norms to assess whether the results found in the current study differed significantly from 
what had been found previously in other studies using the CANTABeclipse test battery.  
Norms were obtained directly from CANTAB on request.  Norms supplied were for adult 
females, aged between 16 and 80 years, with IQ range between 100 and 110. Z scores were 





Table 4.10  Z scores for neuropsychological variables based on CANTAB norms for adult 
females, IQ range 100-110. 





 mean sd mean sd   
MOT mean error 9.26  2.55 18.79 24.61 0.39 65 
MOT mean latency (ms) 937  233 1015 279 0.28 61 
RVP total hits 18.17  4.64 16.92 3.74 -0.33 63 
RVP mean latency 419  81 485 90 0.74 77 
BCLC mean correct latency (ms) 810  193 738 121 -0.60 73 
BCLC % correct 99.95  0.34 100 0.0 0.00 50 
IED total errors adjusted 26.22  21.93 34.31 29.71 0.27 61 
IED stages completed 8.52  0.86 8.39 1.11 -0.12 55 
IED total trials adjusted 98.41  39.18 96.76 42.59 -0.04 52 
SOC problems in min moves 9.29  1.74 8.03 2.22 -0.57 72 
SOC mean moves  6.31  1.33 6.4 1.32 0.07 53 
SOC mean initial thinking time (ms) 12239  8897 12468 10352 0.02 51 
SOC mean subsequent thinking time (ms) 1449  2867 2069 2194 0.28 61 
SRM number correct 18.26  1.74 15.8 1.23 -2.00 98 
SRM mean correct latency (ms) 2244  577 2314 854 0.08 53 
DMS % correct  88.04  10.23 75.39 12.49 -1.01 84 
DMS mean correct latency (ms) 3838  1387 3828 1055 -0.01 50 
DMS A' 0.53  0.24 0.51 0.2 -0.10 54 
DMS B"  -0.85  0.38 -0.41 0.58 0.76 78 
SWM between errors 20.57  16.05 39.14 26.43 0.70 76 
SWM within errors  1.29  2.44 3.03 5.48 0.32 62 
SWM total errors 21.13  16.40 23.26 17.9 0.12 55 
SWM strategy  31.39  5.60 34.98 5.11 0.70 76 
BCLC = Big Circle/Little Circle; DMS = Delayed Matching to Sample;  IED = Intra-Extra 
Dimensional Set-Shift; NART = National Adult Reading Test;  RVP = Rapid Visual Information 
Processing;  SOC = Stockings of Cambridge; SRM = Spatial Recognition Memory;  SWM = 
Spatial Working Memory; VRM = Verbal Recognition Memory 
 
Participants in the current study were more accurate and faster in completing the motor 
screening tasks compared with the CANTAB norms.  In the current study Z scores were at 






In the Rapid Visual Information Processing Test, the current study had similar accuracy to 
the CANTAB norms but were faster to respond. On average fewer errors were made in the 
current study than the CANTAB norms in the Intra-Extra Dimensional Set-shift Test.  In 
the Stockings of Cambridge Test the current study sample solved problems in fewer moves 
and although the initial thinking time was not very different to the normative values, 
thinking time for subsequent moves was shorter suggesting that overall the current study 
participants were more accurate and faster than the CANTAB norms. The current study 
participants were faster and more accurate on all measures on the Spatial Recognition 
Memory and Spatial Working Memory Tests.  Finally, in the current study participants 
were more accurate in the Delayed Matching to Sample Test.  There were no 
neuropsychological variables in which the current study mean scores were below the 50th 
percentile of the CANTAB norms. This suggests that participants in the current study had 
a higher level of neuropsychological functioning overall.   
 
4.4 Eating Disorder Psychopathology 
Differences in eating disorder psychopathology among the groups are reported in Table 
4.11.  Significantly more of the BN group had a history of anorexia nervosa compared with 
the BED and HC groups. The BED group had a significantly longer duration of any eating 
disorder compared with those in the BN group.  The BN group scored more highly on the 
EDI Total score than the BED group but this was not statistically significant.  The BN and 
BED groups had lower GAF scores than the HC group indicating a lower level of overall 






Table 4.11 Comparison of eating disorder psychopathology by diagnostic group. 















p d Post Hoc 
(LSD) 
History AN 
9     
(15.5%) 
1    
(1.9%) 
0 13.48 b 0.001   






_ 2.73c 0.01 0.51  




_ 1.70c 0.09   








a = ANOVA df = (2,156),; b = Chi square (χ2);  c = t test (t);  d =  Cohen’s d;  *** = p<0.001;  AN = anorexia 
nervosa; BN = bulimia nervosa; BED = binge eating disorder; ED = eating disorder; EDI-2 = Eating Disorder 
Inventory-2;  HC = healthy controls;  GAF = Global Assessment of Functioning. 
 
The associations between neuropsychological variables and measures of eating disorder 
severity, and global functioning for the BN and BED groups combined (n=112) was 
investigated with Pearson’s product-moment correlation coefficients.  Results of the 
analysis are reported in Table 4.12.  There were no significant correlations between the 
number of binges in the four weeks before testing and any of the neuropsychological 









Table 4.12  Correlations between measures of eating disorder psychopathology and 
neuropsychological variables in the binge eating sample (n=112) 
 
Test  Binges past 
4 weeks 
Duration of 




NART IQ -0.05 0.34** 0.28** 0.09 
Motor function     
MOT mean error -0.09 -0.04 0.07 0.01 
MOT mean latency (ms) -0.021 0.16 -0.12 -0.05 
Visual Attention     
RVP total hits -0.08 -0.19* 0.01 0.06 
RVP total misses 0.08 0.19* -0.01 -0.07 
RVP mean latency (ms) -0.12 0.21* -0.11 -0.15 
Memory      
VRM free recall  0.13 -0.28** 0.16 -0.04 
VRM recognition  0.05 -0.19* 0.04 0.01 
VRM recognition delayed  0.15 -0.17 0.08 0.07 
SRM number correct -0.09 0.10 -0.03 0.11 
SRM mean correct latency (ms) 0.07 0.14 -0.04 -0.10 
DMS % correct  0.09 -0.17 -0.16 -0.02 
DMS mean correct latency (ms) 0.13 0.31** -0.20* 0.04 
DMS A' 0.30 -0.35 0.29 -0.20 
DMS B" -0.10 -0.11 0.16 0.06 
SWM between errors 0.01 0.28** 0.10 -0.03 
SWM within errors -0.04 0.21* 0.17 0.01 
SWM total errors 0.00 0.29** 0.11 -0.03 
SWM strategy -0.02 0.17 -0.06 -0.04 
Set-shifting     
IED total errors adjusted -0.10 0.19* -0.05 0.09 
IED stages completed 0.11 -0.11 0.03 -0.13 
IED total trials adjusted -0.11 0.19 -0.05 0.10 
TMT proportional score  0.01 0.09 -00 -0.10 
Inhibitory control     
AGN SP mean correct latency (ms) 0.02 0.16 -0.14 -0.23* 
AGN SN mean correct latency (ms)  0.07 0.10 0.03 -0.15 
AGN SP commissions  -0.01 0.22* -0.01 0.15 
AGN SN commissions  -0.09 -0.15 0.03 0.04 
AGN  SP omissions  0.00 -0.21* 0.05 -0.18 
AGN  SN omissions  -0.04 -0.06 0.17 -0.17 
Problem solving     
SOC problems in min moves 0.07 -0.18 0.00 0.07 
SOC mean moves  -0.03 0.15 -0.13 0.07 
SOC mean initial thinking time (ms) 0.01 0.11 -0.00 0.02 
SOC mean subsequent thinking time 
(ms) 
0.10 0.21* 0.06 0.01 
* = p<0.05; ** = p<0.01; ED = eating disorder; EDI = Eating Disorder Inventory-2; GAF = Global 
Assessment of Functioning; AGN SN = Affective Go/No-go Shift Negative; AGN SP = Affective 
Go/No-go Shift Positive;  BCLC = Big Circle/Little Circle; DMS = Delayed Matching to Sample; FMPS 
= Frost Multidimensional Perfectionism Scale; IED = Intra-Extra Dimensional Set-Shift; NART = 
National Adult Reading Test;  RVP = Rapid Visual Information Processing;  SOC = Stockings of 
Cambridge; SRM = Spatial Recognition Memory;  SWM = Spatial Working Memory; TMT = Trail 





A number of small correlations that reached statistical significance were found between 
duration of any eating disorder and some of the neuropsychological variables.  Longer 
duration of illness was correlated with poorer accuracy and slower response times on 
Rapid Visual Performance tests, lower recall on tests of verbal memory both in free recall 
and recognition conditions, increased errors on the Intra-Extra Dimensional Set-Shift, longer 
subsequent thinking time on Stockings of Cambridge 5-move problems, and increased 
errors on both between and within conditions on Spatial Working Memory.  Contrary to 
this trend was the significant, moderate sized correlation between duration of illness and 
higher NART IQ scores.  Two of the shift positive Affective Go/No-go variables had small 
correlations with duration of illness, with illness duration associated with a higher rate of 
commission errors and a lower rate of omission errors.  No significant correlations were 
found between any of the other neuropsychological test variables and duration of eating 
disorder. 
As duration of any eating disorder was significantly correlated with age (r = 0.77, n = 112, 
p<0.001), a partial correlation between duration of eating disorder and neuropsychological 
variables controlling for age was conducted to investigate this association further.  Results 
of these analyses are reported in Table 4.13.  
When age was controlled for, there was no longer a significant association between illness 
duration and neuropsychological performance other than a significant modest negative 







Table 4.13  Partial correlations between duration of eating disorder and psychometric test 
performance controlling for the effects of age in the binge eating sample (n=112). 
Test  Duration of ED  
(years) 
r 




RVP total hits -0.22 0.02 -0.17 0.08 
RVP total misses 0.21 0.02 0.17 0.09 
RVP mean latency (ms) 0.21 0.02 0.09 0.09 
VRM free recall correct -0.28 0.002 -0.22 0.03 
VRM recognition total correct -0.19 0.04 -0.12 0.22 
AGN SP total commissions  0.22 0.03 0.01 0.91 
AGN SP total omissions  -0.21 0.03 -0.18 0.07 
IED total errors adjusted 0.19 0.001 0.08 0.42 
DMS mean correct latency (ms) 0.31 0.001 -0.08 0.42 
SWM between errors 0.28 0.001 0.17 0.08 
SWM within errors 0.21 0.02 0.11 0.26 
SWM total errors 0.29 0.001 0.13 0.20 
NART IQ 0.34 0.001 0.12 0.24 
r = Pearson’s r; * p<0.05;  ED = eating disorder; AGN SN = Affective Go/No-go Shift Negative; AGN SP = 
Affective Go/No-go Shift Positive;  BCLC = Big Circle/Little Circle; DMS = Delayed Matching to Sample;  
IED = Intra-Extra Dimensional Set-Shift; NART = National Adult Reading Test;  RVP = Rapid Visual 
Information Processing;  SOC = Stockings of Cambridge; SP = shift positive; SRM = Spatial Recognition 
Memory;  SWM = Spatial Working Memory; VRM = Verbal Recognition Memory 
 
The EDI Total score, an overall measure of eating disorder severity, did not show any 
significant correlations with any of the neuropsychological variables other than a small 
negative correlation with latency to respond on the DMS task and a small positive 
correlation with NART IQ scores. 
GAF scores were not significantly correlated with any neuropsychological variables other 





4.5 Comorbidities: Depression and Anxiety 
Prevalence of lifetime depression and depression in the past month, measured by the 
criteria in the SCID-I  were significantly higher in the BN and BED groups than the HC 
group as reported in Table 4.14.   
Table 4.14  Comparison of current and lifetime depression on SCID-I by diagnostic group 
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1    
(2.1%) 
13.62 0.001 BN>HC*** 
BED>HC** 
Anxiety past month 
(SCID-I) 
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(6.3%) 










17.39 <0.001 BN>HC*** 
BED>HC** 
** = p<0.01; *** = p<0.001BN = bulimia nervosa, BED = binge eating disorder, HC = healthy 
controls;  SCID-I = Structured Clinical Interview-I 
 
Prevalence of lifetime anxiety and anxiety in the past month, measured by the SCID-I  
were significantly higher in the BN and BED groups than the HC group as reported in 
Table 4.14.   
The binge eating sample (BN and BED groups combined) were divided into those than had 
comorbid current depression and those that did not have co-morbid depression and 
compared in neuropsychological performance. Results of the analyses (t-tests) are reported 
in Table 4.15. No differences were found between the groups for any neuropsychological 
variable other than on the Delayed Matching to Sample DMS B”.   
A comparison of neuropsychological functioning in women with binge eating with and 




anxiety scored fewer hits on the Rapid Visual Processing Test compared to women who 
did not have co-morbid anxiety.   Women with co-morbid anxiety had fewer correct 
responses on both the Spatial Recognition Memory Test and Delayed Matching to Sample 
Test compared with the women without co-morbid anxiety.  No other significant 






Table 4.15  Comparison of neuropsychological function in women with binge eating with 
and without comorbid depression.  










t p d 
NART IQ 104.57 (7.15) 105.05 (7.79) 0.29 0.78  
Motor function      
MOT mean error 9.09 (2.23) 9.30 (2.61) 0.40 0.69  
MOT mean latency (ms) 893 (254) 901 (231) 0.15 0.88  
Visual attention      
RVP total hits 18.27 (5.01) 17.90 (4.85) 0.35 0.73  
RVP total misses 8.73 (5.01)  9.09 (4.85) 0.34 0.74  
RVP mean latency (ms) 417 (78) 418 (89) 0.03 0.98  
Memory       
VRM free recall  7.83 (2.00) 8.17 (1.67) 0.90 0.37  
VRM recognition  23.13 (1.04) 23.27 (0.98) 0.63 0.53  
VRM recognition delayed  22.67 (1.83) 23.17 (1.03) 1.84 0.07  
SRM number correct 18.33 (2.17) 18.48 (1.66) 0.37 0.71  
SRM mean correct latency (ms) 2254 (762) 2226 (519) 0.23 0.82  
DMS % correct  88.44 (8.92) 87.48 (10.75) 0.44 0.66  
DMS mean correct latency (ms) 3881 (1583) 3823 (1221) 0.21 0.84  
DMS B" -0.96 (0.18) -0.75 (0.47) 2.08 0.04 0.59 
SWM between errors 21.77 (17.53) 21.93 (15.61) 0.06 0.96  
SWM within errors 1.33 (2.26) 1.23 (2.46) 0.19 0.85  
SWM total errors 22.30 (17.88) 22.52 (15.89) 0.06 0.95  
SWM strategy 31.67 (6.13) 31.86 (5.17) 0.16 0.87  
Set-shifting      
IED total errors adjusted 24.97 (19.01) 23.60 (20.54) 0.32 0.75  
IED stages completed 8.77 (0.63) 8.59 (0.80) 1.12 0.27  
IED total trials adjusted 96.23 (33.10) 94.07 (37.11) 0.28 0.78  
TMT proportional score  34.58 (23.19) 31.49 (13.99)    
Inhibitory control      
AGN SP mean correct latency (ms) 552 (72) 524 (66) 1.95 0.05  
AGN SN mean correct latency (ms) 546 (67) 515 (62) 2.20 0.03  
AGN  SP total com  3.40 (2.42) 3.46 (3.08) 0.12 0.92  
AGN SN total com  2.03 (1.99) 2.11 (2.15) -0.17 0.87  
AGN SP total omissions  3.17 (4.02) 2.53 (1.95) 1.43 0.15  
AGN SN total omissions  2.07 (2.97) 1.40 (1.68) 1.49 0.14  
Problem solving      
SOC problems in min moves 9.07 (1.91) 9.41 (1.59) 0.97 0.33  
SOC mean moves  6.20 (1.43) 6.39 (1.33) 0.59 0.56  
SOC mean initial thinking time (ms) 12626 (7856) 13166 (8467) 0.30 0.71  
SOC mean subsequent thinking time 
(ms) 
1534 (2921) 1661 (3269) 0.19 0.85 
 
 
d = Cohen’s d; AGN SN = Affective Go/No-go Shift Negative; AGN SP = Affective Go/No-go Shift 
Positive;  BCLC = Big Circle/Little Circle; DMS = Delayed Matching to Sample; IED = Intra-Extra 
Dimensional Set-Shift; NART = National Adult Reading Test;  RVP = Rapid Visual Information 
Processing;  SOC = Stockings of Cambridge; SRM = Spatial Recognition Memory;  SWM = Spatial 





Table 4.16  Comparison of neuropsychological function in women with binge eating with 
and without comorbid anxiety disorders. 










t p d 
NART IQ 105.02 (7.39) 104.84 (7.84) 0.12 0.91  
Motor function      
MOT mean error 9.51 (2.55) 9.01 (2.46) 1.05 0.30  
MOT mean latency (ms) 895 (220) 901 (251) 0.14 0.89  
Visual attention      
RVP total hits 16.92 (4.15) 18.97 (4.44) 2.25 0.03 0.32 
RVP total misses 10.06 (5.15) 8.03 (4.44) 2.23 0.03  
RVP mean latency (ms) 426 (85) 410 (87) 1.04 0.30  
Memory       
VRM free recall  7.92 (1.57) 8.22 (1.91) 0.89 0.38  
VRM recognition  23.21 (1.03) 23.25 (0.98) 0.25 0.81  
VRM recognition delayed  23.17 (1.28) 23.92 (1.32) 1.03 0.30  
SRM number correct 18.06 (1.90) 18.78 (1.65) 2.16 0.03 0.40 
SRM mean correct latency (ms) 2242 (692) 2226 (487) 0.14 0.89  
DMS % correct  85.41(11.48) 89.83 (8.61) 2.32 0.02 0.43 
DMS mean correct latency (ms) 3781 (1335) 3891 (1316) 0.44 0.66  
DMS B" -0.74 (0.47) -0.89 (0.35) 1.61 0.11  
SWM between errors 23.73 (16.36) 20.31 (15.77 1.12 0.26  
SWM within errors 1.83 (0.76) 0.76 (1.13) 1.42 0.20  
SWM total errors 24.58 (16.71) 20.59 (15.97) 1.28 0.20  
SWM strategy 32.56 (4.98) 31.14 (5.74) 1.39 0.17  
Set-shifting      
IED total errors adjusted 24.55 (21.07) 23.44 (19.28) 0.29 0.77  
IED stages completed 8.61 90.78 0 8.47 (0.90)               0.95 0.34  
IED total trials adjusted 95.13 (37.82) 94.22 (34.49) 0.13 0.89  
TMT proportional score  34.01 (18.57) 30.79 (15.24) 1.00 0.32  
Inhibitory control      
AGN SP mean correct latency (ms) 531 (66) 533 (71.3) 0.15 0.88  
AGN SN mean correct latency (ms) 520 (67) 527 (63) 0.59 0.56  
AGN  SP total com  3.75 (2.76) 3.17 (3.02) 1.07 0.29  
AGN SN total com  2.30(2.27) 1.89 (1.93) 1.01 0.31  
AGN SP total omissions  2.98 (3.19) 2.20 (2.06) 1.55 0.12  
AGN SN total omissions  1.85 (2.38) 1.34 (1.82) 1.28 0.20  
Problem solving      
SOC problems in min moves 9.06 (1.84) 9.56 (1.49) 1.59 0.11  
SOC mean moves  6.43 (1.38) 6.23 (1.33) 0.78 0.44  
SOC mean initial thinking time (ms) 13213 (8218) 12850 (8395) 0.23 0.82  
SOC mean subsequent thinking time 
(ms) 
1930 (3217) 1354 (3125) 0.96 0.34  
d = Cohen’s d; AGN SN = Affective Go/No-go Shift Negative; AGN SP = Affective Go/No-go Shift 
Positive;  BCLC = Big Circle/Little Circle; DMS = Delayed Matching to Sample; IED = Intra-Extra 
Dimensional Set-Shift; NART = National Adult Reading Test;  RVP = Rapid Visual Information 
Processing;  SOC = Stockings of Cambridge; SRM = Spatial Recognition Memory;  SWM = Spatial 





4.6 Neuropsychological Performance and Impulsivity 
A comparison of Barratt Impulsivity Scale (BIS) subscale scores among the groups are 
presented in Table 4.17.  The BN group scored more highly on the Motor subscale 
compared with the HC group.  Both the BN and BED groups scored more highly for 
impulsiveness on the BIS Cognitive subscale than the healthy control group.  
Table 4.17 Impulsivity measured by the Barratt Impulsiveness Scale Subscales by 
diagnostic group 
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4.8  0.01 0.59 BN>HC 






4.1  0.02 0.54 
0.48 
BN>HC      
BED>HC 
d =  Cohen’s d;   BN = bulimia nervosa, BED = binge eating disorder, HC = healthy 
controls;  BIS = Barratt Impulsivity Scale. 
 
The association between neuropsychological functioning and impulsivity was investigated 
using Pearson product-moment correlation coefficients.  Results of these analyses are 
reported in Table 4.18.  The Non-planning subscale was not significantly correlated with 
any neuropsychological variable. The Motor subscale had a small correlation with Spatial 
Recognition Memory percent correct, Spatial Recognition Memory mean correct latency, 
Delayed Matching to Sample percentage correct, Delayed Matching to Sample mean 
correct latency and NART IQ.  The Cognitive subscale had one moderate negative 




scores were associated with faster or less accurate performance on these 
neuropsychological tasks. 
Table 4.18 Correlations between the Barratt Impulsivity Scale and neuropsychological 
variables in the eating disorder sample (n=112). 
Test  Non-planning Motor Cognitive 
NART IQ -0.08 -0.24* -0.18 
Motor function    
MOT mean error 0.11 -0.02 -0.06 
MOT mean latency (ms) 0.00 0.05 0.06 
Visual attention    
RVP total hits -0.10 -0.09 -0.08 
RVP total misses 0.10 0.09 0.08 
RVP mean latency (ms) 0.17 -0.01 -0.03 
Memory    
VRM free recall correct 0.02 -0.11 -0.22* 
VRM recognition total correct -0.04 -0.09 -0.09 
VRM recognition total correct delayed  0.05 -0.02 -0.09 
SRM number correct -0.02 -0.10 -0.11 
SRM mean correct latency (ms) -0.14 -0.22* -0.03 
DMS % correct  -0.12 -0.21* -0.04 
DMS mean correct latency (ms) -0.11 -0.22 -0.05 
DMS A' -0.04 0.31 0.38 
DMS B" 0.06 0.14 -0.05 
SWM between errors 0.17 0.16 0.11 
SWM within errors 0.14 0.05 0.06 
SWM total errors 0.18 0.16 0.11 
SWM strategy -0.03 0.03 -0.01 
Set-shifting    
IED total errors adjusted -0.11 0.01 0.06 
IED stages completed 0.10 0.03 0.02 
IED total trials adjusted -0.13 -0.01 0.04 
Trails proportional score (B-A/A) -0.01 0.02 0.00 
Inhibitory control    
AGN SP mean correct latency (ms) 0.04 -0.12 -0.00 
AGN SN mean correct latency (ms) 0.12 0.01 0.06 
AGN SP total commissions  0.15 0.08 -0.00 
AGN SN total commissions  0.09 0.13 0.08 
AGN SP total omissions  -0.04 -0.10 0.10 
AGN SN total omissions  -0.07 -0.04 0.04 
Problem solving    
SOC problems solved in minimum moves 0.04 -0.15 -0.15 
SOC mean moves  0.07 0.17 0.18 
SOC mean initial thinking time (ms) -0.01 -0.18 -0.02 
SOC mean subsequent thinking time (ms) 0.01 0.01 0.08 
AGN = Affective Go/No-go; DMS = Delayed Matching to Sample; IED = Intra-Extra Dimensional Set-
Shift; NART = National Adult Reading Test; RVP = Rapid Visual Information Processing; SOC = 
Stockings of Cambridge; SRM = Spatial Recognition Memory;  SWM = Spatial Working Memory; 





4.7 Summary of Key Neuropsychological Findings 
 Key findings from the neuropsychological functioning section of the current study 
including consideration of demographic group differences and confounding factors 
are summarised below: 
 The binge eating disorder group were significantly older and of higher mean weight 
compared with the bulimia nervosa and healthy control groups.  No significant 
differences were found among the groups for ethnicity, years of education or 
premorbid intellectual functioning.   
 Caffeine use was higher in the binge eating groups; however there were no 
differences found for any of the neuropsychological variables between participants 
that had coffee on the day of the testing and those that had not. 
 No differences were found among the groups for ingestion of alcohol or cannabis.  
Current illness and medication use was higher in the binge eating group than the 
other two groups. 
 No differences were found in accuracy of motor function among the groups; 
however the binge eating group had faster response times compared with the 
bulimia nervosa and healthy control groups. 
 No differences were found among the three groups on tests of visual attention. 
 Learning and memory was found to be intact in the binge eating groups other than 
a significant reduction in verbal recall in the binge eating group. 
 The bulimia nervosa group had superior function in one measure of the Intra-Extra 
Dimensional Set-shifting test compared with the healthy control group; however 




 No differences were found among the groups on measures of inhibitory control, 
although there was a non-significant trend towards a negative response bias in both 
the binge eating groups compared with a positive bias in the healthy control group. 
 No differences were found among the groups on tests of planning. 
 The total sample of the current study consistently performed at a higher level than 
CANTABeclipse computerised neuropsychological battery norms.   
 Duration of any eating disorder was correlated with poorer performance on tests of 
visual attention, verbal recall and spatial working memory; however, these 
associations were not found when the effect of age was accounted for. 
 The bulimia nervosa and binge eating disorder groups were more likely to meet 
criteria for both lifetime and current depression and anxiety than the healthy control 
group.  However, very few significant associations were found between depression 
or anxiety and neuropsychological performance for the eating disorder sample. 
 Levels of impulsivity on the Motor and Cognitive subscales of the Barrett 
Impulsivity Scale were found to be higher in the binge eating groups compared 
with the healthy control group.  Very few significant associations were found 
between levels of impulsivity and neuropsychological performance in the eating 










Analysis of demographic variables showed that the three groups did not significantly differ 
in levels of education, premorbid intelligence or ethnicity.  The ethnic makeup of study 
participants reflected the female population of Christchurch. The majority of participants 
(85.6%) identified as New Zealand European which is very similar to the proportion found 
in the latest census in which 76.8% of Christchurch females identified as New Zealand 
European (Statistics New Zealand, 2016).  The proportion of the sample that identified as 
Maori was 8.8% compared with 7.3% in the local population and 5.6% were Asian 
compared with 8.0% of the local population.  These similarities suggest the results of the 
current study can be generalised to the general Christchurch population. 
The groups differed in age and BMI and as expected the binge eating disorder group were 
older with higher BMIs than both the bulimia nervosa and healthy control groups.  These 
differences in age and BMI were taken into account when analysing neuropsychological 
differences among the groups. 
5.2 Potential Confounding Factors on Neuropsychological 
Functioning 
One of the strengths of the current study is consideration taken of a number of potential 
confounding factors that have not always been taken into account in previous studies.  




eating groups having a higher intake.  The binge eating groups also reported higher daily 
intake of caffeinated drinks.  Caffeine is known to improve performance, particularly on 
tests requiring speed and attention (Haskell et al., 2005).  No differences were found 
between those that had consumed caffeine before the testing and those that had not for any 
of the neuropsychological test variables.  It is possible that the amount of caffeine 
consumed was not large enough or was not consumed close enough in time to the testing to 
affect the results.  The strength of the caffeine drinks or the time consumed was not 
recorded in the present study so this question remains unanswered.  Previous studies have 
shown that the dose of caffeine is an important consideration (Haskell et al., 2005; Rees, 
Allan & Lader, 1999) as it the time of ingestion before testing. 
No differences were among the groups in the use of alcohol in the 24 hours before testing, 
although there was a trend towards more participants in the bulimia nervosa group using 
cannabis in the previous 24 hours.  Three of the bulimia nervosa group had used cannabis 
compared with none in the binge eating disorder or healthy control groups.  Increased use 
of cannabis in binge eating has been reported previously (Jordan et al., 2014).  Although 
this difference was not statistically significant in the current study, this trend suggests that 
information on cannabis use should be collected before neuropsychological testing in 
future studies of binge eating.    
The proportion of participants needing visual aids (glasses, contact lenses) was higher in 
the binge eating disorder group which is likely to be a reflection of the older mean age of 
this group.  All participants who required them were wearing glasses or contact lenses for 
testing so this is unlikely to be an important factor in interpreting differences in 
neuropsychological functioning among the groups.  No differences were found in the 




incidences of mild seriousness. Although the binge eating group reported more current 
illnesses, on inspection these seemed unlikely to significantly influence performance on 
the testing. 
5.3 Motor Function 
Motor function was not impaired in bulimia nervosa or binge eating disorder groups in 
terms of accuracy or speed of moto response.  Unexpectedly, the binge eating disorder 
group responded significantly faster than the bulimia nervosa and healthy control groups.  
This result suggests that on timed tests, motor function is not likely to have a negative 
effect on neuropsychological test performance.  In contrast to this result, several studies 
have reported some degree of motor slowing in bulimia nervosa (Bosanac et al., 2007; 
McKay et al., 1986) and binge eating disorder (Aloi et al., 2015).  However, the current 
study’s finding is consistent with Darcy et al. (2012) who found no motor slowing in a 
group of adolescents with bulimia nervosa.  As the majority of studies investigating 
neuropsychological functioning in binge eating have not reported measures of motor 
function it is difficult to make any conclusions about the role of motor functioning in 
neuropsychological functioning in binge eating. 
Although motor functioning was not impaired in women with binge eating in the current 
study it remains an important component of any comprehensive neuropsychological test 
battery, regardless of whether motor function impairment is predicted or not.  In 
computerised batteries it is essential that the ability of each participant to use a mouse or 






Sustained attention appears to be unimpaired in women with binge eating.  Results of the 
Rapid Visual Information Processing Task showed no impairment in accuracy or speed of 
responding. This result is consistent with the majority of previous studies which have also 
reported no impairment in sustained attention in either bulimia nervosa  (Alvarez-Moya et 
al., 2009; Beatty et al., 1990; Brand et al., 2007; Darcy et al., 2012; Murphy et al., 2004; 
Weider et al., 2015) or binge eating disorder (Kelly et al., 2013; Manasse et al., 2015).   
The ability to sustain attention is important to understand in the context of examining 
complex neuropsychological performance, as it is required for some of the more complex 
executive function skills such as set-shifting.  As attention is not impaired in women with 
binge eating this allows interpretation of executive performance independent from 
attention.  
5.5 Memory and Learning 
Immediate recall of verbal information was relatively impaired in the binge eating disorder 
group compared with the bulimia nervosa group, even after accounting for the difference 
in mean age and BMI among the groups.  I contrast to this result immediate verbal 
recognition was not impaired in the binge eating disorder group.  This is not surprising as 
recall of verbal information is a more cognitively demanding task than recognition.  This is 
reflected in results of the current study with the mean percentage of words recalled ranging 
from 65% in binge eating disorder to 73% in the healthy control group, compared with 
rates of over 95% for verbal recognition.  There may have been a ceiling effect in the 




possible that a more cognitively demanding test of recognition may have revealed 
differences among the groups.   
Memory for verbal information in the delayed condition also appears to be unimpaired for 
both bulimia nervosa and binge eating disorder; however there was an interesting finding 
of higher rates of false positive responses in the binge eating disorder group.  This pattern 
may suggest a tendency towards impulsivity in responding in this group.   
Overall results from the current study suggest that there may be some reduction in 
performance on cognitively demanding tasks of verbal memory, such as recall, in 
individuals with binge eating disorder; however on less demanding tasks, such as verbal 
recognition, there appears to be no relative impairment in verbal memory compared with 
either the bulimia nervosa or healthy control groups.   
Previous research has not found a consistent pattern of verbal memory impairment in binge 
eating.  Some previous studies have found impairment in verbal memory in bulimia 
nervosa (Bosanac et al., 2007; Weider et al., 2015), whereas others have not reported 
verbal memory impairment (Degortes et al., 2015; Pendleton Jones et al., 1991).  There are 
problems interpreting previous findings as many studies have not reported whether verbal 
memory impairments were in recall or recognition, or immediate or delayed conditions.   
Research on verbal memory in binge eating disorder has not been reported to date so 
although the results of the current study suggest there may be some relative impairment 
compared with women without binge eating.  Further investigation is required before any 





The current study did not assess verbal learning; however, this may be an interesting area 
to explore further.  Brand et al. (2007) used an auditory verbal learning test in women with 
bulimia nervosa and although they found no differences in memory on the first trial, they 
found reduction in learning the fifth trial in the bulimia nervosa group compared with the 
control group.  This is further support for the need to use cognitively demanding tasks to 
investigate neuropsychological function in binge eating as if differences are present, they 
are likely to be found only at more challenging levels. 
Visual memory was not impaired in either the bulimia nervosa group or the binge eating 
disorder group measured on the Delayed Matching to Sample Test. This task requires the 
ability to perceive and retain information about complex combinations of objects, which 
differ in shape and colour, in order to recognise the same combination among four choices. 
Despite this complexity, many participants were able to identify a high percentage of 
object combinations accurately.  As with the tests of verbal memory, there may have been 
a ceiling effect on this test, particularly as it is a test of recognition rather than recall, in 
that participants had a choice of four options and did not need to recreate the object 
combinations.  This test was designed as part of the wider CANTAB battery to 
differentiate between those with brain injury and dementia (Robbins et al., 1994) however 
it has been shown to differentiate other mental health populations as previously discussed.  
Ability to recall spatial position information using the Spatial Recognition Memory Task 
appears to be intact in bulimia nervosa and binge eating disorder.  However, this task may 
not be as cognitively demanding as other tests of visual memory used in some other 
studies. The Spatial Recognition Memory test does not have a copy component and so is 
not influenced by drawing ability as with complex figure tasks (such as the Rey Osterrieth 




spatial information it is a test of recognition only, requiring memory of position rather than 
shape or design, this task is less challenging than the complex figure tasks. The outcome 
variable on this task is the number of correct responses.  Many participants in the current 
study scored close to the maximum score of 20 on this task and it seems likely there was a 
ceiling effect.  It is possible that a more complex task may have found differences among 
the groups.  This should be considered when planning future studies investigating spatial 
memory.  
Previous research has reported conflicting findings regarding visuo-spatial ability in 
individuals with binge eating.  Most studies investigating spatial ability in bulimia nervosa 
have used the Rey Osterrieth Complex Figure Test.  A number of studies reported 
impairment in the copy and recall of conditions (Kim et al., 2011; Roberts et al., 2013; 
Weider et al., 2015), whereas others have not found impairment (Darcy et al., 2015; 
Degortes et al., 2015; Murphy et al., 2004).  Impairment in copy and recall on the Rey 
Osterrieth Complex Figure Test was found in one study of women with binge eating 
disorder (Aloi et al., 2015).  Although the results of the current study do not suggest 
impairment in this domain, the test used may not have been demanding enough to detect 
differences in visuo-spatial perception and memory.   As some existing research has found 
evidence of impairment in visuo-spatial perception and memory, further research using 
more challenging tasks is required, particularly in individuals with binge eating disorder.  
Working memory does not appear to be impaired in women with binge eating in the 
current study.  Those with bulimia nervosa and binge eating disorder did not make more 
errors or nor was there evidence of poor strategy on the Spatial Working Memory test 
compared with healthy controls.  Two studies have also reported no impairment in working 




study (Weider et al., 2015), found working memory was impaired in bulimia nervosa.  
However, Weider et al.’s study (2015) reported a composite score of working memory and 
did not report individual tests, making it difficult to compare with other studies.  
In summary, memory for verbal and visuo-spatial information appears to be unimpaired in 
women with bulimia nervosa.  If impairments are present, they would appear to be on 
more cognitively demanding tasks.  There may be a greater degree of memory impairment 
in binge eating disorder for recall of verbal information indicated by fewer words recalled 
and more false positive responses on tests of recognition.  Again impairments are only 
evident on more cognitively demanding tasks.  Overall it seems unlikely that impairment 
in memory significantly affect individuals with binge eating. 
5.6 Inhibitory Control and Attentional Bias 
No differences were found in the ability to inhibit responses in emotionally neutral 
conditions suggesting that inhibitory control is unimpaired in both bulimia nervosa and 
binge eating disorder when there is no emotional component to the task.  This is consistent 
with previous studies in bulimia nervosa (Degortes et al., 2015; Galimberti et al., 2012 and 
binge eating disorder (Kittel, Brauhardt, & Hilbert, 2015; Mole et al., 2015; Wu et al., 
2013); however at least one study has found inhibitory control to be lower in bulimia 
nervosa than controls for neutral stimuli (Wu et al., 2013). 
Tests of inhibitory control which include conditions containing emotional targets measure 
not only inhibitory control but also attentional bias.  Responding more quickly to a specific 
valence (positive or negative) suggests attentional bias towards that valence.  Women with 
binge eating did not differ from healthy controls in either the latency to respond, number of 




positive or negative valence conditions.  This result suggests the absence of an emotional 
bias in women with binge eating.  However, results from the emotional bias index, 
although not significant, suggest that further exploration of this area is warranted.     
A positive Emotional Bias Index suggests a positive processing bias, that is, a faster 
response to a word with a positive valence than a word with a negative valence.  
Conversely a negative Emotional Bias Index suggests that a respondent has a negative 
bias, that is, a faster response to a work with a negative valence. Although those in the 
binge eating groups had a tendency towards a negative emotional bias, this was not 
statistically significant, probably due to the large variance in responses within the groups.  
It is possible that some women with binge eating process emotional targets differently 
from some others, which suggests that these women may be more vulnerable to negative 
experiences overall.  
Harrison et al. (2010) found a significant bias towards negative social stimuli in their study 
and suggest that this bias may play a role in the development and maintenance of eating 
disorders.  It is possible that a negative bias may pre-date the development of an eating 
disorder as attention bias to negative social stimuli was reported in twin sisters of women 
with eating disorders including bulimia nervosa and binge eating disorder. (Kanakam et 
al., 2013).   
Attentional bias using the Stoop Test paradigm (Stroop, 1935) has been reported in 
individuals with bulimia nervosa (for a review see Dobson & Dozois, 2004)).  The Stroop 
Test paradigm measures the interference in processing stimuli in which the printed colour 
of a word is different from the meaning of the word to be read, resulting in longer reaction 
times and increased errors.  The Stroop Test has been modified to assess processing of 




to neutral or colour words appear not to be different from those of healthy controls but 
women with bulimia nervosa are slower to respond to words that are body or food related  
(Carter et al., 2000; Jones-Chesters, Monsell, & Cooper, 1998; Lovell, Williams, & Hill, 
1997).  It is thought that the processing of these words results in interference from 
emotions elicited from the eating disorder related words (Lovell et al., 1997). The only 
study investigating attention bias using Stroop tests in binge eating disorder found no 
difference between binge eating disorder and control groups (Duchesne et al., 2010).  
In summary, inhibitory control in emotionally neutral conditions appears to be relatively 
unimpaired in women with binge eating and this finding is consistent with previous 
research.  In tests of inhibitory control that included an emotional component, although 
there was no significant difference among the groups in the current study, there was a non-
significant pattern of a negative attention bias in both binge eating groups.  Attentional 
bias towards negative stimuli has been previously reported in eating disorders.  Overall, if 
inhibitory control impairments are present in women with binge eating it seems more 
likely that this may be due to interference from attentional biases related to stimuli that 
have a negative emotional valence (affecting the ability to shift to positive valence stimuli) 
or are eating disorder-related (where body or food related words are disrupting attention 
resulting in slower responses).  
5.7 Set-shifting 
The Trail Making Test and the Intra-Extra Dimensional Set-shifting Test were used to 
investigate set-shifting in the current study but results were inconsistent.  The proportional 
score on the Trail Making Test accounts for differences among participants’ motor skills 
and is thought to more accurately measure set-shifting than the score from Part B alone.   




impairment in set-shifting in women with bulimia nervosa.  Although the Trail Making 
Test is commonly used as a test of set-shifting, it does not explore the concept of set-
shifting in as much complexity as other tests such as the Wisconsin Card Sorting test or the 
Intra-Extra Dimensional Set-shift test which was administered in the current study. 
All groups made a similar level of errors in the Intra-Extra Dimensional Set-shift Test; 
however, the bulimia nervosa group completed more stages on average than the healthy 
control group, and both the bulimia nervosa and binge eating disorder groups had a greater 
proportion complete all nine stages of this test. This suggests that in some conditions 
women with binge eating show superior set-shifting compared with women without binge 
eating.  This was unexpected, as overall existing research has found either no difference in 
set-shifting or poorer performance in set-shifting when using the Trail Making Test and 
Wisconsin Card Sorting Test in women with bulimia nervosa (Roberts et al., 2007; Wu et 
al., 2014) or binge eating disorder (Kittel et al., 2015).  In the only study to use the Intra-
Extra Dimensional Set-shift Test in bulimia nervosa no differences in set-shifting were 
found in bulimia nervosa compared with healthy controls (Galimberti et al., 2012).  No 
studies that have used the Intra-Extra Dimensional Set-shift Test in individuals with binge 
eating disorder.   
The Wisconsin Card Sorting Test is considered to be a more difficult task than the Intra-
Extra Dimensional Set-shift Test as the number of choices on the Intra-Extra Dimensional 
Set-shift Test are fewer (Oh et al., 2014).  Therefore, tests of set-shifting in the current 
study may not have been of sufficient difficulty to show differences between individuals 
with binge eating compared to those that do not binge eat.  However, the Intra-Extra 
Dimensional Set-shift Test may be more complex in other ways as it requires the 




colours (pink and white) which are novel and cannot be simply described.  This is 
compared with the Wisconsin Card Sorting Test, which uses recognisable shapes such as 
diamonds, circles and triangles, which are boldly coloured in yellow, red, blue or green, 
and are able to be categorised in more simple terms (e.g. yellow stars).  The Intra-Extra 
Dimensional Set-shift Test may tap into detail and global processing (central coherence), 
as this test requires substantial focus on small details of visual information.  If this is the 
case, the finding of superior performance by the bulimia nervosa group in the current study 
would be consistent with previous findings of weak central coherence in bulimia nervosa 
with enhanced detail processing (Lopez et al., 2008).  Central coherence was not 
specifically investigated in the current study so this interesting finding cannot be related to 
the central coherence characteristics of the eating disorder groups in this study. 
In summary, although previous research suggests that there may be some set-shifting 
difficulties in women with bulimia nervosa, the results of the current study do not support 
this finding.  It is possible that the test used in the current study was not of sufficient 
difficulty to be able to detect differences among the groups, although differences have 
been found using this test in some previous studies.  However, in the only significant 
difference found, the bulimia nervosa group completed more stages of the Intra-Extra 
Dimensional Set-shift Test compared with healthy controls.  It could be speculated that the 
Intra-Extra Dimensional Set-shift Test may tap into the central coherence with the bulimia 
nervosa group showing skill in detail processing, as has been found in some previous 
research into central coherence in binge eating (see Lopez et al., 2009).  
5.8 Eating Disorder Psychopathology 
As previously noted there is significant movement among diagnostic groups within eating 




bulimia nervosa had a history of anorexia nervosa, compared with 1.9% of those with 
binge eating disorder and none of the healthy control group.  Agras et al. (1997) found 
24% of 220 women recruited for a large treatment study of bulimia nervosa had a previous 
history of anorexia nervosa.  A history of anorexia nervosa has been associated with higher 
levels of psychopathology (Monteleone et al., 2011; Vaz-Leal et al., 2011) and a poorer 
outcome in treatment studies (Eddy et al., 2007).   There is some evidence that individuals 
who have recovered from anorexia nervosa may not completely recover 
neuropsychological functioning (Degortes et al., 2015; Tenconi et al., 2010).  This has 
implications for understanding neuropsychological function in women with bulimia 
nervosa with a history of anorexia nervosa.  The current study did not find a significant 
difference in neuropsychological function in women with bulimia nervosa with or without 
a history of anorexia.  This section of the study was statistically under-powered with only 
nine women having a previous history of anorexia nervosa and therefore conclusions 
regarding the lasting impact of anorexia nervosa cannot be drawn.  Longitudinal studies, 
rather than cross sectional as in the current study would have greater utility in 
understanding whether a history of anorexia nervosa has a negative impact on women who 
have moved into a bulimia nervosa diagnosis. 
Duration of eating disorder was significantly associated with a number of 
neuropsychological variables including poorer performance on some measures of attention, 
verbal memory (recall and recognition), visuo-spatial recognition memory, spatial working 
memory, inhibitory control, and set-shifting.  However, there was a significant positive 
correlation between duration of eating disorder and age.  When age was used as a covariate 
in the analyses, only one variable, verbal free recall memory, retained a significant 




impact on neuropsychological functioning in women with binge eating.  This pattern has 
been found in previous studies (Laessle et al., 1990; Roberts et al., 2013).   
Illness severity, rather than illness duration, is more likely to impact on neuropsychological 
function. In the current study eating the Eating Disorders Inventory-2 (EDI-2), an eating 
disorder specific measure of illness severity, was not associated with neuropsychological 
functioning in women with binge eating.  A more global measure of illness severity, the 
Global Assessment of Functioning, was also not associated with neuropsychological 
function.  The sample size for these analyses was sufficient to detect a difference among 
the groups if there was one present.  In the current study at least, eating disorder severity 
does not seem to be associated with neuropsychological functioning in women with binge 
eating. This is in contrast to findings reported by some other studies, for example, Roberts 
et al. (2013) found weak central coherence was associated with higher eating disorder 
severity in women with bulimia nervosa.  Roberts et al. (2013) used a clinician-rated 
measure of illness severity (SCID-I) in contrast to the self-rated EDI-2 measure used in the 
current study.    It would be useful to consider other ways of measuring illness severity 
other than a self-report measure such as clinician-rated methods.  Consideration of 
biological markers of illness severity in future studies would also be interesting, 
particularly those that measure nutritional status.  BMI has also been used as a measure of 
illness severity, particularly in studies of women with anorexia nervosa or bulimia nervosa, 
however, this is not seen as a reliable estimate.  More promising measures of nutritional 
status could include measures of glucose availability and vitamin levels.  
Although many studies have reported measures of illness severity, few have specifically 





5.9 Depression and Anxiety 
On assessment the SCID-I revealed that 29% of the bulimia nervosa group and 24% of the 
binge eating disorder group met criteria for depression in the past month compared with 
only 2.1% of the healthy control group.  Rates of lifetime depression have been reported to 
be as high as 55% in bulimia nervosa and 42% in binge eating disorder (Kessler et al., 
2013).  When lifetime prevalence was included rates rose to 60% of the bulimia nervosa 
group and 72% of the binge eating groups.  The healthy control group had a lifetime 
prevalence of 44%.  Depression is therefore a substantial comorbidity for a large majority 
of women with binge eating in the current study. 
Depression is known to be associated with specific impairments in neuropsychological 
functioning (Snyder, 2013), particularly executive function (Castaneda et al., 2008), 
including set-shifting, planning and verbal fluency (Rogers et al., 2004).  Although little if 
any impairment was found in individuals with binge eating compared with healthy controls 
it is possible that there may be some association between depression and 
neuropsychological functioning within the binge eating disorder sample.  However, the 
results of the current study does not indicate this to be the case. 
This suggests that although depression is prevalent in women with binge eating, it does not 
appear to negatively impact on overall neuropsychological functioning.  Alternatively it is 
possible that the neuropsychological tests used were not of sufficient difficulty to detect 
small differences among the groups if they were present.  One of the limitations of this 





Another limitation is the lack of a measure of mood state at the time of testing.  As 
discussed in a previous section, a recent study (Dingemans et al., 2015) examining mood 
and set-shifting in women with binge eating disorder found that negative mood state was 
associated with poorer set-shifting ability. 
Lifetime prevalence of anxiety disorders in the current study was 60% in bulimia nervosa 
and 50% in binge eating disorder. This is comparative to that reported by Kessler et al. 
(2013) of 65% in bulimia nervosa and 56% in binge eating disorder.  Anxiety is therefore a 
significant comorbidity in women with binge eating.  Anxiety may affect 
neuropsychological function by increasing attentional bias to negative stimuli (Bauer et al., 
2016) and creating interference in processing information (Mathews & Mackintosh, 1998; 
Singhal et al., 2012).  Pallister & Waller, (2008) have found women with eating diosrders 
dislpay atentional bias and interferrence effects which are assocaited with anxiety.   
As few significant assocaitions were found in the current study between anxiety and 
neuropsychological functioning is seems unlikely that there was interferrence in processing 
stimuli as would be expected if anxiety was affecting performance on these tasks.  It may 
be that a current of an anxiety disorder diagnosis may not be a good measure of anxiety in 
test-taking situations.  A measure of state anxiety may be more useful to explore this 
further. 
5.10 Impulsivity 
Levels of impulsivity appear to be higher in women with binge eating disorders.  In the 
current study the bulimia nervosa group had significantly higher motor impulsivity and 
cognitive impulsivity.  Previous studies have also reported increased impulsivity using the 




(2012) reported higher scores in the Cognitive subscale in women with bulimia nervosa 
compared with healthy controls but did not report a difference in Motor impulsivity.  Other 
studies have not reported BIS subscale scores, but have used the BIS total score with some 
studies reporting higher total scores in bulimia nervosa (Kemps & Wilsdon, 2010; Rosval 
et al., 2006); and others no difference between individuals with bulimia nervosa and 
healthy controls despite having sufficient power to detect such a difference (Claes et al., 
2006; Liao et al., 2009). 
In the current study the binge eating disorder group did not show the same elevation in 
Motor impulsivity as the bulimia nervosa group but were higher on the Cognitive 
impulsivity subscale than healthy control group.  Previous studies in binge eating disorder 
have not reported on individual subscale scores; however, one study found elevations in 
the BIS total score (Danner et al., 2012) with another finding no elevation (Svaldi et al., 
2010).  As with many study investigating neuropsychological functioning in binge eating, 
sample sizes were likely to have been insufficient to detect even a large effect size. 
It could be expected that both motor and cognitive impulsivity may be associated with 
impulsive responding on neuropsychological tests.  Faster responding with increased errors 
on neuropsychological tests would be consistent with impulsivity.  Results from the 
current study did not find this pattern for Non-planning impulsivity which is thought to 
measure the ability to think ahead.  Motor impulsivity showed a small, yet significant 
correlation with faster responding and increased errors on the Delayed Matching to Sample 
Test, which measures of visuo-spatial memory.  The one other significant correlation 
found with Motor impulsivity was with faster responding on another visuo-spatial test, 
Spatial Recognition Memory.  A single small negative correlation was found in the current 




(n=122) was large enough to be able to detect significant associations if they were present.  
However, given the large number of analyses (uncorrected) here and no other findings 
supporting this result, the possibility that it is a spurious finding cannot be discounted.  
Hypothetically, the mechanism of such a relationship might be that cognitive impulsivity 
could be interfering with either storage or retrieval of verbal information however further 
research is required to determine whether this result has any validity. 
Overall, results did not find that impulsivity in women with binge eating was associated 
with neuropsychological functioning, although further exploration of recall of verbal 
information and visuo-spatial memory may be warranted.  The current study did not 
include tests of decision-making ability which may be more sensitive to an impulsive 
response style than some of the tests administered in the CANTAB battery. 
 
5.11 Strengths and Weaknesses 
A broad recruitment strategy was a strength of the current study as it drew participants 
from a range of sources ranging from referrals from the South Island Eating Disorders 
Service, a specialist eating disorders treatment unit, through to advertisements in the 
community.  This gives greater confidence in the ability to generalise results to the wider 
binge eating population.  The large sample size allowed the study sufficient statistical 
power to detect differences among the diagnostic groups. The range of potential 
confounding variables considered in the analyses was a strength that allows greater 
confidence in the results.  
The use of a computerised neuropsychological testing battery was a strength of the study 




administration among participants. The battery covered a wide range of 
neuropsychological domains in one testing session so it is time efficient.   
However, the use of a computerised test battery also presents some limitations.  CANTAB 
tests have not been well validated against standard non-computerised versions and recent 
factor analyses found the computerised versions did not always measure the same 
construct as the traditional versions (Lenehan et al., 2016; Smith et al., 2013).  These 
studies suggested that although CANTAB is able to discriminate healthy adults from those 
with mild cognitive impairment, it is more a measure of general neuropsychological 
functioning rather than a measure of distinctive domains.  For example, as already 
discussed in section 5.6 above, the current study the computerised tests of visual spatial 
memory, the Delayed Matching to Sample and Spatial Recognition Memory Tests, do not 
test the ability of the participant to learn and reproduce the target shape in a physical way 
as required by the possibly more challenging Rey Osterrieth Complex Figure Test.  As 
such they are likely to be measuring different visuo-spatial constructs.  Both computerised 
and traditional formats are likely to have a role in understanding neuropsychological 
functioning and it would be useful if validation studies comparing these two formats were 
undertaken.  Note that one of the measures of set-shifting used in the current study was a 
pen and paper administered test, the Trail Making Test, and this format did not show any 
difference in performance between those with binge eating and those without.  Overall it 
seems unlikely that the findings of little or no impairment in neuropsychological 
functioning in women with binge eating in the current study would be solely due to the test 




It also seems likely that some of the tests selected were not of sufficient difficulty as there 
appeared to be a ceiling effect on some tests.  This problem has previously also been 
reported in studies of  neuropsychological functioning in obesity (Fitzpatrick et al., 2013). 
The neuropsychological test battery required the participant to focus on the testing for a 
reasonably prolonged period (average of 109 minutes).  This could have led to fatigue, 
particularly on tests towards the end of the battery.  However, as the tests were 
administrated in the same order in both the eating disorder and control groups, participants 
were exposed to the same conditions so this should not have influenced the results when 
comparing neuropsychological functioning among the different groups. 
The current study did not include tests of decision-making, or central coherence, two areas 
of executive function that have been found to be impaired in some studies of binge eating 
and should be included in future studies.   
 
5.12 Future Research 
Future research would benefit from recruitment of larger samples to give greater power to 
detect difference in studies investigating neuropsychological functioning in binge eating.  
It seems likely that more demanding tasks are required to explore relative differences in 
neuropsychological functioning in individuals with binge eating compared with healthy 
controls.  Care should be taken to account for potential factors such as drug use and 
caffeine intake prior to testing as these factors have not commonly been accounted for in 
previous studies, yet are known to influence neuropsychological performance. Although 
these factors were found not to be a significant factor in the current study, this result does 




samples given the high rates of caffeine, alcohol and drug use in not only those with binge 
eating but also the general population. 
Some areas of neuropsychological functioning have been under-researched including those 
focusing on learning and memory, and planning ability. It may be important to explore 
learning and memory tasks in the context of eating disorder salient stimuli such as food 
and body related stimuli as her is evidence of impairment in such tasks. 
Binge eating disorder is under-researched compared with bulimia nervosa and more 
studies are necessary to understand neuropsychological functioning in those individual 
with binge eating disorder.  Most studies investigating neuropsychological functioning 
have not accounted for movement of individuals between different eating disorder 
diagnostic categories.  A longitudinal approach to studying this would be challenging yet 
useful in understanding whether neuropsychological changes occur over the course of an 
eating disorder as an individual moves between diagnostic categories.   
It may be that other factors such as nutritional status may be more important than 
diagnostic category.  Nutritional status is well known to significantly impact on 
neuropsychological functioning as famously reported in the Minnesota Starvation Study 
(Keys et al., 1950).   Within eating disorders there is some evidence that nutritional status 
may be a factor in neuropsychological function, for example, Laessle et al., (1990) found 
that intermittent starvation in people with bulimia nervosa negatively affected performance 
on tests of sustained attention.  It is important to separate out BMI from nutritional status 
for example, weight gain did not always restore normal set-shifting performance in women 
with anorexia nervosa (Tchanturia et al., 2004).  Potential biological mechanisms include 
the availability of glucose to fuel neuronal activity, but also the effects of poor nutrition on 




membrane fluidity (Gibson & Green, 2002).  The impact of nutritional status in 
neuropsychological functioning in women with binge eating is an area yet to be fully 
explored. 
5.13 Summary 
Overall there were very few significant findings of neuropsychological impairment in the 
current study.  This suggests that neuropsychological functioning as measured here is not 
significantly impaired in women with binge eating, and if relative impairments are present 
they are unlikely to have a major impact on overall functioning.  Co-morbid depression 
and anxiety was not associated with neuropsychological functioning in women with binge 
eating.  Furthermore, despite elevated levels of impulsivity on the Barratt Impulsiveness 
Scale, neuropsychological function was not associated with measures of impulsivity. 
In eating disorders neuropsychological investigations are generally looking for relatively 
small and subtle impairments in neuropsychological functioning and this is particularly 
likely to be the case in the binge eating groups as they do not exhibit the more extreme 
starvation state of some of those with severe anorexia nervosa.  Consequently the selection 
of neuropsychological tests is an important consideration when planning these studies.  
The appropriateness of the tests selected in the current study has already been discussed in  
section 5.11 above. 
Although neuropsychological tests used in the current study may not have been of 
sufficient difficulty, the same tests have been used in other studies to detect 
neuropsychological problems in other mental health conditions including depression (Lee 
et al., 2015), schizophrenia (Patel et al., 2010; Pantelis et al., 2009) and obsessive 




neuropsychological battery has been found to be moderately correlated with other 
commonly used neuropsychological tests (Smith et al., 2013). Despite this, the 
CANTABeclipse neuropsychological battery may not be a suitable test battery for use with 
individuals with binge eating disorders, as the one published study with individuals with 
binge eating using the CANTABeclipse also did not find significant differences compared 
with a healthy control group (Galimberti et al., 2012). 
Problems in the methodologies of some existing studies into neuropsychological 
functioning include small sample sizes resulting in statistically underpowered studies, 
varying methodologies including the reporting of different variables even on the same 
neuropsychological test batteries, and limited consideration of potential confounding 
factors.  This makes it difficult to draw clear conclusions about the nature and magnitude 
of neuropsychological impairment in individuals with binge eating disorder and bulimia 
nervosa. Future research would benefit from ensuring samples sizes are sufficient to be 
able to detect differences.  Areas warranting further research include executive function 
and verbal memory, with more studies investigating binge eating disorder in particular.  
The consideration of nutritional status and the potential mechanisms by which this factor 






This section of the thesis examines the role of ghrelin in those with binge eating disorders.  
Chapter six will review current knowledge of ghrelin and present the research questions to 
be addressed.  Chapter seven presents the methods for this section.  The results are 
resented in Chapter eight and the key findings are discussed in Chapter nine. 
6. LITERATURE REVIEW: GHRELIN   
This chapter will describe the biochemistry of ghrelin, how ghrelin fits into body 
regulatory systems including the gut-brain axis of neurohormones that control appetite, 
feeding behaviour and energy homeostasis, and how ghrelin interacts with other hormones 
involved in appetite. Normal patterns of ghrelin secretion will be described.  Research 
about ghrelin in eating disorders, the role of ghrelin in the reward system and the role of 
ghrelin in exercise and obesity will be reviewed.  Finally, methodological issues that must 
be considered in ghrelin studies will be discussed. 
6.1 Ghrelin Structure and Function 
Ghrelin, was first described in 1999 (Kojima et al., 1999).  The receptor for ghrelin, 
growth hormone secretagogue receptor (GHS-R), had been identified some years before 
(Guan et al. 1997), and so the existence of a hormone to activate the receptor had been 
predicted, as had the possibility that it played a role in growth hormone stimulation.  It was 
therefore an important discovery when the ghrelin molecule was identified and found to be 
the first appetite hormone that promoted feeding behaviour (orexigenic) as all previously 
known appetite hormones were involved with pathways that suppressed feeding 




date. Unsurprisingly ghrelin and its role in feeding behaviour and energy regulation has 
been of interest to eating disorder researchers.  
Ghrelin is a 28-amino-acid peptide produced from preproghrelin, a 117 amino acid 
precursor.  In mammals the majority of ghrelin production occurs in the X/A-like cells in 
the gastric oxyntic glands of the stomach (Alvarez-Castro, Pena, & Cordido, 2013) but 
smaller amounts are secreted by other areas of the body including intestines (Sakata et al., 
2002), pituitary (Korbonits, et al., 2001), pancreas, kidney, lung, ovary and brain 
(Ueberberg et al., 2009).  Ghrelin is present in two different molecular forms; acyl-ghrelin 
and des-acyl ghrelin.  Acyl ghrelin is relatively unstable in this form and easily to converts 
to des-acyl ghrelin (Rauh, Groschl, & Rascher, 2007).  The half-life of acyl-ghrelin is 
around 10 minutes compared to 35 minutes for des-acyl ghrelin (Tong et al., 2013).  In 
stomach tissues, acylated ghrelin makes up approximately a third of total ghrelin (Hosoda 
et al., 2000) whereas in circulation acyl ghrelin makes up between 10% and  25% (Ariyasu 
et al. 2001; Bang et al., 2007).  It was initially thought that the acylated form was the most 
biologically active but there is increasing evidence that des-acyl-ghrelin is also 
biologically active across a number of different roles depending on where in the body it is 
active; as an agonist to acyl-ghrelin, in support of acyl-ghrelin, and actions independent 
from the acylated form (Delhanty, Neggers, & van der Lely, 2014;  Pemberton & Richards, 
2007).  
Ghrelin is implicated in the modulation of a range of metabolic pathways in which cell 
growth is vital (Pradhan, Samson, & Sun, 2013)  including bone growth (Delhanty, van der 
Eerden, & van Leeuwen, 2014), the reproductive system (Rak-Mardyla, 2013), 




Nagaya et al., 2001) including repair of heart muscle after myocardial infarction 
(Frascarelli et al., 2003) and in the growth of tumour cells (Chopin et al., 2011).   
The primary role of ghrelin has been found to be involved with energy homeostasis, 
appetite and body weight regulation across a number of vertebrates including mammals, 
birds (Kaiya et al., 2002) and amphibians (Kaiya, et al., 2001).  Ghrelin is able to cross the 
blood-brain barrier (Asakawa et al., 2001; Banks, Burney, & Robinson, 2008) where it 
activates the site of the hypothalamic neuropeptide signalling pathway that is involved 
with feeding initiation, meal size and increasing body weight (Natalucci et al., 2005; Wren 
et al., 2001).   Ghrelin receptors in the hypothalamus, specifically in the arcuate nucleus 
(ARC) and paraventricular nucleus (PVN), activate neurones which produce the orexigenic 
neuropeptide Y (NPY) and agouti-related protein (AgRP) and de-activate neurones 
involved in the production of the anorexigenic proopiomelanocortin (POMC) and cocaine-
amphetamine-regulated transcript (CART).  Ghrelin acts in opposition to the anorexigenic 
action of leptin, insulin and cholecystokinin (CKK).   
6.2 Normal Ghrelin Secretion Patterns 
Ghrelin is not secreted evenly across the day but in a pulsatile manner.  Ghrelin secretion 
peaks pre-prandially (before a meal) followed by reduced in secretion after the ingestion of 
a meal.  The timing of the peaks of ghrelin secretion appear to be related to the routine 
pattern of eating, for example sheep that are fed at regular times of the day show an 
increase in ghrelin before each meal time, but this increase is not seen when sheep have 
access to food ad libitum (Sugino et al., 2004).  A study in rats also found the pattern of a 
ghrelin surge before an expected meal but not if there was an ad libitum feeding regime 




conditions of food restriction compared with those that have sufficient food available 
(Carlini et al., 2008) apparently in an attempt to increase food ingestion. 
In humans, ghrelin has also found to peak before eating and to decline afterwards 
(Callahan et al., 2004;Cummings et al., 2001; Drazen et al., 2006; Shiiya et al., 2002).  The 
observed pattern of ghrelin secretion for people who eat three regular meals a day can be 
seen in Figure 6.1.  It is not clear whether ghrelin increases sensations of hunger.  
Increasing ghrelin levels have been associated with an increase in hunger ratings in some 
studies (Cummings et al., 2004); however, high ghrelin levels are not necessarily essential 
for hunger to be experienced (Di Francesco et al., 2006;  Freka & Mattes, 2005;  Frecka & 
Mattes, 2008) examined patterns of ghrelin secretion in 21 men and women who had a 
regular eating pattern and found the time of ghrelin peak was approximately 20 to 30 
minutes before the regular time of lunch.  Ghrelin fell post prandially (the period after a 
meal) with the nadir (lowest point) occurring between 40 and 60 minutes post breakfast 
and 60 to 85 minutes post lunch.  Ghrelin showed a positive relationship with hunger and a 
negative relationship with ratings of fullness. Ghrelin secretion was likely to be entrained 
to regular eating patterns and peaked in anticipation of a meal rather than higher ghrelin 





Figure 6.1 The association between ghrelin secretion and meal ingestion over 24 hours 
Higher ghrelin levels may increase the amount of food ingested during a meal. Wren et al., 
(2001) found that healthy individuals who had received an intravenous infusion of ghrelin 
consumed an average of 28% more while dining at a free-choice buffet than those who had 
not had a ghrelin infusion. 
Ghrelin levels are known to rise when humans are placed on a restricted diet.  Cummings 
et al., (2002) showed this clearly in a study of 13 obese participants, whose 24 hour pattern 
of ghrelin secretion was recorded before dieting and then again while dieting.  In both the 
pre-dieting and dieting conditions the pre-prandial ghrelin peaks are clearly evident; 
however the area under the curve in the dieting condition is significantly higher.  This 
indicates that the body resists conditions of food restriction by producing more ghrelin in 
an attempt to increase food ingestion back to pre-dieting levels.  This finding aids 
understanding of the limited success of dieting for weight loss.  In the second part of the 
study the same participants underwent gastric bypass procedures resulting in a significant 




decrease in ghrelin secretion with little oscillation associated with meals suggesting that 
ghrelin suppression may be a factor in the success of weight loss after such surgery. 
There appears to be no difference in ghrelin secretion between men and women (Bellone et 
al., 2003) or different ethnicities (Tschop et al., 2001).  Patterns of ghrelin secretion 
change across the lifespan in accordance to energy needs. Ghrelin levels are higher in 
children than adults and do not show the same post-prandial fall (Misra et al., 2009).  
Ghrelin levels fall after puberty (Whatmore et al., 2003). Across adulthood ghrelin levels 
are fairly stable but are lower in older adults, reflecting reduced energy requirements in 
this group (Di Francesco et al., 2006).  This pattern of higher ghrelin in children and lower 
levels in older adults seems to reflect the changes in need for nutrition to meet growth 
demands across the lifespan. 
6.3 Ghrelin and Insulin 
The association between ghrelin and insulin is complex.  Ghrelin and insulin have been 
found to be negatively correlated in humans regardless of BMI or diabetic status (Tschop 
et al., 2001).  An increase in acylated ghrelin has been found to reduce insulin secretion 
and increase insulin resistance (Barazzoni et al., 2007).  Higher insulin levels as a result of 
increase in blood glucose seem to decrease ghrelin (Flanagan et al., 2003; Möhlig et al., 
2002; Saad et al., 2002); however, it is thought that this is not a direct effect but is 
moderated through other mechanisms.  The reduction of ghrelin in response to insulin has 
been found to be less in people with type 2 diabetes and this has been related to insulin 
resistance in this group (Anderwald et al., 2003).   It appears that ghrelin moderates insulin 
secretion and vice versa due to some overlap in the signaling pathways involving the 




Insulin levels are typically low before a meal and rapidly rise on ingestion of food.  It has 
been postulated that insulin may be involved in the post-prandial reduction of ghrelin; 
(Flanagan et al., 2003;  Möhlig et al., 2002; Saad et al., 2002).  Murdolo et al., (2003) 
investigated the association between ghrelin and insulin in humans by comparing healthy 
controls with a group of people with Type 1 diabetes who do not produce insulin in 
response to food.  They found insulin was essential to trigger the post-prandial fall in 
ghrelin and suggested that the abnormal insulin response in the diabetes group could 
possibly explain hyperphagia in some individuals with uncontrolled type 1 diabetes.  This 
result suggests that if the ghrelin system together with insulin may be involved in 
hyperphagia in diabetes, this could also be implicated in individuals who binge eat or are 
obese.  
However, the mechanism by which ghrelin secretion is reduced post-prandially is 
contentious and may not depend entirely on insulin as the pulsatile pattern of ghrelin 
secretion across a day has also been found in conditions of fasting.  In humans, despite no 
food intake to stimulate insulin, a fall in ghrelin was observed in accordance with the 
participant’s regular meal time (Natalucci et al., 2005).  Even sham feeding (where 
participants chew, smell and taste but do not swallow) has been found to decrease ghrelin 
secretion (Arosio et al., 2004).  Both these studies indicate that ghrelin regulation is not 
solely determined by insulin and nutritional status measured in the gut, but suggest that the 
processes involving the brain are also likely to play a role in ghrelin secretion and the 
regulation of feeding behaviour. 
6.4 Ghrelin and Obesity 
Obesity is a significant factor in the development of a range of health problems including 




with a number of metabolic conditions due to the role of body fat in many hormonal 
pathways (Ashburn & Reed, 2010; Kim, Cho, & Kim, 2014).  As previously described, 
ghrelin plays a role in metabolic pathways involved in feeding and energy regulation.  
Therefore it is important to consider the association between obesity and ghrelin secretion.   
It is well established that there is a negative association between obesity and ghrelin.  
Fasting ghrelin has been found to be lower in people who are obese (Blom et al., 2009; 
Shiiya et al., 2002; Tschop et al., 2001. The post-prandial fall is also less pronounced in 
this group (English et al, 2002). This suggests that the desire to eat following a meal may 
be impaired in individuals with very high weight, possibly due to reduced sensitivity to 
ghrelin.  This pattern has also been found in rodents.  Perreault et al. (2004) found ghrelin 
sensitivity was decreased in obese mice but that secretion levels returned to normal on 
weight loss.  This suggests that the change in ghrelin secretion is related to increased 
weight, rather than causing weight gain because of altered secretion.   
6.5 Ghrelin Secretion in Eating Disorders 
A summary of research investigating ghrelin secretion in bulimia nervosa and binge eating 
disorder is presented in Table 6.1.  Most studies have used only female participants, 
although three have included males, and either matched with controls for age and BMI or 
have corrected for any differences in age and BMI.  All have used radioimmunoassays to 
measure total ghrelin after an overnight fast.  Many have explored ghrelin secretion in 
response to either a standardised meal or glucose tolerance test.  
Studies generally report altered fasting ghrelin secretion in individuals with bulimia 
nervosa but results are inconsistent as to how secretion is altered.  Fasting ghrelin was 




(Fassino et al., 2005; Kojima et al., 2005; Tanaka et al., 2003; Tanaka et al., 2006).   
However, no difference in fasting ghrelin was found in a number of other studies (Devlin 
et al., 2012; Monteleone et al., 2003; Monteleone et al., 2005; Nedvidkova et al., 2011).  
Troisi et al. (2005) is the only group to report that fasting ghrelin was lower in women with 
bulimia nervosa than controls. Fasting ghrelin is negatively correlated with both BMI and  
body fat in women with bulimia nervosa (Monteleone et al., 2003). 
Area under the curve (AUC) measures the change in plasma ghrelin secretion over time 
and is often used to describe changes in secretion in response to a standardised meal or 
glucose drink.  Devlin et al. (2012) used a liquid meal replacement to compare ghrelin 
secretion in 32 women with bulimia nervosa to that of 24 healthy control women.  They 
found no difference in the pattern of secretion over time between women with BN and 
those with no eating disorder.  This is in contrast to most other studies that have found the 
secretion of ghrelin in response to a standardised meal is reduced in women with bulimia 
nervosa even when BMI is taken into account (Kojima et al., 2005; Monteleone et al., 
2005; Monteleone et al., 2003).  This blunted response means that for women with binge 
eating, ghrelin reduces more slowly, and in some cases even rises before falling 
(Monteleone et al., 2003) and may not fall as much in women who do not binge eat. 
Differences in ghrelin secretion in women who binge eating may be linked to eating 
disorder behaviours such as the frequency of bingeing and purging.  Tanaka et al. (2003) 
found ghrelin had a positive correlation with the frequency of bingeing and purging in 
women with bulimia nervosa binge-purge and anorexia nervosa binge-purge subtypes.   
There is also some evidence that successful treatment results in a normalisation of ghrelin 
secretion in bulimia nervosa (Tanaka et al., 2006), possibly due to the restoration of more 




between binge/purge behaviours and ghrelin secretion (Monteleone et al., 2005; Troisi et 
al., 2005).  
For women with binge eating disorder fasting ghrelin has consistently found to be lower 
than for healthy control groups (Geliebter, Hashim, & Gluck, 2008; Geliebter, Gluck, & 
Hashim, 2005; Geliebter et al., 2004) along with a blunted decrease in ghrelin secretion in 
response to a meal.  This blunting effect is found even when comparing obese women with 
binge eating disorder to obese non-eating disordered women, which suggests that this 
change is not due to obesity alone.  Munsch et al. (2009) is the only study of binge eating 
disorder which has not found this pattern of reduced fasting ghrelin and a blunted response 
to a test meal.  As for individuals with bulimia nervosa, ghrelin secretion returns to normal 
levels fairly quickly after successful treatment  (Geliebter et al., 2008). 
Lower fasting ghrelin and a blunting of the post-prandial fall in individuals with binge 
eating may be a down regulation of the ghrelin system in an attempt by the body to reduce 
food intake.  If this is the case, the presence of binge eating is in opposition to this and 
therefore requires an individual to over-ride the neurohormone signals to reduce energy 
intake.  Alternatively feedback mechanisms including the ghrelin system could be 
impaired in this group but there is no evidence to support this. 
In binge eating disorder there is no food energy deficit, although there may be periods of 
time (typically hours) without ingestion of food (for example in people with a pattern of 
fasting or restricted eating in the first part of the day who then consume the majority of the 
day’s energy at the end of the day – often as part of a binge or objective over-eating 
episode) or individuals who are nutritionally deficient but not calorie deficient due to not 




Night eating syndrome has been the focus of one study (Allison et al., 2005).  Ghrelin 
secretion was monitored over a 24 hour period in 15 women with night eating syndrome 
and 14 healthy controls.  Women with night eating syndrome had lower total ghrelin in the 
early morning than the healthy control group which was attributed to suppression of 
ghrelin due to ingestion of food at night by the night eating syndrome group. As with binge 
eating disorder and bulimia nervosa it appears that the neuroendocrine profile is different 
in night eating syndrome and this is a result of eating patterns, not the cause of disordered 
eating. This finding is in contrast to a published case study of one woman with night eating 
syndrome who was treated with citalopram (Rosenhagen et al., 2005).  Her ghrelin levels 
in the early morning were higher pre-treatment and during a relapse than they were during 
recovery.  They concluded that higher ghrelin levels at this time may be promoting early 
morning eating in this woman. 
Although anorexia nervosa is not a focus of the current study, an understanding of the 
patterns of ghrelin in this group is useful in understanding the role of ghrelin in binge 
eating.  There is consensus among studies that circulating ghrelin is increased in anorexia 
nervosa (Tanaka et al., 2003; Troisi et al., 2005).  The increase in ghrelin is likely to be 
influenced by not only by BMI, but also by both body composition and nutritional status, 
as women who are constitutionally thin have lower circulating ghrelin than BMI matched 
individuals with anorexia nervosa (Germain et al., 2007). 
On weight restoration, ghrelin secretion reduces in women with anorexia nervosa 
(Nakahara et al., 2007; Tanaka et al., 2004).  This suggests that any changes in ghrelin 
secretion in women with anorexia nervosa are at least in part due to the body attempting to 





Interestingly there is some support for the role of ghrelin administration as a component of 
treatment for anorexia nervosa to potentially increase appetite (Stoving, et al., 2009).  
Human trials suggest it is safe to administer ghrelin with a low rate of side-effects reported 
(Alvarez-Castro et al., 2013).  
To summarise, although not all studies are in agreement, it seems likely that changes in 
ghrelin secretion across eating disorders are related to the nutritional status of the 
individual.  At one end of the spectrum, individuals with anorexia nervosa are in a 
nutritionally deprived state which leads to an increase in ghrelin secretion in an attempt to 
correct this.  However while the eating disorder continues, these neurohormone signals are 
ignored and the individual engages in behaviours that are contrary to this signal such as 
food restriction and purging.  At the other end of the spectrum are individuals with binge 
eating disorder, often with high weight, who engage in regular episodes of eating where a 
large number of kilojoules are ingested in the absence of purging behaviours.  In this group 
fasting ghrelin levels are reduced and ghrelin secretion does not fall as quickly or to the 
same extent as in non-obese and non-bingeing people.  Individuals are over-riding the 
neurohormone signals to reduce energy intake.  This failure in ghrelin to drop quickly after 
eating may encourage continued consumption of food in this group. 
The bulimia nervosa group falls somewhere in the middle and this may explain some of 
the conflicting results in this area.  The bulimia nervosa group may or may not be over-
weight or obese and some studies have included participants diagnosed as having bulimia 
nervosa who are under a healthy BMI (less than 20), who may or may not purge by 
vomiting and who may or may not attempt to control their weight by other methods 
including exercise.  They may or not be nutritionally compromised.  However, despite 




weight there is a blunting of ghrelin secretion in response to a meal, possibly as a signal to 





Table 6.1  Summary of studies investigating ghrelin secretion in binge eating  




Results Summary Comments 










F Overnight fast, Ensure 
plus (600ml, 1.5kcal/g 
=6.3kJ), Blood samples -
20, -10, 0, 5,15, then 15 









BNP = HC. No differences in TG. 
No difference in rate 











F Overnight fast, IV 
administration of acyl-
ghrelin (1.0μg/kg), blood 
samples at 15 min 







 BN elevated TG at 
baseline. Response to 
AG no different from 










F Overnight fast, 
standardised breakfast 
(400kcal = 1674kJ).  









BN < HC, 
p=0.04 
BN fasting TG higher 
than HC. Lower 
ghrelin response post-











F Overnight fast, 
standardised breakfast 
192 kcal = 803kJ 
,standardised lunch 
1217kcal = 5092kJ. 










Fasting TG positive 
correlation with BMI 
and body fat%. Pre-
prandial BN-P no 
different from HC. 
Post prandial TG 
blunted response in 
BN compared to HC. 
Italy 
Monteleone 







F Overnight fast, 
standardised breakfast 







Pre-prandial BNP no 











Results Summary Comments 
5460kJ, samples taken at 
times 0,45,60,90,120 and 
180 min 
"Blunted" response to 
food in BNP. 
study 
published 
2003.   
Monteleone 


























BED, BEDO and 
HCO had lower TG 
than the normal 
weight HC and BN.  
TG negative 
correlation with BMI 
and % body fat. TG 
not correlated with 

















F Overnight fast, TG 
baseline, after exercise, 
after exercise + Aci,• 90 
min post exercise, 90 min 









NA No difference in 
fasting TG. 
Aci administration 
and exercise -   BN < 
HC after 45 min 
exercise.  Aci + 
exercise decreased 




































































NA TG higher in BN than 
HC.  After treatment 
TG levels fell in BN 
























F Overnight fast, single 
blood sample, 
questionnaires: BULIT-
R, EAT-26. Thyroid 










(953)   
 
 
NA TG lower in women 
with binge-purge 
behaviours.  No 
difference between 
BN-P and BN-NP. 
TG was correlated 
with lower BULIT 
scores.  TG negative 
correlation with T3 
and T4 
Italy.  Small 
sample sizes 






made up of  6 





8 HCNW  









16 F  
8 M 
 
Light breakfast, 2 hours 
later Trier Social Stress 
Test (TSST).  Blood 
samples taken at -30, 0, 







 No change in ghrelin 
during stress test; 
however, when HC-




stress test did 
























and non-responders  
those at higher stress 
showed an increase in 
ghrelin.  Suggested 
HPA axis involved.  
No correlation 
between urge to eat 
due to stress and 
ghrelin levels.  
Conclude that ghrelin 
levels reflect 
nutritional status 
rather than other 
factors such as stress. 















(3337 kJ).  Blood 
samples at -20, -5, 15, 
30,45,60,90,120,180 min. 
Repeated after CBT 
treatment in BED group. 





BED = HC No differences 
between BED and 
controls.  Treatment 



















F Overnight fast, 
standardised liquid meal 
(1254kJ), samples taken 
at    -15, 









Fasting ghrelin lower 
in BED, Blunted fall 
post-prandially, 
returns to normal 









Results Summary Comments 
Compared pre-treatment 













F Overnight fast, 
standardised meal 








BED<HCO BED lower baseline 
ghrelin compared to 
HC, lower AUC and 
smaller decline post 
meal. Sub threshold 
BED group 
intermediate but not 
significantly different 
from either BN or 
HC.  No differences 
among groups for 
insulin or glucose.  




increased as did AUC 
but not sig different 

























F Overnight fast, liquid test 
meal (600ml, kJ not 
reported), blood samples 








BED  < HC 
p=0.03 
Lower fasting ghrelin 
in BED, smaller 
decrease in ghrelin 




























F 3 day inpatient stay, food 
intake recorded, blood 
sampled on 3rd 2 hourly 




  NES Ghrelin lower in 
early morning hours 
than HC. Concluded 
lower ghrelin at night 
due to suppression 
due to ingestion of 
food. Neuroendocrine 
profile different in 
NES is a result of 










et al. (2005) 
1 NES 
3HC 
27 23.5 F Blood samples at 20 
minute intervals 
overnight. 3 time points; 
before treatment, during 
treatment with 
citalopram, relapse, full 
remission 
  NA Ghrelin levels were 
higher at pre-
treatment and relapse 




ghrelin levels are 
elevated in NES. 
Case study 
only 












Overnight fast, single 
blood sample, Cognitive 
Restraint Scale, eating 
questionnaire.  Grouped 








NA Ghrelin negative 
correlation with BMI.  
Ghrelin had positive 
correlation with 









Results Summary Comments 






p=0.004   
No differences 
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6.6 Ghrelin and Food Reward  
Ghrelin may not only play a role in the gut-brain axis but may also have involvement in 
the hedonistic aspects of eating via dopaminergic action (Menzies et a., 2013).  High levels 
of ghrelin receptors have been found in the ventral tegmental area (VTA) of the 
mesolimbic region of brain which is thought to be involved with mediating the reward 
properties of food (Schellekens, Dinan, & Cryan, 2013).  Studies in mice have shown that 
direct injection of ghrelin into the VTA increases dopamine release (Jerlhag et al., 2007).   
In humans it has been shown that peripheral administration of ghrelin increases the activity 
as measured by f-MRI in the areas of the brain that are involved with reward in response to 
seeing pictures of food (Malik et al.,2008).   
This increase in activity in the reward centres is relevant to binge eating as there is clearly 
a hedonistic aspect to bingeing for some individuals at least (Dalton, Blundell, & 
Finlayson, 2013; Murray et al., 2014).   People with binge eating are more likely to have 
higher levels of other reward motivated behaviour such as alcohol consumption (Ferriter & 
Ray, 2011). This suggests shared neural pathways for binge eating and alcohol addiction 
(Leggio et al., 2011).  Ghrelin may act as a reward amplifier, with highly palatable foods 
(Menzies et al., 2013), particularly foods high in sugar (Landgren et al., 2011).  
6.7 Ghrelin and Exercise 
Research on ghrelin and exercise is relatively recent and currently there is no clear 
association between ghrelin and exercise in healthy adults as findings differ depending on 
the type, intensity and duration of exercise (King et al., 2013).  
A three month programme of diet and exercise in healthy women found that ghrelin 




deficit though diet restriction as well as exercise, so changes may be attributable to this 
rather than the exercise itself (Leidy et al., 2007).  
There is some evidence that moderately intense exercise has the immediate effect of 
reducing ghrelin (Vestergaard et al., 2008), but this decline may be transitory with ghrelin 
levels returning to pre-exercise levels within 30 minutes (King et al., 2010; Schubert et al., 
2014).  Even low intensity exercise may reduce ghrelin secretion (Erdmann et al., 2007).  
However, other studies have not found a change in ghrelin secretion after intense exercise 
(Alajmi et al., 2016; Kraemer & Castracane, 2007). 
In studies of longer term exercise programmes, results suggest that ghrelin secretion 
increases over a course of exercise; however, this is likely to be due to the resulting weight 
loss of the exercise regime rather than the exercise itself (Garcia et al., 2006; Leidy et al., 
2007; Ravussin et al., 2001). 
Exercise can be a component of bulimia nervosa and binge eating disorder as a method of  
weight suppression (Cook et al., 2015), and excessive exercise can be a purging method in 
bulimia nervosa (Stiles-Shields, Lock, & Le Grange, 2015).  Therefore exercise could 
influence ghrelin secretion in both bulimia nervosa and binge eating disorder.  To date 
there has been only one study that has specifically looked at the relationship between 
ghrelin and exercise in women with binge eating (Nedvidkova et al., 2011).  Ghrelin levels 
decreased after exercise in women with bulimia nervosa but not in healthy controls. This 
decrease was considered most likely to be a reflection of poor nutritional status in bulimia 




6.8 Problems with Previous Research 
The ghrelin literature is a relatively recent, but fast moving area of research and as such 
there have been a number of studies publishing conflicting results.  To help understand the 
possible reasons behind this, it is important to consider the methodologies when 
interpreting these studies as a number of different methodologies have been used.  Such 
considerations include differences in ghrelin assays, participants, and methods of 
manipulating ghrelin to investigate its influences on different systems in the body. 
The form of ghrelin that is measured is one such important consideration.  Earlier studies 
did not differentiate between acyl and des-acyl forms of ghrelin and tend to report their 
findings as “total ghrelin”, “peripheral ghrelin” or “circulating ghrelin”; all different terms 
for the same thing.  In studies that report only “ghrelin” it must be assumed that this is total 
ghrelin unless stated otherwise.  In the current study the term “total ghrelin” will be used to 
refer to the total amount of ghrelin, inclusive of all forms, circulating in the blood.  The 
growing recognition that different forms of ghrelin may have different functions together 
with development of ghrelin assay technology has resulted in the reporting of acyl and des-
acyl forms, often along with total ghrelin, to give a more complete picture of how ghrelin 
acts in the body.    
Human studies are of most relevance when considering the in vivo actions of ghrelin that 
are relevant to the topic of this thesis; women who binge eat.  Methods used to explore 
patterns of ghrelin secretion in humans include monitoring ghrelin levels over a 24-hour 
period to describe the diurnal patterns, measuring ghrelin levels in response to fasting, test 
meals of known energy composition, oral glucose tolerance tests, and presenting meals of 





6.9 Summary of Literature and Research Questions: 
Ghrelin is the only orexigenic hormone found to date and has been shown to play a role in 
energy homeostasis.  Some studies have found differences in ghrelin secretion in 
individuals with binge eating. It is unlikely that ghrelin is a contributor to the development 
of eating disorders whether restrictive, purging or bingeing in nature.  Rather, it is likely 
that the disruption or alteration of the ghrelin system is likely as a result of these 
behaviours.  In bulimia nervosa and binge eating disorder, the disruption in regular eating 
patterns changes the normal feeding regulation pathways which manage the initiation of 
eating, sensations of hunger, and body weight and composition.  It appears that ghrelin 
may be down-regulated which may have implications for the many other systems of the 
body that it is involved in.  These changes may also have implications for the maintenance 
and recovery from disorders of binge eating. 
It is useful, therefore, to explore the changes in ghrelin in individuals with binge eating to 
further understand the associations between ghrelin and eating disorder behaviours, 
neurocognitive functioning, anxiety, depression, and addictive behaviours.  In the next 
section of this thesis patterns of ghrelin secretion in women with bulimia nervosa and 
binge eating disorder will be compared with women who do not binge eat.  The potential 
relationships between ghrelin and eating disorder behaviours will be explored. 
The following questions will be addressed: 
1. Are there differences in ghrelin secretion among women with binge eating and 
women who do not binge eat? 










7. METHODS:  GHRELIN 
A description of the methodology of the overall study has already been given in Section 3.  
Methods for collection of age, ethnicity, BMI and percent body fat have previously been 
described in sections 3.5 and 3.6.  The following section describes methodology specific to 
the neurohormone section of the current study. 
7.1 Biological Procedure 
All participants were required to fast overnight.  The biological assessment was carried out 
by the research nurse.  On arrival at the Clinical Research Unit they were measured for 
height and weight and BMI was calculated.  An indwelling intravenous catheter was 
inserted and the participant was rested for 45 minutes before baseline bloods were taken at 
-15 and 0 minutes.  An oral glucose load (75g glucose in 300mls, 1330kj) was given with 
blood samples taken at 15, 30, 45, 60, 120 and 150 minutes. Blood samples for hormones 
(total ghrelin, C-ghrelin and insulin) were centrifuged and frozen for later analysis.  
Glucose was measured at the same time points using finger prick testing kits.   
At least some portion of the biological assessment was carried out in 144 study 
participants.  However, of these, 26 participants were excluded from biological analysis: 
16 participants were not able to sustain cannulation for obtaining blood samples, samples 
from 10 participants were lost due to the 2011 Canterbury earthquakes affecting freezer 
storage of samples, and two participants were excluded as they had fasting insulin levels 
more than two standard deviations from the mean suggesting either undiagnosed diabetes 




7.2 Description of Neurohormone Variables  
Ghrelin was assayed as total plasma ghrelin (including both acylated and des-acylated 
forms) and C-ghrelin measured in an assay for the C-terminus of the ghrelin molecule 
which is present in the acylated form of ghrelin and therefore is a measure of acylated 
ghrelin.  A ratio of C-ghrelin to total ghrelin was calculated to allow investigation of 
possible changes in each form of ghrelin relative to the other.  The higher the ratio, the 
more acylated ghrelin is present relative to total ghrelin.   Not all participants have results 
for C-ghrelin as this assay was not carried out on the first 26 participants.  
Fasting total ghrelin, C-ghrelin, insulin and glucose were measured at two time points (-15 
minutes and 0 minutes) before oral glucose was given.  Hormone and glucose levels at 
these time points were averaged to give a measure of mean fasting levels.   
Area under the curve (AUC) was calculated for total ghrelin, C-ghrelin, insulin and 
glucose using the trapezoid method (Pruessner et al., 2003). Where there were up to two 
missing time points for any one participant these were estimated by averaging the time 
points either side, and adjusting proportionally for timing of the sample.  If participants 
had more than one missing time point that could not be estimated their data were excluded 
from AUC analysis.  Where missing data points were potentially the nadir (ghrelin and C-
ghrelin) or peak (insulin and glucose) estimations were not calculated and so were not used 
to calculate nadir or peak levels or time to nadir or peak. 
Homeostatic Model Assessment known as HOMA-IR is a commonly used index of insulin 
resistance (Wallace, Levy, & Matthews, 2004).   HOMA-IR was calculated using the 
following equation:  




The higher the HOMA-IR value the greater the insulin resistance.   After an oral glucose 
tolerance test normal levels are below 3.82.   
7.3 Description of Demographic and Psychological Variables 
The number of binge-eating and vomiting episodes for the past month were obtained from 
the number of binges or vomits reported by each participant as part of the semi structured 
Eating Disorder Examination (EDE).  EDI subscales Bulimia, Impulsivity and 
Perfectionism have also been used for this section of the study. 
7.4 Statistical Analysis 
Participants were grouped according to diagnosis (bulimia nervosa, binge eating disorder 
and healthy controls).  The bulimia nervosa group was further divided into purging (BN-
BP) and non-purging (BN-NP).  This division was deemed to be meaningful as purging 
behaviour potentially has an influence on ghrelin secretion.  The number of participants in 
each group for these analyses differs from analyses of neuropsychological data reported in 
Part B as not all participants were able to complete the biological assessment, usually due 
to difficulties with cannulation.   
All analyses were performed using IBM SPSS Statistics version 23.   Descriptive statistics 
were used to report sample characteristics.  The associations of ghrelin, insulin and glucose 
levels and age, BMI, and body composition were explored using Pearson’s product-
moment correlations to identify possible confounders of ghrelin secretion patterns. 
Differences in hormone secretion and glucose among diagnostic groups were investigated 
using ANOVA.  Associations between psychopathology and ghrelin secretion were 
analysed using Pearson product-moment correlations for normally distributed variables, 




distributed.  Results are reported as means and standard deviation or standard errors for 
continuous variables.  Means and confidence intervals are reported in tables where at least 
one variable had been log transformed.  Number and percentage are reported for 
categorical variables. Post hoc analyses were carried out using LSD analysis.   All 





8. RESULTS: GHRELIN 
8.1 Description of the Total Sample 
Demographic variables and total ghrelin, C-ghrelin, insulin and glucose for the total 
sample are described in Table 8.1.   
Table 8.1  Demographic and biological characteristics of the total sample. 
 Number Mean sd 
Age (years) 144 33.7 12.3 
BMI 144 28.5 6.9 
% Body fat 117 37.0 10.2 
Fasting total ghrelin (pmol/L) 144 239 108 
Fasting C-ghrelin (pmol/L) 100 90 49 
Fasting insulin (pmol/L) 114 51 47 
Fasting glucose (mmol/L)  134 5.6 1.1 
Total ghrelin nadir (pmol/L) 116 145 57 
C-ghrelin nadir (pmol/L) 83 50 28 
Insulin peak (pmol/L) 92 554 558 
Glucose peak (mmol/L)  129 10.6 2.9 
Total ghrelin time to nadir 
(min) 
116 96 39 
C-ghrelin time to nadir (min) 83 89 34 
Insulin time to peak (min) 92 68 31 
Glucose time to peak (min)  129 59 29 
Total ghrelin % change 116 -31 19 
C-ghrelin % change 83 -42 12 
Insulin % change 92 2173 7191 
Glucose % change 129 92 53 
% change is the difference at 120 min post glucose load compared to pre glucose load 
 
Normality of distribution for all variables was examined.  All were either normally 
distributed or approximated normal distributions with the exception of insulin variables 
which were strongly right skewed.  Therefore natural log (loge) transformations were 




presented in subsequent tables are based on these analyses with back-transformed (exp(x)) 
means and 95% Confidence Intervals (95% CI) reported to allow clinical interpretation.  
As age, BMI and % body fat are potential confounding factors for biological variables, 
Pearson product-moment correlations were calculated between these variables and all 
fasting biological measures (total ghrelin, C-ghrelin, insulin and glucose).  No significant 
association was found between age and total fasting ghrelin (r = 0.08, n = 144, p = 0.36), 
C-ghrelin (r = 0.04, n = 100, p = 0.68), or loge insulin (r = -0.10, n = 114, p = 0.31).  A 
small positive correlation was found for age with glucose (r = 0.27, n = 134, p = 0.002).   
For BMI, moderate negative correlations were found with total ghrelin (r = -0.37, n = 144, 
p<0.001), and C-ghrelin (r = -0.42, n = 100, p<0.001).  Positive correlations with BMI 
were found for loge insulin (r = 0.58, n = 114, p<0.001), and glucose (r = 0.40, n = 134, 
p<0.001). 
Percent body fat was also negatively associated with both fasting ghrelin (r = - 0.45, n = 
117, p<0.001), and C-ghrelin (r = -0.50, n = 87, p<0.001), and positively associated with 
loge insulin (r = 0.55, n = 88, p<0.001) and glucose (r = 0.43, n = 108, p<0.001).   
Across the total sample Body Mass Index and % body fat were very highly correlated (r = 
0.94, n = 117, p<0.001).   
Pearson product-moment correlations were calculated to measure associations between 
fasting total ghrelin, C-ghrelin, insulin and glucose and are presented in Table 8.2 .  
Fasting total ghrelin and C-ghrelin were highly correlated (r = 0.69, n = 100, p<0.001).  
Loge insulin was negatively associated with both total ghrelin and C-ghrelin.  Glucose did 




Table 8.2  Associations between total ghrelin, C-ghrelin, loge insulin and glucose 
 Total ghrelin C-ghrelin Insulin (Loge) 
C-ghrelin 0.69***   
Insulin -0.35*** -0.48***  
Glucose 0.08 -0.12 0.24 
Values reported are Pearson coefficient (r),  
*** = p<0.001 (two tailed). 
A ratio of C-ghrelin to total ghrelin was calculated for the total sample and for the AUC as 
a measure of ghrelin secretion response to energy ingestion (glucose).  The mean ratio for 
the total sample at baseline was 0.39, (SD = 0.17, n = 83).  The ratio for the AUC was 0.46 
(SD = 0.21, n = 83).  A paired samples t-test found that the ratio at baseline was 
significantly lower than the ratio for the AUC (t = 7.04, df = 82, P<0.001.  This indicates 
that total ghrelin falls faster than C-ghrelin in response to ingestion of glucose. 
8.2 Metabolic Disorders 
Five of the total sample had been diagnosed with type 2 diabetes, of which three were 
taking the diabetes medication, metformin. None were insulin dependent.  Of those with 
type 2 diabetes, two were from the BED group, two from BN-NP and one from BN-BP.  
None of the HC group had diabetes or took metformin. The mean age of those with type 2 
diabetes or insulin resistance was 45.8 years and the mean BMI was 38.0.   
A further five participants reported a diagnosis of polycystic ovary syndrome of which 
three were from the BED group and two from the BN-NP group.  One of the BED 
participants with diabetes also reported a diagnosis of polycystic ovary syndrome. Two 
participants with polycystic ovary syndrome, both from the BED group, were taking 
metformin for this condition.  None of the HC group reported a history of polycystic ovary 
syndrome.  Of those with polycystic ovary syndrome, the mean age was 27 years and mean 




Five participants reported hypothyroidism (four from the BED and one from the HC 
group).  All those with BED were taking thyroxine whereas the HC participant was not 
medicated.  One participant from the BN-BP group reported hyperthyroidism but did not 
report being on any medication.  Of those with hypothyroidism, the mean age was 38 and 
mean BMI was 24.5.  None of those with hypothyroidism also had diabetes or insulin 
resistance.   Thyroid stimulating hormone (TSH) was measured at baseline.  Levels 
suggestive of hypothyroidism were found in three participants (2.1%), one from the BN-
NP group and two from the BED group.  One of these women had diagnosed 
hypothyroidism and was taking thyroxine whereas the remaining two did not report 
hypothyroidism and were not taking thyroid medication.  A further three participants had 
TSH levels suggestive of hyperthyroidism.  One of these women had a diagnosis of 
hyperthyroidism but did not report taking medication.  The remaining two women did not 
report any medical diagnoses and were not taking any medication. 
8.3 Age, BMI and Body Composition by Diagnostic Group 
Results of a comparison of age, BMI and % body fat by diagnostic group are found in 
Table 8.3.  Participants in the BED group were older and had higher BMIs than all other 
groups. There were no differences among the other three groups in age or BMI.  Those in 
the BED group had a higher percentage body fat than all other groups.  Of participants 
with BN, those who purged had lower body fat than those who did not purge.  
As BMI and percentage body fat were significantly different among the groups, allowance 
for this was made in subsequent analyses.  As reported in section 7.1 above, BMI and 
percentage body fat were highly correlated across the sample.  BMI was chosen as a co-
variate rather than percent body fat as BMI was available for the complete sample whereas 




age was significantly correlated with glucose, as the groups did not differ with respect to 
age, it was not used as a co-variate in subsequent analyses. 
Table 8.3  Results of ANOVA comparing age, BMI and body composition among women 
with bulimia nervosa, binge eating disorder and healthy controls.   
 BN-BP  







































































*  % Body fat measured in only 19/46 HC 
BN-BP = bulimia nervosa binge-purge subtype; BN-NP = bulimia nervosa non-purging subtype; 
BED = binge eating disorder; HC = healthy controls. 
 
8.4 Fasting Ghrelin, Insulin and Glucose by Diagnostic Group 
Comparisons of mean fasting total ghrelin, C-ghrelin, loge insulin and glucose by 
diagnostic group are found in Table 8.4.  Those in the BED group had lower total ghrelin 
than those in the BN-BP and HC groups, but were not different from the BN-NP group. 
There was no difference in C-ghrelin among the groups.    Fasting insulin was significantly 
higher in the BED when compared with all other groups.  Fasting glucose was higher in 






Table 8.4  Mean fasting total ghrelin, C-ghrelin, insulin* and glucose by diagnostic group. 
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* All analyses of insulin were performed on loge transformed variables. Insulin variables reported 
in this table have been back transformed (exp(x)). 
BN-BP = bulimia nervosa binge-purge subtype; BN-NP = bulimia nervosa non-purging subtype; 
BED = binge eating disorder; HC = healthy controls. 
 
significant difference among the groups for fasting total ghrelin or C-ghrelin. There was no 
difference among the groups for the C-ghrelin/total ghrelin ratio.  Fasting loge insulin was 
significantly different among the groups with post hoc analysis indicating that the HC 
group had higher fasting insulin than the BN-NP group.  The HC group also had higher 
fasting glucose than the BN-NP group.   Insulin was significantly correlated with BMI 
across the total sample (Pearson product moment correlation, r = 0.55, p<0.001, n=144). 
HOMA-IR is an index of insulin resistance.  The majority of the total sample was in the 
normal range (HOMA-IR<3.85); however 15.2% of the sample were above the cut off for 
insulin resistance.   HOMA-IR distribution had a strong right skew and a loge 





Table 8.5  Fasting ghrelin, C-ghrelin, insulin and glucose with BMI as co-variate by 
diagnostic group.     
 BN-BP  

























































































ANCOVA reporting adjusted mean and 95% CI.  F value for group interaction after adjusting for BMI. d = 
Cohen’s d;   
* Analyses of insulin were performed on loge transformed variables. Insulin variables reported in this table 
have been back transformed (exp(x)). 
BN-BP = bulimia nervosa binge-purge subtype; BN-NP = bulimia nervosa non-purging subtype; 
BED = binge eating disorder; HC = healthy controls. 
 
There was a significant difference in loge HOMA-IR among the groups (F=3.58 (3,101), 
P=0.017).  Women with BED had significantly higher HOMA-IR than women in the BN-
BP (LSD, p=0.007) and BN-NP (LSD, p=0.04) groups but was not different from the HC 
group.  The BN-BP group had lower HOMA-IR scores than the HC group (LSD, p=0.014).   
HOMA-IR was significantly associated with BMI across the total sample (r=0.56, 
p<0.001, n=105).  Comparison of the four groups with BMI as a co-variate revealed 
significant differences remained among the diagnostic groups (F=0.65, df = (3,100), 
p=0.015).  Post hoc comparisons showed that the BN-BP (p=0.015) and BN-NP (p=0.007) 
groups had significantly lower insulin resistance than the HC group but were not 




Over the total sample HOMA-IR had a small to moderate negative correlation with fasting 
total ghrelin (r=-0.29, p=002, n=105) and with fasting C-ghrelin (r=-0.43, p<0.001, n=71). 
8.5 Response to Oral Glucose Challenge by Diagnostic Group 
Change in levels of total ghrelin over time in response to an oral glucose challenge can be 
seen in Figure 8.1.  All three eating disorder groups had lower levels of total ghrelin 
secretion compared with the HC group as shown by the AUC and nadir.   There were no 
differences among the groups in the time to reach nadir or the percentage fall from 
baseline as reported in Table 8.6. 
The pattern of C-ghrelin secretion after the oral glucose challenge is shown in Figure 8.2.  
C-ghrelin secretion falls in all groups with no significant differences in AUC, nadir, time 
to nadir and the percentage fall from baseline (Table 8.7).    
Insulin levels rise rapidly in response to the oral glucose in all four groups as shown in 
Figure 8.3.  The AUC is significantly different among the four groups with post hoc 
analyses showing the BED group had a larger AUC than those in the BN-BP group.  There 
were no differences among the groups for peak insulin, time to the peak or percentage rise 
from baseline as reported in Table 8.8. 
Change in glucose in response to the oral glucose challenge is shown in Figure 8.4  There 
were no differences among the groups for AUC, peak glucose, time to reach peak glucose 





Figure 8.1 Change in total ghrelin in response to an oral glucose challenge by diagnostic 
group 
 
Table 8.6  Change in total ghrelin (pmol/L) in response to an oral glucose challenge by 
diagnostic group 
 BN-BP  
























































































.27   
d = Cohen’s d;  BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-purging subtype; 



























Figure 8.2  Change in C-ghrelin in response to an oral glucose challenge by diagnostic 
group 
 
Table 8.7  Change in C-ghrelin (pmol/L) in response to an oral glucose challenge by 
diagnostic group 
 BN-BP  






































































BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-purging subtype; BED = 



























Figure 8.3 Change in insulin in response to an oral glucose challenge by diagnostic group 
 
Table 8.8  Change in insulin* (pmol/L) in response to an oral glucose challenge by 
diagnostic group 
 BN-BP  
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.46   
* Analysis of insulin was performed on loge transformed variables. Insulin values reported in this table have 
been back transformed (exp(x)) to allow clinical interpretation. d = Cohen’s d;  BN-BP = bulimia nervosa 





























Figure 8.4 Change in glucose in response to an oral glucose challenge by diagnostic group 
 
Table 8.9  Change in glucose in response to an oral glucose challenge 
 BN-BP  







































































BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-purging subtype; BED 


























Comparisons of total ghrelin and C-ghrelin secretion in response to a glucose challenge 
when controlling for the effect of BMI is found in Table 8.10.  For total ghrelin there was 
no difference in AUC among the four groups.  The nadir was significantly higher in the 
BN-BP and BED groups compared to the HC group.  There were no differences in the time 
to nadir or percent fall from baseline among the groups.  There were no differences in C-
ghrelin AUC, nadir, time to nadir or percent fall from baseline among the groups.  
The C-ghrelin/total ghrelin ratio was significantly different among the groups (F=2.75, df 
(3,79), p=0.048).  Post hoc analysis showed that the C-ghrelin/total ghrelin ratio in the BN-
BP group was significantly higher than all other groups.  This suggests that total ghrelin is 
falling faster than C-ghrelin in response to the glucose challenge.  This finding remains 
when the difference in BMI among the groups is taken into account.  Adjusted means for 





Figure 8.5 C-ghrelin/total ghrelin ratio for AUC by diagnostic group with BMI as 
covariate.  Adjusted means and standard errors reported.  
 
Response to the oral glucose challenge for insulin and glucose when controlling for the 
effect of BMI is reported in Table 8.10.  There were no differences in insulin AUC, peak 
insulin, time to peak insulin or percent change from baseline.  For glucose, the AUC was 
significantly different among the groups, with the BN-BP and BED groups having smaller 
AUCs than the HC group.  Peak insulin was also lower in the BN-BP and BED groups 
when compared with the HC group.  There were no differences in the time to peak glucose 































p = 0.045 
BN-BP n =11 
BN-BP n =11 
BED n =38 




Table 8.10  Total ghrelin, C-ghrelin, insulin and glucose levels in response to an oral 
glucose challenge by diagnosis controlling for BMI 
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Glucose (mmol/L) n = 20 n = 24 n = 42 n = 43    
















































* Analysis of insulin was performed on loge transformed variables. Insulin values reported in this table have 
been back transformed (exp(x)) to allow clinical interpretation.  AUC = Area Under the Curve; BN-BP = 
bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-purging subtype; BED = binge eating 




8.6 Association between Eating Disorder Psychopathology and 
Biological Measures  
Eating disorder specific variables, exercise, BMI and percentage body fat by diagnostic 
group are described in Table 8.11.  All eating disorder specific variables were strongly 
skewed to the right except for BMI, percentage body fat and minutes of exercise which 
approached a normal distribution.   
Table 8.11  Description of eating disorder psychopathology variables across the total 
sample and by diagnostic group 
 Total 
sample 




n = 26 
mean (sd)  
 
BN-NP 




n = 47 




mean (sd)  
Binges past month 12.9 (13.3) 23.8 (15.1) 17.0 (9.7) 17.5 (10.6)  0 (0) 
Vomits past month - 26.4 (20.9) - - - 
Total purges past month - 31.9 (22.5) - - - 
Exercise (min/week) 56.0 (44.4) 63.8 (37.3) 65.6 (36.9) 44.8 (33.1) 58.3 (58.1) 
EDI Bulimia 7.0 (5.9) 11.3 (5.5) 10.1 (3.8) 9.6 (3.9) - 
EDI impulsivity 3.2 (4.2) 4.7 (4.7) 4.0 (4.4) 3.7 (4.3) 1.2 (2.9) 
EDI Perfectionism 5.5 (4.5) 8.0 (4.8) 7.0 (4..7) 5.4 (4.1) 3.4 (3.5) 
BMI 28.5 (6.9) 25.1 (6.7) 27.4 (6.3) 33.3 (6.8) 26.4 (5.0) 
% body fat 37.0 (10.2) 30.1 (10.6) 36.6 (8.2) 43.0 (8.0) 33.4 (8.8) 
BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-purging subtype; 
BED = binge eating disorder;  HC = healthy controls 
 
Associations between fasting total ghrelin and eating disorder variables are presented in 
Table 8.12.  Spearman’s rho was calculated to examine nonparametric data and Pearson’s 
product-moment correlations were calculated for normally distributed variables.  A 
moderate positive correlation was found with total ghrelin and the number of binges in the 
past month in BN-BP group but not in any of the other three groups. The BN-BP group 




moderate positive correlation was found between vomiting frequency and fasting ghrelin 
in the BN-BP group.  A very strong correlation was found between the frequency of 
bingeing and purging over the past month in the BN-BP group (r = 0.90, p<0.001, n=26). 
Across the total sample there was a small positive correlation found between the time spent 
exercising and fasting ghrelin.  When examined by diagnostic group, this pattern was 
found in the HC group but not in any of the eating disorder groups.   
A moderate to large negative correlation between both percentage body fat and BMI and 
fasting ghrelin was found in the BED group and not in the other three groups which had 
lower means for BMI and % body fat. 
Table 8.12  Association between fasting total ghrelin and eating disorder psychopathology 
















Binges past month a 0.24* 0.48* 0.15 -0.05 - 
Vomits past month a - 0.51** - - - 
Exercise (min/week) b 0.26** 0.19 -0.07 0.22 0.37** 
EDE Bulimia a -0.21* 0.04 -0.13 -0.05 - 
EDE Impulsivity a -0.04 0.29 -0.18 0.10 -0.02 
EDE Perfectionism a -0.01 -0.01 -0.05 0.27 -0.20 
BMI b -0.39** -0.24 -0.26 -0.57** -0.16 
% body fat b -0.43** -0.29 -0.19 -0.62** -0.20 
*p<0.05, ** p<0.01;   a Spearman’s rank-order correlation (rs);   b Pearson’s product moment 
correlation (r); BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-
purging subtype; BED = binge eating disorder;  HC = healthy controls 
 
Associations between fasting total ghrelin and eating disorder variables are presented in 
Table 8.13.  There was a large positive correlation between C-ghrelin and exercise in the 
bulimia nervosa group. Perfectionism on the EDI-2 also had a large positive correlation 




correlation for both BMI and percentage body fat with C-ghrelin in the binge eating 
disorder group. 
Table 8.13 Association between fasting C-ghrelin and eating disorder psychopathology in 
















Binges past month a -0.07 0.20 -0.34 -0.10 - 
Vomits past month a - 0.01 - - - 
Exercise (min/week) b 0.19 0.50* 0.03 0.07 0.15 
EDE Bulimia a -0.09 0.01 -0.01 -0.05 - 
EDE Impulsivity a 0.01 0.13 -0.29 0.11 -0.22 
EDE Perfectionism a 0.18 0.52* 0.12 0.30 -0.31 
BMI b -0.42** -0.17 -0.45 -0.53** -0.19 
% body fat b -0.47** -0.15 -0.38 -0.64** -0.26  
*p<0.05, ** p<0.01;  a Spearman’s rank-order correlation (rs);  
b Pearson’s product moment 
correlation (r);  BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-
purging subtype; BED = binge eating disorder;  HC = healthy controls 
 
The associations between fasting AUC total ghrelin and eating disorder psychopathology 
in in the total sample and by diagnostic group are shown in Table 8.14.  Total ghrelin AUC 
showed a positive correlation with both the number of binges and the number of vomits in 
the past month in the bulimia nervosa binge-purge group. Exercise was moderately 






Table 8.14 Association between fasting AUC total ghrelin and eating disorder 
















Binges past month a -0.18 0.30 -0.05 0.01 - 
Vomits past month a - 0.37 - - - 
Exercise (min/week) b 0.29** 0.02 0.06 0.20 0.41* 
EDE Bulimia a -0.25** 0.19 -0.25 -0.02 - 
EDE Impulsivity a 0.03 0.17 0.03 0.15 0.13 
EDE Perfectionism a -0.08 0.10 -0.43 0.24 -0.64 
BMI b -0.40** -0.35 -0.22 -0.55** -0.13 
% body fat b -0.42** -0.29 -0.13 -0.65** -0.26 
*p<0.05, ** p<0.01;  a Spearman’s rank-order correlation (rs);  b Pearson’s product moment 
correlation (r);  BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-
purging subtype; BED = binge eating disorder;  HC = healthy controls 
 
The associations between fasting AUC C-ghrelin and eating disorder psychopathology in 
in the total sample and by diagnostic group are reported in Table 8.15.  Both BMI and 
percent body fat were negatively associated with AUC for C-ghrelin in the BED group.   
 
Table 8.15 Association between fasting AUC C-ghrelin and eating disorder 
















Binges past month a -0.05 0.32 -0.25 -0.05 - 
Vomits past month a - 0.19 _ - - 
Exercise (min/week) b 0.16 0.23 0.13 0.11 0.09 
EDE Bulimia a -0.04 0.09 -0.04 -0.001 - 
EDE Impulsivity a 0.12 0.36 -0.06 0.07 0.05 
EDE Perfectionism a 0.11 0.19 -0.07 0.26 -0.26 
BMI b -0.42** -0.14 -0.38 -0.53** -0.22 
% body fat b -0.46** 0.04 -0.29 -0.65** -0.42 
*p<0.05, ** p<0.01;  a Spearman’s rank-order correlation (rs);  
b Pearson’s product moment 
correlation (r);  BN-BP = bulimia nervosa binge-purge subtype;  BN-NP = bulimia nervosa non-





8.7 Summary of Key Findings 
 Total ghrelin secretion was generally lower after an overnight fast in women with 
binge eating compared with women who do not binge eat.   
 Total ghrelin secretion in response to a glucose load was blunted in women with 
binge eating compared with women who do not binge eat. 
 C-ghrelin and total ghrelin were different in the rates of decline after a glucose 
challenge.   
 The BN- BP group had a higher proportion of C-ghrelin after ingestion of glucose 
than all other groups. 
 Insulin levels and insulin resistance were different in some groups of women who 
binge eat and these differences remained even after the effect of BMI is accounted 
for. 
 Fasting glucose levels were lower in women with binge eating compared with 
women who did not binge eat and this difference was more evident after the effects 
of BMI had been accounted for. 
 Some aspects of eating disorder pathology such as frequency of binges, frequency 
of vomiting, levels of exercise and psychological variables such as perfectionism 




9. DISCUSSION: GHRELIN AND OTHER 
NEUROHORMONES IN WOMEN WITH BINGE EATING 
This section will first compare how data from the current study compares to the general 
female population of New Zealand.  Key findings highlighted in the previous chapter will 
then be discussed. 
9.1 Comparison of Sample Characteristics with the General 
Population 
9.1.1 Age 
The mean age of the total sample at 33.7 years is older than many other comparative 
published studies (see Table 6.1) and is likely to be a reflection of recruitment strategies 
which were community based and not recruited from tertiary institutions or eating disorder 
treatment units which tend to have a younger population.  In this study the range of ages of 
the women recruited is fairly wide, ranging from 16 years to 63 years, in comparison with 
studies which have a narrower age range.   
Women in the binge eating disorder group were on average older than women in the 
bulimia nervosa group and those in the control group.  This reflects the often later age of 
onset for binge eating disorder (Kessler et al., 2013) and the transdiagnostic nature of 
binge eating that some women with bulimia nervosa move into binge eating disorder over 
time (Stice et al., 2013).  Despite age being significantly different among the groups in the 
current study, it is unlikely to have had a significant impact on understanding results as the 
biological variables of interest (ghrelin, C-ghrelin, and insulin) were found not 




have increased the incidence of age-related metabolic illnesses including diabetes and 
hypothyroidism.  
No association between age and ghrelin was found in the current study which is consistent 
with ghrelin secretion remaining relatively constant across middle adulthood (Di Francesco 
et al., 2006).  There is evidence that ghrelin reduces in older people but the sample of the 
current study did not include children or adults above 63 years old.   
9.1.2 Body Mass Index 
The mean BMI of women in the current study is very similar to the mean BMI of the 
general population.  The mean BMI of 28.5 across the total sample is similar to results 
reported from the New Zealand Adult Nutrition Study (University of Otago and Ministry 
of Health, 2011) which reported a mean BMI of 27.6 for adult women aged 15 years and 
over.  This similarity suggests these results may be generalisable to the wider population. 
Significant differences in BMI were found among the diagnostic groups.  Women in the 
binge eating disorder group had significantly higher mean BMI than the other three groups 
which were all similar.  Compared with other published studies investigating ghrelin in 
binge eating, BMI in this study tended to be higher for the bulimia nervosa group than 
many of the other studies.  Reasons for this are likely to be that some studies were in Asian 
participants who tend to have lower BMI than other ethnicities.  Some studies had a lower 
average age and BMI is known to increase with age.  Sampling was likely to be more 
representative of the general population than in some other studies which included mainly 
college students.  The inclusion of women with bulimia nervosa non-purging subtype may 
also have had an influence as some studies have included only bulimia nervosa binge-




study.  The wide BMI range has implications for analysis of the neurohormone data as 
some of the sample had BMI related health problems including diabetes and insulin 
sensitivity, polycystic ovary syndrome, and thyroid conditions.   
Significant negative associations between BMI and ghrelin and significant positive 
associations between BMI and both insulin and glucose were found.  These patterns have 
been consistently found in previous research.  This result highlights the importance of 
controlling for BMI in further analyses.  
9.1.3 Prevalence of Metabolic disorders 
In the current study 3.5% of the total sample had a diagnosis of type 2 diabetes.  This 
compares to approximately 5.0% of adult women in New Zealand having diabetes 
although this figure combines both type 1 and 2 diabetes. The percentage of type 2 
diabetes increases to 5.3% when suspected cases (undiagnosed) are included as reported in 
the National Health Survey (Ministry of Health, 2008; Ministry of Health, 2015b).  It is 
likely that some of the participants in this study may also have had undiagnosed diabetes 
as 15% of the sample showed signs of insulin resistance using the accepted cut-off on the 
HOMA-IR index.  It is possible that those with undiagnosed diabetes have skewed some of 
the neurohormone data, specifically insulin levels.  Note that the two participants who 
were excluded from analysis due to outlying insulin levels did not report a diagnosis of 
diabetes.  All abnormal blood results were reported back to the participant to allow them to 
address this with their family doctor. 
The estimated prevalence of diagnosed polycystic ovary syndrome in New Zealand women 
is in the range of 5 to 10% of women of reproductive age (Farquhar et al., 1994).  Results 




healthy control participants are excluded the rate of polycystic ovary syndrome in the 
eating disorder sample rises to 5.1%.  Polycystic ovary syndrome is known to be 
associated with changes in insulin and increased risk of developing diabetes (Balen, 2004; 
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group., 2004).  
This association is found even in women with a BMI in the healthy range (Cattrall & 
Healy, 2004). 
Five percent of the total sample reported thyroid conditions.  The prevalence of thyroid 
conditions (both hypothyroid and hyperthyroid) for adult women in the general population 
in New Zealand is around 5.0% (Ministry of Health, 2008).   
Hypothyroidism is associated with increased insulin resistance (Kapadia, Bhatt, & Shah, 
2012) and higher rates of type 2 diabetes due to a complex chain of interactions between 
thyroid hormones which results in deceased insulin secretion (Wang, 2013). 
Overall 9.7% of the combined eating disorder groups reported a diagnosis of diabetes, 
polycystic ovary syndrome or hypothyroidism.  One participant (2.0%) in the healthy 
control group reported any of these conditions (hypothyroidism).  Because of the inclusion 
of women with diabetes, polycystic ovary syndrome and hypothyroidism it could be 
expected that insulin secretion could be altered in the eating disordered groups more than 
in the healthy control group. 
9.1.4 Fasting ghrelin, insulin and glucose 
Studies with healthy female participants report mean fasting total ghrelin levels between 
121pmol/L (Tanaka et al.,2003) and 385pmol/L (Rouach et al., 2007).  The current study 
fell towards the middle of this range at 273pmol/L.  C-ghrelin has not been reported in 




In the current study C-ghrelin was strongly correlated with total ghrelin as expected.  It 
was found to be at a very similar level to that found by (Bang et al., 2007) who reported a 
correlation coefficient (r) between ghrelin and C-ghrelin 0.61 compared with 0.69 in this 
study. 
Normal levels for fasting insulin (Canterbury Health Laboratories, 2016, retrieved from 
http://www.labnet.health.nz/testmanager 17/03/16) are 10-80 pmol/L, after overnight fast 
for individuals with a BMI lower than 25.  The current study had a mean fasting insulin of 
50.7 pmol/L which falls within this range.  However 15.8% of the total sample had fasting 
insulin levels above 80 pmol/L.  There was a significant correlation between BMI and 
insulin across the total sample.  This suggests that high insulin could be due to the higher 
BMI in many of the participants.  This is consistent with the known association, between 
BMI and insulin (Murray et al., 2014).  It is also likely that some of the sample were 
insulin resistant or had undiagnosed diabetes.  HOMA-IR results are consistent with 15% 
of the total sample having at least some level of insulin resistance.  The positive correlation 
between BMI and HOMA-IR is consistent with individuals of higher BMI being more 
likely to have insulin resistance.  
The normal range for fasting glucose is between 3.5 and 6.0 mmol/L  (Canterbury Health 
Laboratories, 2016, retrieved from http://www.labnet.health.nz/testmanager 17/03/16).  In 
the current study the mean fasting glucose was 5.6 and ranged between 3.2 and 11.7.  
Overall 26.1% of participants had elevated fasting glucose levels.  This finding is 
consistent with the abnormal insulin levels in some of the sample as reported above. In 
response to the oral glucose challenge test (OGCT) a significant proportion of the sample 
showed elevated glucose (>7.8mmol/L) at 120 minutes post oral glucose and 12.9% 




results, the elevated glucose was correlated with BMI which is consistent with current 
knowledge of the association between BMI, glucose, and insulin secretion. 
9.2 Discussion of Key Findings 
9.2.1 Total ghrelin is lower in binge eating 
Fasting ghrelin levels were found to be lower in women with binge eating disorder 
compared with those who do not binge eat.  This is consistent with finding from other 
studies which have also reported a lower ghrelin in binge eating disorder (Geliebter et al., 
2008; Geliebter et al., 2005; Geliebter et al., 2004; Monteleone et al., 2005).   
There is less clarity around fasting ghrelin levels in women with bulimia nervosa.  
Although both the bulimia nervosa groups had lower fasting total ghrelin than the healthy 
control group in the current study, these were not statistically significantly.  This finding is 
consistent with a number of published studies which found no significant difference in 
fasting total ghrelin in bulimia nervosa compared with women without an eating disorder 
(Devlin et al., 1990; Monteleone et al., 2003; Monteleone et al., 2005; Nedvidkova et al., 
2011).  In contrast, other studies have reported fasting ghrelin to be higher in women with 
bulimia nervosa than healthy controls (Fassino et al., 2005;  Kojima et al., 2005; Tanaka et 
al., 2003; Tanaka et al., 2006).   The characteristics of the sample may be an important 
consideration when trying to understand these different findings as studies differ on 
average BMIs, ethnicities and recruitment strategies.  The current study sample is older 
and has a higher mean BMI than many previous studies.  The current study is likely to be 
more representative of the general population as it was recruited from the community 




When BMI is taken into account, differences in total ghrelin by diagnosis reduce or 
become non-significant. It is well established that fasting ghrelin is lower at a higher BMI.  
This suggests that BMI has more influence over ghrelin secretion in a fasting state than 
having regular binge eating.   As Monteleone et al. (2005) suggest, lower total ghrelin in 
women who binge eat could be due to the secondary effect of high BMI and may serve as a 
mechanism to reduce energy intake.  Despite the reduction in strength of the association 
when BMI is taken into account, the pattern of lower total ghrelin in groups with binge 
eating remained which suggests that although BMI has a significant impact on ghrelin 
secretion there may be more subtle effects of binge eating that are harder to detect. 
The reduction in ghrelin secretion in response to energy ingestion is less in women with 
binge eating.  In the current study an oral glucose challenge test (OGCT) was used to 
observe the response to ingestion of energy after a period of fasting.  The resulting AUC, 
an indication of the overall change in hormone secretion, together with the shape of this 
curve also gives information about the timing of response, duration of effect and change 
from baseline levels.  The binge eating groups all had a lower AUC for total ghrelin 
compared to the healthy control group.  The binge eating disorder group had the lowest 
AUC of all groups and the bulimia nervosa binge purge group and bulimia nervosa non-
purging group fell in between the binge eating disorder and control groups.  
Correspondingly the nadir was lower in all the eating disorder groups compared to the 
control group.  This pattern suggests that ghrelin secretion is blunted in the eating disorder 
groups.  Studies comparing binge eating disorder and healthy controls have generally 
found this pattern of a blunted ghrelin response to ingestion of energy whether it be from a 
liquid meal or a standardised breakfast of known energy content (Geliebter et al., 2005; 
Geliebter et al., 2008; Geliebter et al., 2004); however, one small study did not find 




most studies have been carried out by one research group the replication of this finding in 
the current study is an important contribution to the understanding of ghrelin secretion in 
binge eating.   
The timing of the response to glucose ingestion appears to be the same regardless of eating 
disorder diagnosis.   In the present study the time to nadir for total ghrelin was not different 
among the groups including healthy controls.  The size of the response indicated by the 
percent fall from baseline levels was also not different among the four groups.  This may 
reflect the pattern of secretion but may also be due to a floor effect as those groups with 
already lower secretion have less room to fall than those beginning at a higher level. 
The strength of the differences in ghrelin secretion in response to oral glucose reduce when 
the effect of BMI is accounted for.  This again suggests that the differences among the 
binge eating groups and healthy controls may be due to BMI rather than diagnosis.  As 
with the fasting ghrelin results, the general trend of reduced secretion in the eating disorder 
groups remained but the differences were not statistically significant.  It is possible that 
this section of the study was underpowered.  The two bulimia nervosa groups had 18 
participants each which may not have been a sufficient sample size to detect differences as 
there was a large amount of variance within each group. 
It has been suggested that ghrelin is a stronger signal for meal initiation when the body is 
in need of energy such as in lower weight participants compared with higher weight (Blom 
et al., 2009).  It seems that women who regularly binge eat, and particularly those with 
higher BMI may have lower levels of total ghrelin which in theory would result in lower 
levels of hunger and food ingestion.  Reduction in ghrelin is more likely to be a response to 
high BMIs than to bingeing.  This is supported by the finding when individuals without an 




normal sized meal (Votruba et al., 2009).  It appears that binge eating is not driven by 
ghrelin levels and seems more likely to be driven by other mechanisms.    
9.2.2 Changes in C-ghrelin levels are different to total ghrelin 
The correlation between C-ghrelin and total ghrelin is high (r=0.69 p<0.001).  This is 
expected as C-ghrelin makes up part of total ghrelin, being a combination of both acyl and 
des-acyl ghrelin.  C-ghrelin is more unstable as it easily loses its serine ring to transform 
into des-acyl ghrelin and makes up a smaller proportion of total ghrelin than des-acyl 
ghrelin (Bang et al., 2007).  Across the total sample C-ghrelin made up 39% of total 
ghrelin after an overnight fast.  However in response to ingestion of glucose the proportion 
of C-ghrelin rose to 46%.  This suggests that acyl and des-acyl ghrelin may be differently 
affected by ingestion of glucose and that total ghrelin falls faster than C-ghrelin. 
When comparing the ratio of C-ghrelin to total ghrelin among the diagnostic groups it was 
found that there were no differences for this ratio in the fasting condition; however the 
groups differed after glucose ingestion with the bulimia nervosa binge-purge group having 
a significantly higher ratio of C-ghrelin to total ghrelin.  This difference remained even 
after the effect of BMI was accounted for.  However, C-ghrelin levels were not found to be 
different among the groups after the glucose challenge.  This finding suggests that total 
ghrelin is falling faster compared to C-ghrelin in the bulimia nervosa binge purge group 
than other three groups.  These two findings suggest that the des-acyl form of ghrelin is 
reduces more rapidly in response to glucose.  This is a surprising result as acyl ghrelin is 
thought to be the more active form and is easily converted to des-acyl ghrelin.   This 
suggests that in the bulimia nervosa binge-purge group acyl ghrelin is either continuing to 
be secreted by the stomach or is not degrading to des-acyl ghrelin at the same rate as the 




response to energy ingestion.  If this is the case it is essential to measure both forms of 
ghrelin to understand ghrelin secretion in women with binge eating.  Most studies have not 
done this to date. 
However, caution must be taken when making conclusions from this result in the current 
study.  The sample size for this analysis, particularly in the two bulimia nervosa groups, 
was smaller than in some of the other analyses.  C-ghrelin was not being analysed for the 
first 26 participants who were mostly from the bulimia nervosa groups. 
9.2.3 Insulin and insulin resistance are higher in binge eating 
As expected, insulin increased in response to glucose ingestion in all groups.  The size of 
this increase as measured by the AUC was greatest in the binge eating disorder group.  
This is consistent with a higher BMI, and increased insulin resistance.  The higher insulin 
response may be involved in explaining the blunted ghrelin response in this group as 
insulin is thought to be involved in reducing ghrelin secretion (Chabot et al., 2014).   The 
pattern of insulin secretion over time as indicated by the time to peak was not different 
among the groups indicating that it is the size of the response and not a delay in responding 
that is responsible for the differences among the groups.   
This result suggests that those with binge eating and particularly those with higher BMIs 
such as the binge eating disorder group are at increased risk of developing diabetes and the 
health consequences of that diagnosis. 
9.2.4 Glucose is lower in binge eating 
Results of the current study suggest a state of comparative hypoglycaemia in women who 




glucose levels after ingestion of a glucose drink as expected and there were no differences 
among the groups in the timing of the increase in blood glucose with all groups reaching 
peak glucose levels at the same rate.  However, fasting blood glucose was significantly 
lower in the eating disorder groups compared with healthy controls when the effect of BMI 
was accounted for.  Blood glucose levels remained lower in response to the oral glucose 
challenge in the eating disorder groups.  
To understand this pattern it is important to consider the association between ghrelin, 
insulin and blood glucose.  In healthy individuals increased ghrelin suppresses insulin 
release which results in increased blood glucose levels in both fasting conditions and 
glucose challenge tests (Yada et al., 2008).  The current study has shown that women who 
binge eat have a blunted pattern of ghrelin secretion. Therefore in women with binge 
eating lower levels of ghrelin will result in relatively higher levels of insulin independent 
from BMI (which also increases insulin levels).  The resulting increase in insulin levels 
results in reduced blood glucose levels even when BMI is taken into account.  This is 
consistent with ghrelin playing a role in insulin release and glucose metabolism and again 
highlights the potential health consequences of a pattern of regular binge eating.  
Interestingly, low glucose levels have been found to be associated with an increase in 
behaviours showing reduced self-control (Gailliot & Baumeister, 2007).  Furthermore 
when glucose is restored to normal levels, self-control is also restored.  This is of interest 
in individuals with binge eating as loss of self-control is central to defining binge eating.  




9.2.5 Eating disorder psychopathology is associated with ghrelin 
Eating disorder psychopathology is associated with ghrelin secretion in women with binge 
eating but different factors appear to be relevant for different diagnostic groups.   
The frequency of bingeing was positively associated with ghrelin secretion but only within 
the bulimia nervosa binge-purge group.  The frequency of bingeing was highest in this 
group with slightly lower levels in those with bulimia nervosa non-purging and binge 
eating disorder.  Higher levels of bingeing were associated with higher fasting total ghrelin 
and a greater AUC for total ghrelin within the bulimia nervosa binge-purge group.  There 
was a similar nonsignificant trend in the bulimia nervosa non-purging group but no 
association between total ghrelin and bingeing frequency in the binge eating disorder 
group.  This finding of an increase in ghrelin with increased bingeing is interesting as 
overall the eating disorder groups had lower total ghrelin than the healthy control group.  
This pattern may be better understood by considering the frequency of vomiting. 
Within the bulimia nervosa binge-purge group increased vomiting was linked to higher 
total ghrelin levels.  Vomiting may reduce nutrient intake overall and although on average 
this group was of normal weight, they may be energy or nutrient deficient at times due to 
the binge-purge cycle.  This result is consistent with that found by Tanaka et al., (2003) in 
women with bulimia nervosa and anorexia nervosa.  They found that those with a binge-
purge pattern had higher ghrelin secretion compared with those who followed the more 
restrictive pattern in anorexia nervosa or non-purging forms of bulimia nervosa.   As there 
was a very strong correlation between bingeing and vomiting in the bulimia nervosa group 
in the present study (r = 0.90) it is likely that ghrelin secretion is related more to vomiting 




When considering the association between eating disorder characteristics and C-ghrelin in 
the current study it is important to note that the sample sizes are small in some groups and 
this section of the study is likely to have insufficient sample sizes to detect a difference 
among the groups.  There appears to be a similar relationship for C-ghrelin and bingeing 
and vomiting as that previously reported for total ghrelin.  This adds further support to the 
importance of the binge-purge cycle in understanding ghrelin secretion in bulimia nervosa 
and reinforces the need to identify those with purging and non-purging form of this 
disorder. 
The association between ghrelin secretion and exercise is complex.  Exercise in healthy 
participants is known to increase ghrelin secretion (King et al., 2013) but is complicated by 
intensity and duration of exercise and the effect of weight loss.  In women with binge 
eating, exercise can be an important compensatory or attempted weight loss behaviour, 
particularly in the non-purging form of bulimia nervosa.   However, in the current study 
there was no difference in the number of minutes of exercise per week among the groups.  
There was a wide range of time spent exercising both across the total sample and within 
diagnostic groups with some participants exercising extensively and others doing little or 
no exercise.  Across the total sample increased exercise was associated with higher fasting 
total ghrelin, supporting the concept that exercise creates a state of energy deficit resulting 
in an increase in ghrelin in order to restore this deficit.  When the effect of exercise was 
explored within the diagnostic groups this association with exercise was only statistically 
significant in the healthy control group, although there was a non-significant trend for this 
pattern in both bulimia nervosa binge purge subtype and binge eating disorder.  This 
pattern was not found in the bulimia nervosa non purging group which is surprising 




When examining ghrelin secretion in response to an ingestion of energy (glucose), women 
with a binge-purge pattern of bulimia nervosa who exercised more had higher total ghrelin 
secretion compared with women who binge but do not purge, and to healthy women who 
do not binge or purge.   Overall this is a pattern of results which suggests that eating 
disorder behaviours such as vomiting and exercise are associated with increases in total 
ghrelin, particularly in those women with bulimia nervosa binge-purge subtype, but the 
frequency of bingeing may not be associated with increased total ghrelin.  There are likely 
to be a number of factors involved in this association and further research is needed in 
order to understand this complexity.   
One study has reported the impact of exercise in women who binge eat (Nedvidkova et al., 
2011) finding that ghrelin levels reduced immediately after exercise in women with 
bulimia nervosa, but this study did not investigate the long term effects of exercise in this 
group and did not differentiate between purging and non-purging forms of bulimia 
nervosa. The current study did not investigate the immediate effects of exercise on ghrelin 
secretion in women with binge eating; however more research is needed to look at both the 
immediate and longer term influence of exercise in women with binge eating.  
An interesting difference was found between total ghrelin and C-ghrelin when examining 
the amount of exercise in the current study.  The bulimia nervosa binge-purge group had a 
significant association between exercise and fasting C-ghrelin.  There was a similar trend 
which did not reach significance for the AUC.  It appears that in women with bulimia 
nervosa binge-purge subtype, activities such as vomiting and exercise that affect energy 
balance in a negative way are associated with higher C-ghrelin, a measure of the form 




the levels of ghrelin remain lower overall than those that found in women who do not 
binge eat. 
The EDI has commonly been found to differentiate between different diagnostic groups 
and healthy controls and has good reliability to assess both eating disorder specific 
behaviours and attitudes (e.g. Bulimia subscale), and also more general psychological 
characteristics that have been associated with eating disorders (e.g. Impulsivity and 
Perfectionism subscales) (Gleaves et al., 2014).  Eating disorder samples frequently 
display higher scores on these subscales which can differentiate between eating disorder 
and healthy control groups.  In the current study eating disorder groups scored significantly 
higher than healthy controls on the Bulimia, Impulsivity and Perfectionism subscales as 
expected.   
No association was found between EDI Bulimia scores and total ghrelin in the current 
study despite the finding of a positive association between the number of binges and total 
ghrelin as discussed above.  No association was found between ghrelin and either 
Impulsivity or Perfectionism across the total sample or within diagnostic groups.  The EDI 
does not appear to be a useful instrument in understanding patterns of ghrelin secretion. 
Higher Perfectionism scores were associated with increased C-ghrelin but not total ghrelin 
in the bulimia nervosa binge-purge group but this pattern was not in any of the other two 
diagnostic groups.  Again the small sample size is noted and caution is required in making 
conclusions from this result other than it is an interesting finding that fits alongside the 
finding that C-ghrelin is associated with increased purging and exercise.  Perfectionism 
may be a proxy for these variables or may be a factor in its own right.  It is unclear at this 




As expected, BMI and percentage body fat was significantly negatively associated with 
total ghrelin in the binge eating disorder group but not in the other three groups, although 
trend was the same in the other groups. This reinforces the findings that body composition 
is one of the most important factors in understanding hormone secretion in eating 
disorders. 
9.3 Strengths and Weakness of the Current Study 
The current study differed from many other studies investigating ghrelin in women with 
binge eating as an oral glucose drink was used as an energy source compared with 
standardised breakfasts or liquid meal replacements used in many other studies.  A glucose 
drink is not a usual breakfast food and is lacking some of the components of a meal such as 
texture and therefore the need to chew, and is made up of simple carbohydrates rather than 
a range of carbohydrate, protein, fats and fibre.  However, Doubkova et al. (2010) found 
that ingestion of dietary fibre which provided volume but no energy did not change ghrelin 
secretion whereas fibre plus glucose did in both healthy women and women with bulimia 
nervosa, although sample sizes were very small. Their study did not use a typical meal 
which would have been an interesting comparison. 
Regularity of breakfast eating by participants was not accounted for in the current study. 
(Frecka & Mattes, 2008) found that in healthy women, fasting ghrelin was higher in those 
who ate breakfast regularly compared with those who tended to eat their first meal later in 
the day.  It is possible that in the current study the healthy control group ate breakfast more 
regularly which had the potentially to elevate fasting ghrelin levels in the healthy control 




Other weaknesses of the current study include some missing biological data. Care was 
taken to estimate values where appropriate using an established method (trapezoid) but to 
avoid estimating values where inappropriate, for example if the time of peak or nadir was 
not clear, or where there were more than three missing values in a row.  Sample sizes in 
some groups, particularly for C-ghrelin, were compromised due to unavailability of 
samples for a number of reasons, including collapse of vein, unavailability of assay at the 
time of sampling and loss of some samples due to the effect of significant earthquakes in 
Canterbury resulting in power loss and subsequent failure of freezers in which samples 
were stored.  The current study was largely observational and did not involve experimental 
manipulation of ghrelin to investigate effects of ghrelin on neuropsychological function.  
Future studies may be able to advance this area using methods to manipulate ghrelin 
secretion.  
The current study had considerable strengths in study design.  Care was taken to accurately 
place participants in diagnostic categories using the SCID-I semi-structured interview 
which is considered the gold standard for research.  Particular care was taken to 
differentiate purging from non-purging bulimia nervosa and this proved essential when 
investigating differences in ghrelin and insulin secretion in these groups.  The current 
study is one of few to include assays for both total ghrelin and a measure of the acyl form 
of ghrelin (C-ghrelin assay).  This allowed identification of patterns of ghrelin secretion, 
particularly in the BN-BP group that would not have been evident otherwise. 
Participants were recruited from both community and clinical sources which is important 
to enable generalisation of the results to a wide range of women with binge eating – not 




recruitment strategy in the current study also allowed a large sample overall, and adequate 
sample sizes to detect differences among groups for most comparisons. 
9.4 Research for the Future 
Results from the current study suggest a number of areas for further research.  Firstly, 
assays for both acyl and des acyl ghrelin need to be included in studies of ghrelin secretion 
as both appear to alter independently in binge eating, particularly when purging is present.  
It would be useful to compare ghrelin secretion in response to test meals of different 
nutritional characteristics.  It seems clear that glucose ingestion results in a decrease in 
ghrelin; however, different meal compositions (those including fat, glucose, protein, fibre) 
could potentially affect ghrelin secretion in different ways that at present are unknown.  It 
may be interesting to consider psychological variables, beyond hunger, such as subjective 
reports of satiety and the hedonistic qualities of the food. 
Further exploration of eating disorder characteristics is needed.  Inclusion of participants 
with purging disorder may be helpful to understand the contribution of bingeing as 
opposed to vomiting to ghrelin secretion.  The role of exercise in ghrelin secretion both 
immediate and long term would also be helpful to aid in understanding the role of 
activities that create a negative energy balance. Other aspects potentially of interest include 
further examination of psychological traits associated with binge eating such as reward 
dependence and impulsivity. 
The current study has not investigated changes in ghrelin secretion after treatment of binge 
eating.  A small number of studies have found that ghrelin secretion levels normalise after 
treatment in women with binge eating disorder (Geliebter et al., 2008; Munsch et al., 2009 




changes to ghrelin secretion after treatment for bulimia nervosa and binge eating disorder 
would contribute to understanding this more fully. 
9.5 Summary of Ghrelin in Binge Eating 
Ghrelin is part of a complex relationship between systems regulating energy balance as 
well as other functions in the body, particularly those involved in growth.  Results from the 
current study suggest that there is some disruption to the ghrelin system in women with 
binge eating.  Ghrelin is blunted in women with binge eating and this is partially due to 
higher body fat/BMI.  The reduction in ghrelin may be part of the system controlling 
insulin, resulting in higher insulin and lower blood glucose in women with binge eating 
leading to increases in insulin resistance and potential to develop diabetes. 
The level of purging and other activities such as exercise that negatively affect energy 
balance may work in the opposite direction and act to increase ghrelin secretion, although 
not to a level that fully compensates for the reduced ghrelin overall.  The bulimia nervosa 
binge-purge group also differs from the other groups in that C-ghrelin is higher, again 
suggesting a mechanism to improve energy balance in this group.  In the bulimia nervosa 
non-purging group and binge eating disorder group the major influence on ghrelin 
secretion appears to be BMI, an indirect measure of body fat, rather than eating disorder 
behaviours.  
Ghrelin is likely to be implicated in insulin secretion and may increase insulin resistance 







10. LITERATURE REVIEW: GHRELIN AND COGNITIVE 
FUNCTION  
Ghrelin is known to play a role in regulating brain functions other than just energy 
metabolism and appetite and has been implicated in cognitive function, particularly in 
learning and memory through increasing neuronal density (Beck & Pourie, 2013).  
Increasing the number of neuronal connections, sometimes termed neuroplasticity, is 
thought to be a necessary for development of learning and memory, particularly in the 
hippocampus.  The majority of studies investigating the relationship between ghrelin and 
cognitive functioning have been carried out in animals; however, as the hippocampus is 
structurally similar across species animal models can be reliably extrapolated to human 
hippocampus physiology and anatomy (Beck & Pourie, 2013).   
A series of experiments by Diano et al., (2006) showed that peripherally administered 
ghrelin crosses the blood-brain barrier in rodents and is taken up by different areas of the 
brain including the hippocampus.  The number of synapses in the hippocampus was found 
to increase with ghrelin administration suggesting neuroplasticity of this area is enhanced 
by ghrelin.  They were able to demonstrate that administration of ghrelin improved 
learning and memory in both rats and mice.  Furthermore, they found that ghrelin knock-
out mice (those mice in which researchers have inactivated, or "knocked out", the ghrelin 
gene by replacing it or disrupting it with an artificial piece of DNA) which exhibited 
learning and memory deficits improved performance after administration of ghrelin.   This 
comprehensive suite of studies reported in this single publication by this research group 




rodents, which in turn is likely to have improved performance on tasks of memory and 
learning even in animals with learning and memory deficits.  Similar findings of increased 
spatial memory and evidence of neuroplasticity in response to acyl-ghrelin administration 
have been reported by other studies (Chen et al., 2011; Carlini et al 2002; Carlini et al., 
2004).   
It is possible that there is some survival value if memory is improved when ghrelin levels 
are high when animals are in a starvation state as this could potentially improve food 
finding ability.  To examine this Carlini, et al (2008) used a mouse model of food 
restriction in an attempt to mimic conditions of humans with anorexia nervosa.  They 
compared mice on 50% food restriction with mice with ad lib feeding regimes.  As 
expected total ghrelin levels in the food restricted group were almost three times that of the 
control group.  Despite this, food restricted mice showed an impairment in memory using 
the Spontaneous Object Recognition Test and exhibited an increase in anxiety-like 
behaviours.  Central administration of ghrelin to the food restricted mice improved 
memory to the level of the control group.  This result does not support the theory that 
elevated ghrelin levels enhance learning and memory in food deprived animals as a way of 
increasing survival in times of food shortages.  However, as the authors note, the novel 
stimulus task used might not be an ecologically valid test for learning and memory related 
to feeding opportunities and it may not have been advantageous for the hungry mice to 
expend energy on investigating non-food items.  The increase in anxiety was not predicted 
in this study and it was suggested that it may have been due to the central administration of 
ghrelin rather than being administered peripherally.  A similar result was also found by 
Carvajal et al., (2009) who found that ghrelin decreased memory retention and increased 




Ghrelin may also have a neuroprotective effect by inhibiting apoptosis (cell death) after 
brain injury or stroke and reducing the impact of inflammation on neuronal loss (Spencer, 
Miller, & Andrews, 2013; Moon et al., 2009), and this effect is found irrespective of 
ghrelin acylation (Chung et al., 2008).  This protective function is of interest in dementia 
research in humans.  
In the only human study investigating ghrelin and cognitive function to date (Spitznagel et 
al., 2010) investigated the  relationship between fasting ghrelin and cognitive function in 
35 older healthy adults (age 60-85 years).  In contrast with most animal studies they found 
a correlation between high ghrelin and lower cognitive performance on tasks of verbal 
memory, working memory and naming tasks.  The authors suggested this effect may have 
been modulated by an association between ghrelin and disinhibition; however, this was not 
specifically examined. 
In summary, ghrelin increases neural density in the hippocampus, an area of the brain 
associated with learning and memory.  The increase in neural density, often described as 
neuroplasticity in these studies, has been shown to improve performance on tests of 
memory and learning in rodents when administered peripherally although studies using 
centrally administered ghrelin do not consistently show this pattern and have found ghrelin 
increases anxiety in rats and chickens. Ghrelin has also been found to have a 
neuroprotective function by decreasing the impact of neuronal loss after brain injury.  Only 
one study to date has examined ghrelin and cognitive function in humans and unexpectedly 





Table 10.1 Table of literature regarding cognitive function and ghrelin 
Author Participants Method Results Comments 
Carlini et al. (2002) Rats Injected ghrelin intracebrally, Open-
field test (habituation), Elevated 
plus-maze anxiety behaviours), Step-
down test (memory) 
Single administration of ghrelin 
increased memory retention (positive 
relationship with ghrelin dose) and 
anxiogenic behaviour. 
First to show ghrelin 
administration improves memory 
retention 
Carlini et al. (2004) Rats Injected ghrelin intracebrally 
comparing 3 sites (hippocampus, 
amygdala, dorsal raphe nucleus).  
Open-field test (habituation), 
Elevated plus-maze anxiety 
behaviours), Step-down test 
(memory). 
Single administration of ghrelin 
increased memory retention (positive 
relationship with ghrelin dose) and 
anxiogenic behaviour. Ghrelin 
receptors in hippocampus, amygdala, 
dorsal raphe nucleus.  Hippocampus 
highest impact on memory retention.  
Shows ghrelin increases 
hippocampal receptors  
Diano et al. (2006) Rats, mice Series of experiments on rats, mice 
and ghrelin knock-out mice.  
Histology, memory testing 
(Spontaneous alternation plus-maze 
task, T-maze footshock avoidance 
and step-down inhibitory avoidance 
paradigms, Object recognition 
memory tests, peripheral 
administration of ghrelin 
Ghrelin receptors present in 
hippocampus.  Peripherally 
administered ghrelin can enter 
hippocampus. Spine synapse density 
increased with ghrelin.  Evidence of 
increased neuroplasticity with ghrelin.  
Improved learning and memory 
performance in rats and mice.  
Restoration of learning and memory in 
ghrelin knock-out mice 
Demonstrates that ghrelin 
increases neuronal plasticity in 
hippocampus and the relationship 
between this physiological change 
and memory improvement.   
Shows ghrelin can restore 





Carlini et al. (2008) Mice Compared memory performance in 
food restricted mice compared to 
unrestricted mice.  Intracebral 
administration of ghrelin. 
Despite 3x normal ghrelin levels in 
food restriction found decreased 
memory function. 
Does not support naturally high 
ghrelin improving memory in 
food restricted state but did show 
memory restoration on 
administration of ghrelin in food 
restricted state. 
Chaung et al. (2008) 
   
Both acylated and non-acylated 
ghrelin appear to have 
neuroprotective action. 




Injected ghrelin intracebrally, Open-
field test (habituation), One-trial 
passive avoidance task (memory 
retention) 
No significant effect on memory 
retention, increase in anxiogenic 
behaviours. 
Does not support relationship 
between ghrelin and improved 
memory. 





Single fasting ghrelin sample, 
neuropsychological battery including 
tests of verbal memory, working 
memory and naming task 
Negative correlation between ghrelin 
and verbal memory, working memory 
and naming 
Only study investigating ghrelin 
and cognitive function in humans.  
Correlational study with no 
experimental manipulation of 
ghrelin levels. 
Chen et al. (2011) Rats Measured intrahippocampal electrical 
activity  following infusion of ghrelin 
to hippocampus, Spatial memory 
testing with Morris water maze 
Single ghrelin infusion increased 
activity in the hippocampus in a way to 
suggest synaptic plasticity, and 
produced  significant improvement in 
spatial memory 
Ghrelin increases neuroplasticity 
in hippocampus and improves 
spatial memory. 
Moon et al. (2014) Mice Ghrelin administered peripherally to 
mice with cognitive deficits and 
neuronal loss 
Hippocampal neurogenesis improved 
after ghrelin administration. 
Ghrelin increased neurogenesis in 




11. GHRELIN AND NEUROPSYCHOLOGICAL 
FUNCTION IN WOMEN WHO BINGE EAT 
11.1 Research Question 
Animal studies suggest that ghrelin may affect neuropsychological functioning in animals 
as increased ghrelin levels appear to improve cognitive functions associated with food 
gathering.  Conversely, low ghrelin levels potentially impair neuropsychological 
functioning related to food finding in animals.   As ghrelin secretion is altered in humans 
with binge eating it is possible that ghrelin levels could be associated with neurocognitive 
functioning in this group.  This section of the current study investigates associations 
between fasting total ghrelin and C-ghrelin, and neuropsychological function in women 
with binge eating compared with women who do not binge eat. 
11.2 Methods 
The methods for this section have been described in previous methods and can be found in 
Chapters 3 and 7.  The participants in this section of the study differ slightly from the 
neuropsychological testing section as 14 eating disorder participants and two healthy 
control participants did not have neurohormone data available.    
11.3 Results 
Descriptive statistics for neuropsychological variables for the total sample and by 




Table 11.1  Mean and standard deviations for neuropsychological variables for the total 
sample and by diagnostic group. 










RVP total hits 18.2 (4.6) 18.9 (3.9) 18.0 (5.0) 17.9 (4.6) 17.7 (5.4) 
RVP total misses 8.8 (4.6) 8.1 (3.9) 8.9 (5.0) 9.1 (4.6) 9.3 (5.4) 
RVP A 0.91 (0.04) 0.92 (0.04) 0.91 (0.05) 0.91 (0.04) 0.91 (0.05) 
RVP B 0.94 (0.07) 0.94 (0.05) 0.94 (0.05) 0.95 (0.07) 0.93 (0.09) 
RVP mean latency 418.9 (81.1) 423.6 (97.5) 412.9 (77.3) 414.7 (85.1) 415.0 (75.8) 
VRM free recall 8.3 (1.7) 8.4 (1.8) 8.1 (1.6) 7.8 (1.8) 8.6 (1.5) 
VRM recognition 23.3 (1.0) 23.2 (1.0) 23.5 (0.7) 23.1 (1.1) 23.3 (0.9) 
VRM delayed 
recognition  
21.2 (1.2) 23.2 (1.3) 23.2 (0.9) 22.9 (1.6) 23.3 (0.9) 
SOC prob solved in 
min moves 
9.3 (1.7) 9.3 (1.6) 9.3 (1.7) 9.2 (1.8) 9.6 (1.8) 
SOC 5 moves 6.3 (1.3) 6.1 (1.0) 6.4 (1.3) 6.3 (1.5) 6.3 (1.4) 
SOC thinking 1st 12239 (8897) 14604 (9079) 12237 (8369) 12209 (7963) 13479 (10335) 
SOC thinking sub 1449 (2867) 1096 (1297) 1552 (2013) 1964 (4064) 1375 (2870) 
SRM %correct 87.3 (8.7) 88.1 (10.3) 86.6 (11.3) 85.6 (8.0) 87.5 (7.4) 
SRM latency 2244 (577) 2178 (489) 2224 (612) 2315 (654) 2232 (553) 
DMS % correct 90.6 (8.0) 91.5 (6.7) 89.0 (9.5) 90.5 (8.2) 90.8 (7.8) 
DMS latency 3589 (1176) 3446 (792) 3512 (1298) 3682 (1272) 3707 (1336) 
SWM total errors 21.1 (16.4) 22.6 (19.2 20.2 (15.9) 21.3 (13.9) 22.4 (18.7) 
SWM strategy 31.4 (5.6) 32.1 (5.2) 31.9 (6.2) 31.7 (5.4) 30.9 (5.9) 
TMT proportional 1.2 (0.6) 1.4 (0.8) 1.3 (0.6) 1.3 (0.6) 1.1 (0.6) 
BN-BP = bulimia nervosa binge-purge;  BN-NP = bulimia nervosa non-purging, BED = binge eating 
disorder;  HC = healthy controls;  DMS = Delayed Matching to Sample; RVP = Rapid Visual Information 
Processing;  SOC = Stockings of Cambridge; SRM = Spatial Recognition Memory;  SWM = Spatial 
Working Memory; TMT = Trail Making Test;  VRM = Verbal Recognition Memory 
 
There were no significant differences among the four groups for any of the 
neuropsychological variables using ANOVA for normally distributed variables and 
Kruskall Wallis Tests for those variables without a normal distribution. 
Associations between neuropsychological performance and fasting total ghrelin were 
examined using correlational analysis and are presented in Table 11.2.  Pearson’s product-
moment correlations were used for normally distributed variables and Spearman’s rank-
order correlations were used for variables that were not normally distributed.  There were 
no significant associations between ghrelin and neuropsychological performance for any of 
the variables across the total sample.  When analysed by diagnostic group, there were no 




significant moderate correlation (rs = 0.35, p<0.05) between fasting total ghrelin and RVP 
B (a measure of false alarm on a test of visual attention) in the BED group. This result 
showed increased ghrelin was associated with fewer false alarms as indicated by a higher 
RVP B score. 
Table 11.2 Associations between ghrelin and neuropsychological variables for the total 
sample and by diagnostic group. 










RVP Total Hits -0.05 -0.28 -0.17 -0.04 0.10 
RVP Total Misses 0.05 0.28 0.17 0.04 -0.10 
RVP mean latency 0.03 -0.10 0.11 0.29 -0.16 
RVP A -0.05 -0.25 -0.19 -0.02 0.09 
RVP B # 0.03 0.06 -0.13 0.35* -0.14 
VRM free recall 0.09 0.07 0.24 -0.16 0.10 
VRM recognition # -0.13 0.12 -0.21 -0.26 -0.06 
VRM delayed recognition # -0.01 0.21 0.002 -0.17 -0.06 
SOC problems solved min moves # -0.16 0.07 -0.007 -0.27 0.12 
SOC time 5 moves # 0.07 0.25 0.09 -0.10 -0.26 
SOC thinking 1st # -0.02 0.26 -0.04 -0.03 -0.03 
SOC thinking sub# -0.07 0.07 -0.08 -0.06 -0.21 
SRM %correct -0.02 -0.02 0.11 -0.02 -0.24 
SRM latency -0.003 -0.06 0.22 -0.01 -0.03 
DMS % correct # 0.01 -0.10 0.04 -0.06 0.21 
DMS latency -0.01 -0.07 0.13 0.08 -0.19 
SWM errors # 0.003 0.07 0.32 -0.02 0.08 
SWM strategy 0.03 0.09 0.18 -0.13 0.10 
TMT proportional score -0.02 -0.14 0.27 0.02 -0.02 
*p<0.05;  Variables marked with # are reported as Spearman’s rank-order correlations 
(rs)  All other variables reported are Pearson’s product-moment correlations (r) 
BN-BP = bulimia nervosa binge-purge;  BN-NP = bulimia nervosa non-purging, BED = binge 
eating disorder;  HC = healthy controls;  DMS = Delayed Matching to Sample; RVP = Rapid 
Visual Information Processing;  SOC = Stockings of Cambridge; SRM = Spatial Recognition 
Memory;  SWM = Spatial Working Memory; TMT = Trail Making Test;  VRM = Verbal 
Recognition Memory 
 
Associations between fasting C-ghrelin and neuropsychological performance for the total 
sample and by diagnostic group are presented in Table 11.3.  There were no significant 




total sample.  A significant moderate correlation (rs = -0.52, p<0.05) was found between 
fasting C-ghrelin and RVP B in the BN-NP group.  This result indicates that there is an 
association between fasting C-ghrelin and a higher RVP B score indicating fewer false 
alarms on a test of visual attention. There were no other significant correlations found 
between fasting C-ghrelin and neuropsychological variables in any of the other diagnostic 
groups. 
Table 11.3  Associations between neuropsychological performance and C-ghrelin in the 
total sample and by diagnostic group. 










RVP Total Hits -0.10 -.016 -0.20 -0.11 -0.08 
RVP Total Misses 0.10 0.16 0.20 0.11 0.08 
RVP mean latency 0.03 -0.17 -0.17 0.16 -0.04 
RVP A -0.11 -0.13 -0.20 -0.11 -0.10 
RVP B # 0.05 0.13 -0.52* 0.19 -0.24 
VRM free recall -0.11 -0.21 -0.09 -0.09 -0.30 
VRM recognition # -0.11 0.12 -0.33 -0.06 -0.33 
VRM delayed recognition # -0.05 0.16 -0.28 -0.05 -0.12 
SOC problems solved min moves # -0.08 0.07 0.13 -0.16 -0.19 
SOC time 5 moves # 0.03 -0.11 0.14 0.09 0.03 
SOC thinking 1st # 0.05 0.41 0.11 -0.05 -0.03 
SOC thinking sub# -0.07 -0.10 0.07 -0.07 -0.03 
SRM %correct -0.07 0.29 0.19 0.19 -0.26 
SRM latency 0.05 0.44 -0.08 0.04 0.14 
DMS % correct # -0.07 -0.13 0.01 -0.03 -0.23 
DMS latency 0.10 0.35 0.15 0.15 0.11 
SWM errors # 0.11 -0.02 0.36 0.04 0.19 
SWM strategy 0.07 0.02 0.01 0.04 0.19 
TMT proportional score 0.07 -0.26 0.30 0.06 0.14 
*p<0.05;  Variables marked with # are reported as Spearman’s rank-order correlations (rs)  All 
other variables reported are Pearson’s product-moment correlations (r).  BN-BP = bulimia 
nervosa binge-purge;  BN-NP = bulimia nervosa non-purging, BED = binge eating disorder;  HC 
= healthy controls;  DMS = Delayed Matching to Sample; RVP = Rapid Visual Information 
Processing;  SOC = Stockings of Cambridge; SRM = Spatial Recognition Memory;  SWM = 






As previously reported in the neuropsychology section of this thesis there was no 
meaningful difference in neuropsychological performance between those with binge eating 
and those without binge-eating.  Within the three binge eating groups there was also no 
differences in psychological function.  There were however, some differences in ghrelin 
secretion among the groups with the binge eating participants having a lower fasting 
ghrelin and a blunted response to energy ingestion.  Therefore if there were to be any 
association between neuropsychological function it would be expected that lower ghrelin 
would be associated with lower neuropsychological performance on tasks of learning and 
memory.  This pattern was not found in this study.  All but one of variables showed no 
association with ghrelin.  Rapid Visual Processing RVP B”, a measure of false alarms in a 
task of visual attention, was associated with ghrelin.  Higher total ghrelin was associated 
with better performance on this variable in the binge eating disorder group only.  However, 
this could be a spurious result considering the relatively large number of tests carried out, 
and even if not, the mean score for this test was very close to the optimal score and even a 
relatively low score on this test may still indicate a high level of performance so would not 
be clinically meaningful. 
Similarly there was no indication of any association between psychological function and 
C-ghrelin.  There was only one significant finding of ghrelin having a negative association 
with Rapid Visual Processing RVP B”, indicating a poor performance was associated with 
higher ghrelin in the bulimia nervosa non-purging group only.  Again it seems likely that 
this result is spurious.  This result is contrary to that predicted by some animal models 
which predict that higher ghrelin should show increased performance (Diano et al. 2006).  




would have higher levels of circulating ghrelin which may help to increase attention to 
increase the likelihood of finding food . Overall it appears that in the current study at least, 
there is no relationship between ghrelin secretion and neuropsychological function in 
women with binge eating. 
There are a number of problems with the design of this part of the study which make it 
difficult to draw meaningful conclusions.  Firstly there were no neuropsychological 
impairment reported in the binge eating groups which makes it unlikely that differences in 
ghrelin would impact on performance.  Sample size in some groups was lower than ideal 
and the C-ghrelin section was likely to be underpowered.  This was a study by observation 
and did not include any experimental manipulation of ghrelin. 
It would be more useful to investigate the influence of ghrelin on neuropsychological 
function in women with anorexia where there is more evidence of neuropsychological 
functioning changes.  It may be that ghrelin plays a more significant role when the body is 







This study has reported on neuropsychological functioning and ghrelin secretion in a group 
of women with binge eating who were recruited as part of the Binge Eating Psychotherapy 
Study.  The recruitment of 112 women with binge eating and a comparison group of 50 
healthy women who did not binge eat allowed sufficient power to detect meaningful 
differences in neuropsychological functioning and ghrelin secretion for many of 
comparisons made.   
The five hypotheses explored in this study are revisited below: 
 Women with binge eating will have poorer neuropsychological performance 
compared to women who do not binge. 
Overall the current study did not find a consistent pattern of neuropsychological 
impairment in women who binge eat, regardless of a diagnosis or bulimia nervosa or binge 
eating disorder.  The binge eating participants on average performed at a level that would 
be expected of healthy women with similar demographic characteristics including 
educational level.  This result suggests that if neuropsychological changes/impairments are 
present in individuals with binge eating they are likely to be small and would seem 
unlikely to adversely affect the general functioning of those with binge eating.  This is in 
contrast to some previous studies which have reported impairment in neuropsychological 
function in binge eating but is in agreement with other studies which have found 
neuropsychological functioning to be comparable to healthy control groups.   
 Depression and anxiety will be associated with poorer neuropsychological 




Although depression and anxiety might be expected to negatively affect 
neuropsychological functioning in the binge eating groups, the current study did not find 
this pattern.  A substantial proportion of the sample (29% with bulimia nervosa and 24% 
with binge eating disorder) met criteria for a major depressive episode in the past month 
using the SCID-1.   However, no measurement of mood was made at the time of 
neuropsychological testing and this should be included in future studies.  Similarly state 
anxiety was also not measured at the time of testing and again should be included at the 
time of testing as a way of looking at state anxiety rather than a clinical diagnosis of an 
anxiety disorder. 
 The severity of eating disorder symptoms will be associated with poorer 
neuropsychological test performance in women with binge eating. 
The current study did not show consistently support this hypothesis. There was a wide 
range in duration of illness with the average duration of longer than 10 years which could 
be assumed to be long enough to affect functioning.   Despite this, duration of illness was 
not associated with poorer performance once the effect of age had been taken into account.  
Illness severity was also found not to be associated with poorer neuropsychological 
functioning.  This is a surprising result as the relationship has been reported in previous 
studies in women with binge eating (Roberts et al. 2013).  The Eating Disorders Inventory-
2 (EDI-2) was used to assess illness severity in the current study.  This measure focuses on 
eating disorder behaviours and cognitions which are self-reported.  In their study, Roberts 
et al. (2013) used the clinician administered SCID-I as a measure of eating disorder illness 
severity.   It would be useful to consider other ways of measuring illness severity other 
than a self-report measure such as clinician-rated methods.  Consideration of biological 




that measure nutritional status.  For example, the impact of glucose availability and 
vitamin levels may be worthy of future exploration in the binge eating population.   
As with any study, there are strengths and weakness in the current study that need to be 
considered with regard to investigating neuropsychological functioning.  It is possible that 
the CANTAB computerised neuropsychological test battery used in the current study may 
not have been of sufficient difficulty to detect differences in neuropsychological 
functioning in women with binge eating compared with healthy controls; however, the 
same battery has been used to demonstrate impairment in neuropsychological functioning 
in individuals with other mental health diagnoses such as depression and social phobia, 
some of which have been carried out within the same research unit as the current study 
(Bourke et al., 2012) as well as mild cognitive impairment in brain injury and dementia 
(Robbins et al., 1994).  Even if more challenging tests were to demonstrate such 
differences in neuropsychological functioning in individuals with binge eating, it is 
uncertain whether differences would be an important factor affecting overall functioning in 
individuals with binge eating.  Further research into the very few statistically significant 
differences (of very small magnitude) found here is necessary to determine their 
replicability and if replicated, the real life significance of such subtle differences on life 
functioning in this group. 
There is also a lack of consistency in the neuropsychological domains have been tested 
with a focus recently on set-shifting and decision-making but there is a lack of consensus 
around the assessment of some of the more basic executive functions, particularly learning 
and memory. This is in contrast to some other mental health disorders which have 
established protocols to examine neuropsychological functioning, for example in 




attempt to standardise neuropsychological testing in anorexia nervosa with the 
development and testing of the Ravello Profile test battery (Rose et al., 2011; Stedal et al., 
2012).  The development of a test battery specific to binge eating may be a useful approach 
to standardise testing in this area to be able to directly compare studies in order to get a 
more cohesive understanding of the neuropsychological profile in this group. 
It should also be noted that the difficulty in publishing null results may also have skewed 
the published studies towards those that have found differences.  This highlights the 
importance of publication of null results and the contribution that the current study can 
make towards a fuller picture of neuropsychological function in binge eating.   
The strengths of this section of the current study include the emphasis given to assess 
diagnostic categories by using structured clinical interviews and peer review before 
confirmation of final categorisation.  The use of a computerised battery is a strength as it 
improves accuracy, particularly in timed tests and provides confidence that the assessment 
has been administered in a consistent way across participants.  The lack of sufficient 
samples sizes has plagued many of the published studies in the binge eating literature; 
however, in the current study group sizes were of sufficient size to be able to detect 
differences among the groups.   
The neuropsychological results from the current study support a transdiagnostic approach 
in that as a group, there does not seem to be significant neuropsychological differences 
between women with bulimia nervosa and those with binge eating disorder. Although as a 
group there were no strong patterns of neuropsychological changes or impairment in 
women with binge eating, some individual participants did show lower neuropsychological 
functioning. Identification and greater examination of subgroups with impairment is 




to retain normal functioning. This highlights the importance of understanding individual 
differences when formulating treatments rather than a one-size-fits-all approach based 
solely on diagnostic category.   
Overall the results from the current study have contributed to increased understanding of 
binge eating.  Neuropsychological functioning may not be an important factor in 
differentiating individuals with binge eating from healthy individuals without binge eating.  
This finding does not support the use of cognitive remediation as a broad treatment 
approach, other than possibly for those with a history of anorexia or who are exhibiting 
clear impairments in specific domains such as set-shifting and decision-making.   
However, exploration of negative attention bias may be useful to explore further in binge 
eating, and may be particularly relevant for treatment strategies which use cognitive 
techniques such as CBT-E.  
 Ghrelin levels will be altered in women with binge eating compared to women 
who do not binge eat. 
Results from the current study suggest that ghrelin secretion is blunted in women with 
binge eating and this is partially explained by higher levels of body fat.  Reduction in 
ghrelin may be associated with insulin regulation, resulting in elevated insulin and lower 
blood glucose levels in women with binge eating. The current study has also highlighted 
the importance of measuring both acyl ghrelin and des-acyl ghrelin as the ratio of these 
two forms of ghrelin may be important in understanding changes in ghrelin which are 
associated with eating disorder behaviours such as vomiting.   
High weight appears to be the most significant factor in the current study that may 




reduced ghrelin levels.  Frequency of bingeing was not associated with ghrelin secretion in 
any group but vomiting frequency was associated with increased ghrelin in the bulimia 
binge purge group.  Activities that negatively affect energy balance such as vomiting and 
excessive exercise appear to be associated with higher ghrelin levels in women with binge 
eating.  This is consistent with the mechanism of ghrelin in driving appetite to ensure 
organisms gets sufficient food. 
Alterations in ghrelin secretion may have significant implications for the long term health 
of women with binge eating.  The current study suggests that lower ghrelin levels are 
associated with higher insulin levels and increased insulin resistance.  This would increase 
the probability of the development type 2 diabetes, particularly in those of high weight.   
The pattern of lower ghrelin levels in women who binge eat is potentially a mechanism to 
reduce food consumption which is being over ridden possibly by psychological 
mechanisms such as those in Fairburn’s theory of binge eating that emphasises the role of 
cognitions around food and body as well as difficulties with emotion regulation.  
 Higher ghrelin levels will have a positive association on some aspects of 
neuropsychological functioning, particularly an improvement in memory, 
whereas lower ghrelin levels will be negatively associated with 
neuropsychological performance in these area.   
Despite evidence of neuropsychological changes in animals with respect to ghrelin levels, 
this finding was not replicated in the current study in humans.  Although ghrelin levels 
were lower in women with binge eating no significant association was found between 
ghrelin levels and neuropsychological functioning.  This result could have been influenced 




already discussed the above sections.  The ecological validity of the tests being selected is 
an important consideration and it is possible that the tests in the neuropsychological battery 
did not tap into the neuropsychological domains used when in a state of hunger or food 
seeking. Selecting neuropsychological tests that have been modified with eating disorder 
salient stimuli, such as those that are food and body related, may also be more powerful in 
examining neuropsychological functioning in individuals with binge eating. 
The current study did not involve manipulation of ghrelin levels and did not measure 
ghrelin levels during neuropsychological testing.  An experimental design which 
manipulates ghrelin levels may be necessary in order to explore this potential association 
more fully, for example, comparing neuropsychological functioning during low and high 
ghrelin conditions.  The addition of a group of women with anorexia nervosa would also 
be a valuable addition to a study of this kind to be able to cover the range of disordered 
eating as ghrelin levels are known to be elevated in this group (Germain et al. 2007; 
Tanaka et al. 2003).    
The finding that ghrelin is blunted in binge eating suggests that normalising eating patterns 
in women who binge eat in order to restore normal ghrelin secretion could be an important 
part of treatment.  Treatment trials are needed to further examine whether and how quickly 
ghrelin secretion returns to normal patterns on successful treatment of binge eating.  The 
more that is known about the impact of binge eating, the more likely it is that treatments 
can be designed to meet individual specific characteristics in order to improve the lives of 
those who do not currently recover using established treatments.  
It remains unclear whether a transdiagnostic approach is appropriate when considering 
ghrelin secretion as there were significant differences found between those with bulimia 




transdiagnostic psychological treatment approach, the transdiagnostic model may have 
limited applicability in relation to consideration of biological differences given the 
differences found between bulimia nervosa and binge eating disorder were related to 
higher weight in binge eating disorder. There is a need to adapt treatments to take into 
account the extra biological risk factors for those with binge eating disorder. 
This area of research is at a very early stage in the eating disorders field and future studies 
need to be carefully designed to take into account the many potential confounding 
variables which could affect ghrelin secretion. 
In conclusion, although the results of the current study suggest that targeting 
neuropsychological functioning may be unlikely to significantly benefit this group, it is 
clear that carefully designed research is needed to be able to understand the influence of 







































 Test #    
 
Current GAF Score  
 
Code 
91-100-------Superior functioning in a wide range of activities, life’s problems never 
seem to get out of  hand, is sought out by others because of his or her many positive 
qualities. No symptoms. 
81-90--------Absent or minimal symptoms (e.g., mild anxiety before an exam),good 
functioning in all areas,  interested and involved in a wide range of activities, 
socially effective, generally satisfied with  life, no more than everyday problems or 
concerns (e.g., an occasional argument with family  members) 
71-80--------If symptoms are present, they are transient and expectable reactions to 
psychosocial stressors  (e.g.,  some occasional urge to binge or some 
occasional thoughts of dissatisfaction with body                  size\weight but no 
preoccupation, difficulty concentrating after family argument); no more than 
slight       impairment in social, occupational, or school functioning (e.g., 
temporarily falling behind in schoolwork). 
61-70--------Some mild symptoms (e.g., occasional bingeing and/or regular compensatory 
behaviour (restriction/exercise/purging), depressed mood and mild insomnia) OR 
some difficulty in social,  occupational, or school functioning (e.g., 
occasional truancy or theft within the household), but generally functioning 
pretty well, has some meaningful interpersonal relationships. 
51-60--------Moderate symptoms (e.g., regular bingeing and/or regular compensatory 
behaviour     (restriction/exercise/purging), flat affect and circumstantial speech, 
occasional panic attacks) OR moderate difficulty in social, occupational, or 
school functioning (e.g., few friends, conflicts with peers or co-workers). 
41-50--------Serious symptoms (e.g., frequent bingeing and/or frequent or severe 
compensatory behaviour, suicidal ideation, severe obsessional rituals,-frequent 
shoplifting) OR any serious impairment in social, occupational, or school 
functioning (e.g., no friends, unable to keep a job). 
31-40--------Some impairment in reality testing or communication (e.g., Meets full 
criteria for Anorexia  Nervosa-preoccupation’s or rituals interfere with functioning, 
speech at times is illogical, obscure, or  irrelevant) OR major impairment in several 




depressed man avoids friends, neglects family, and is unable to  work; child frequently 
beats up younger children, is defiant at home, and is failing at school). 
21-30---------Behaviour is considerably influenced by delusions or hallucinations OR 
serious impairment  in communication or judgement (e.g., sometimes incoherent, acts 
grossly inappropriately, suicidal  preoccupation) OR inability to function in almost 
all areas (e.g., stays in bed all day; no job, home  or friends). 
11-20---------Some danger of hurting self or others (e.g., suicide attempts without clear 
expectation of death;  frequently violent; manic excitement) OR occasionally fails to 
maintain minimal personal hygiene  (e.g., smears faeces) OR gross impairment 
in communication (e.g., largely incoherent or mute). 
 1-10----------Persistent danger of severely hurting self or others (e.g., complete non 
compliance with  treatment, recurrent violence) OR persistent inability to maintain 
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